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 I 
Abstract 
 
The role of the alternative NF-κB pathway in the development of secondary 
lymphoid organs (SLOs) has been well described. Tertiary lymphoid organs (TLOs) 
include intestinal cryptopatches (CPs) and isolated lymphoid follicles (ILFs). This 
thesis investigates the role of the alternative NF-κB pathway in the development of 
colonic ILFs, using the p100Δ mouse model, where the alternative pathway is 
constitutively active. We present compelling data that p100Δ mice develop 
significantly more lymphoid aggregates in the colon, compared with WT littermates, 
and provide several lines of evidence showing that these aggregates are analogous to 
ILFs. Additionally, we demonstrate that in the p100Δ a significant increase in the 
numbers of B and T cells, and DCs in the colon and show alterations in the subsets of 
colonic T cells and DCs. We also present evidence that constitutively active NF-κB2 
p100 in LTα deficient mice induces recovery of B and T cell segregation in the spleen. 
Most strikingly, we show recovery of iLNs and mLN development in one of five 
p100ΔLTα-/- mice generated.  
These findings demonstrate that the alternative NF-κB pathway plays an 
important role in not only SLO development and splenic organisation, but also in the 
development of TLOs, specifically colonic ILFs. 
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 2 
1. General Introduction 
1.1. The Immune System 
The immune system consists of specialised cells and tissues, which 
collectively, orchestrate defence mechanisms to fight against invading pathogens. The 
two main effector arms of the immune system are the innate and adaptive immune 
responses. 
The innate immune system initiates a non-specific, rapid response to invading 
pathogens. The cellular compartment of the innate immune system includes cells 
capable of endocytosing foreign macromolecules, as well as those able to 
phagocytose whole micro-organisms, these cells include blood monocytes, 
neutrophils, macrophages and dendritic cells (DCs). The innate immune system is 
described in more detail in Section 1.7. 
1.2. The Adaptive Immune System 
The adaptive immune system involves mounting a specific response to 
targeted antigens. The main characteristics of adaptive immunity are the ability to 
recognise self and non-self, the development of antigenic specificity, the 
identification of a diverse range of foreign antigens and the ability to generate 
immunological memory. These responses occur within various lymphoid tissues, 
which are highly organised and tightly regulated. There are three main types of 
lymphoid tissue: primary, including the bone marrow and thymus, secondary, 
including the spleen, lymph nodes and Peyer’s patches (PPs) (Figure 1.1) and tertiary, 
including cryptopatches (CPs) and isolated lymphoid follicles (ILFs). 
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The effector cells of the adaptive immune system include B and T 
lymphocytes, both requiring activation in order to initiate an immune response. 
Activation of naïve B cells occurs following antigen interaction in response to two 
main types of antigens: thymus-independent (TI) antigens, and thymus-dependent 
(TD) antigens. TI antigens include LPS and flagellin, and most TI antigens act as 
polyclonal B cells activators; activating B cells regardless of antigen specificity and 
requiring no direct help from T cells. Conversely, B cell responses to TD antigens 
require direct contact with T helper cells and in this situation activated B cells are able 
to differentiate into plasma cells, capable of producing immunoglobulins, or into 
memory B cells. The humoral response of B cells differs depending on the type of 
antigen encountered and memory B cells are only generated following interaction 
with TD antigens. 
T cells are activated occurs following T cell receptor (TCR) engagement by 
major histocompatibility complex (MHC) molecules presenting antigenic peptide. 
Antigen presenting cells (APCs), such as DCs, macrophages and B cells, are able to 
process antigen and present the associated peptides on surface MHC. Activation of T 
cells induces clonal proliferation and differentiation into either effector or memory T 
cells. Effector T cell subsets include: CD4+ T helper (TH) cells and CD8+ cytotoxic T 
cells (CTL). CD4+ TH cells can be subdivided into several populations: TH1, TH2, 
TH17 (Dong, 2008), inducible T regulatory (Treg) cells (Wing et al., 2006) and T 
follicular helper (Tfh) cells (Vinuesa et al., 2005; Linterman and Vinuesa, 2010). The 
effector cell subpopulations TH1, TH2 and TH17 can be characterised based on their 
differing cytokine production profile and subsequent function (Table 1.1). Memory T 
cells are generated during the initial response to a newly encountered antigen and 
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reside in the body in a quiescent state, ready to induce effector functions if the same 
antigen is encountered a second time. 
 
Effector Immune Response 
TH1 TH2 TH17 
Activation of 
macrophages. 
Production of IgG2a. 
Inflammatory response. 
Activation of 
eosinophils. 
Production of IgM and 
IgE 
Allergic response. 
Induction of neutrophil 
and macrophage 
recruitment. Involved in 
autoimmune and 
inflammatory diseases. 
IFNγ IL-4 IL-17A/ IL-17E 
TNFβ IL-5 IL-21 
IL-2 IL-10 IL-22 
 IL-13  
 
Table 1.1 Overview of TH1 and TH2 immune responses. 
 
1.3. Primary Lymphoid Organs 
Haematopoiesis of immature lymphocytes occurs in the primary lymphoid 
organs, which includes the bone marrow (BM) and thymus. The BM is the major site 
for B cell development, where an intricate network of stromal cells release cytokines 
required for their development. T cell development occurs in the thymus, where a 
tightly organised microarchitecture allows for migration of thymocytes to specific 
areas where they undergo positive selection; a protective survival signal is received 
by the thymocyte if it is able to bind MHC molecules expressed on cortical epithelial 
cells, and negative selection; thymocytes with high affinity receptors for MHC 
molecules bearing self antigen undergo apoptosis. The generation of TCRs is a 
random process and selection in the thymus allows development of T cells 
recognising self and deletion of potentially autoreactive T cells. 
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1.4. Secondary Lymphoid Organs 
The initiation and maintenance of adaptive immune responses occurs in the 
highly specialised and strictly organised SLOs: spleen, LNs and PPs. The spleen and 
LNs are key sites for initiation of adaptive immune responses, providing a micro-
environment where lymphocyte contact with trapped antigens and APCs is optimised. 
To complement this, LNs are located at specific positions along the lymphatic 
vasculature, at sites where their exposure to draining lymph fluid from associated 
tissues is maximised (Figure 1.1). 
 
1.4.1. Structure and Function 
1.4.1.1. Structure of the Lymph Node  
The lymph node can be divided into three main structural regions, i) the 
cortex, ii) the paracortex and iii) the medulla (Figure 1.2. A). The cortex is the outer 
most region of the LN and consists of mainly B lymphocytes, macrophages and 
follicular dendritic cells (FDCs), arranged into primary follicles. The paracortex is 
located beneath the cortex and is the site for T lymphocyte interaction with 
interdigitating DCs. Circulating lymphocytes enter the LN in this region via high 
endothelial venules (HEVs). The innermost layer, the medulla, is more sparsely 
populated with lymphoid cells, including antibody producing plasma cells. 
The main stromal cells generating the three-dimensional structure the LN are 
fibroblastic reticular cells (FRCs), within the paracortex, and FDCs, within the B cell 
follicles. These stromal cells are involved in cellular organisation by the production of 
lymphocyte homing chemokines, and provide the conduit system along which 
lymphocytes are able to traffic (Bajénoff et al., 2006). 
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Figure 1.1 Position of lymph nodes in the body  
 
The lymph nodes (LNs) are located at strategic sites in the body, along the lymphatic 
vasculature. This enables them to perform their function of filtration of lymph fluid, 
sequestration of antigen and antigen-presenting cells (APCs), and provision of a 
specialised micro-environment maximising APC-lymphocyte interaction and initiation 
of an effective immune response. 
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1.4.1.2. Structure of the Spleen 
The spleen consists of two functionally distinct regions, the red and white pulp 
areas. The red pulp area is the location of blood filtration, sequestration of dead and 
damaged red blood cells and subsequent iron recycling. In addition, long-lived plasma 
cells and macrophages are located in the red pulp (MacLennan et al., 2003). The 
white pulp is the lymphoid area of the spleen and is the site for mounting innate and 
adaptive immune responses. The white pulp has a highly organised structure 
specialised to optimise antigen and APC retrieval from the blood and to promote cell-
cell interactions critical for immune responses. The organisation and maintenance of 
splenic structure is dependent on the expression of specific chemokines from 
specialised stromal cells. 
Chemokines are a superfamily of molecules involved in recruitment and 
trafficking of leukocytes. There are several groups, distinguished by the position of 
conserved cysteine residues. The two groups of interest for this thesis are those 
designated CXC, where one amino acid residue sits between the two cysteine 
residues, e.g. CXCL13, and the group designated the CC chemokines, with no amino 
acid located between the two cysteine residues, e.g. CCL19. All chemokines elicit 
their effects through seven transmembrane G-protein coupled receptors. These 
receptors can be promiscuous in their chemokine ligands (Table 1.2). 
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Table 1.2 Overview of chemokines of interest and their respective receptors. 
 
 
Several chemokines have been shown to be crucial in secondary lymphoid 
tissue microarchitecture. Within the spleen, specialised cells in the T-zone express 
CCL19/21 (T-zone stromal cells and DCs (Luther et al., 2000)), allowing localisation 
of T cells and DCs, and Gp38/Podoplanin, a transmembrane mucin-type protein. 
Expression of CXCL13 in the B cell area by stromal cells and FDCs (Ansel et al., 
2000), allows for the migration of B cells to the follicles (Förster et al., 1999; Cyster 
et al., 1999). The expression of these chemokines, and others, creates the unique 
organisation of the white pulp into discrete B and T cell areas (Figure 1.2. B). Mice 
deficient in CXCL13, or its receptor CXCR5, maintain B/T cell segregation but lack 
primary B cell follicles, and GCs form in aberrant locations (Ansel et al., 2000; 
Förster et al., 1996). A spontaneous mutation in plt/plt mice results in non-functional 
CCL19 and CCL21, in these mice T cells fail to migrate into the spleen due to lack of 
expression of these chemokines, resulting in a disrupted splenic microarchitecture 
(Nakano et al., 1998). Furthermore, Ccr7-/- mice present with disorganised splenic 
 Chemokine Expression Receptor Expression 
CCL19 
CCL21 
T-zone reticular 
cells (spleen) CCR7 
T cells, mature 
DCs 
CCL20 Intestinal epithelium CCR6 
B cells, T cells, 
mature DCs 
CCL25 S.I epithelium CCR9 T cells 
CCL 
Chemokines 
CCL28 Colonic epithelium 
CCR3/ 
CCR10 T cells 
CXCL 
Chemokines CXCL13 FDCs CXCR5 
Naïve B cells, 
follicular TH cells 
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architecture, with random distribution of T cells and little evidence of discernable T 
cell areas, however, GCs were able to form in these mice (Förster et al., 1999) (Table 
1.3). 
Therefore, the white pulp is organised into specific compartments: the T zone, 
arranged around the central arteriole; the B cell area, surrounding the T zone and 
arranged into primary follicles, and finally, the marginal zone (MZ) that encapsulates 
the whole structure. The MZ is made up of specialised macrophages and B cells. The 
MZ macrophages express MARCO and are necessary for the recruitment and 
retention of MZ B cells (Karlsson et al., 2003). MZ B cells express alphaLbeta7 
(αLβ7) and alpha4beta1 (α4β1), allowing them to localise to the MZ by interaction 
with the ligands ICAM-1 and VCAM-1, respectively (Lu and Cyster, 2002). 
Positioned beneath the MZ is the marginal sinus, which is lined by a single layer of 
MAdCAM-1+ sinus-lining cells and located underneath is a layer of MZ metallophilic 
macrophages (MMMs) expressing CD169 (Mebius and Kraal, 2005). 
Splenic microarchitecture is tightly regulated and highly organised and this 
signifies the importance of this architecture in the development of adaptive immune 
responses. Orchestration of cells of the immune system in order to maximise cellular 
contact and proximity is crucial for enhancing cellular interaction and subsequent 
immune responses. 
Expression of CXCL13, CCL19 and CCL21 is under the control of 
Lymphotoxin (LT) and tumour necrosis factor alpha (TNFα)ADDIN 
BEC{Ngo, 1999, π07635}(, 1999, π07635Νγο ετ αλ., 1999 and expression of 
Gp38/Podoplanin is dependent on LTβR signalling (Ngo et al., 2001) via expression 
of LT on LTi cells and provision of additional alternative signals from lymphocytes 
(Withers et al., 2007). LT and TNFα are structurally related members of the TNF 
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superfamily. Lymphotoxin alpha (LTα) forms a membrane bound heterotrimeric 
complex with Lymphotoxin beta (LTβ), LTα1β2 and the corresponding receptor is the 
Lymphotoxin beta receptor (LTβR). In mice lacking either LTα or LTβ, chemokine 
levels are significantly reduced, leading to disrupted organisation of splenic white 
pulp, with little segregation of B and T zones (Ngo et al., 1999; Alimzhanov et al., 
1997; Alexopoulou et al., 1998; Kuprash et al., 2002). Interestingly, Tnfα-/- mice 
demonstrate normal B/T cell segregation in the spleen, but with reduced expression of 
CXCL13, CCL19/21, albeit at less severely reduced levels than that seen in Ltα-/- or 
Ltβ-/- mice (Kuprash et al., 2002; Neumann et al., 1996; Ngo et al., 1999) (Table 1.3). 
The maintenance of lymphoid tissue architecture is dependent on continued 
expression of LT and TNF. Indeed, the expression of CXCL13 by splenic stromal 
cells and the maintenance of FDCs in the B cell follicle, are dependent on LT and 
TNF expression by mature B cells (Endres et al., 1999; Fu et al., 1997). Additionally, 
the expression of peripheral node addressin (PNAd) and mucosal addressin cell 
adhesion molecule -1 (MAdCAM-1) by HEVs of the LN, and the marginal sinus of 
the spleen, are dependent on LT signalling (Rennert et al., 1998; Browning et al., 
2005). Interestingly, in mice with a specific lack of LTβ expression on B cells, normal 
chemokine production, FDC differentiation and B cell follicle formation occurs 
(Tumanov et al., 2002; Tumanov et al., 2004), suggesting that LT expression by T 
cells is sufficient to induce/maintain these events. In addition to the maintenance of 
lymphoid tissue architecture, LT also plays a key role in homeostasis of DC 
populations (See Section 1.8.3). 
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1.4.1.3. Spleen and Lymph Node Function 
There are many similarities in function and orchestration of immune responses 
in the spleen and LN. Both organs are responsible for sequestration of antigens and 
APCs and the structure, as already described, is arranged in such a way as to 
maximise presentation of these molecules and cells to B and T lymphocytes, thereby 
eliciting an immune response. 
The LNs are responsible for filtering lymph fluid that has drained from 
peripheral tissue and free antigen and antigen-bearing DCs are trapped ready for 
recognition by naïve T cells. Circulating naïve T cells travel through the blood to 
lymphoid tissues in search of their cognate antigen. They express receptors for cell 
adhesion molecules and chemokine receptors, such as Integrin α4β7 and CCR7, which 
allow them to enter the paracortex of the LN via HEVs, expressing MAdCAM-1 
(ligand for Integrin α4β7) (Berlin et al., 1993), and to home to T cell areas within the 
LN, which express CCL19/21 (ligands for CCR7) (Cuff et al., 1999). It is within the 
paracortex that naïve T cells encounter resident DCs presenting soluble antigen 
collected from the lymph fluid. Activation of naïve T cells results in the maturation of 
TH cells and these effector cells exit the LN via the efferent lymph (Masopust et al., 
2001; Iezzi et al., 2001). A unique subset of T cells remain and express CXCR5, the 
receptor for the B cell homing chemokine CXCL13, that is expressed in the cortical B 
cell areas of the LN, thus allowing migration to the primary B cell follicles in the 
cortex (Schaerli et al., 2001; Moser et al., 2002). These cells are termed T follicular 
helper cells (Tfh cells) and are able to promote terminal B cell differentiation and are 
critical for humoral immunity (Linterman and Vinuesa, 2010). 
One of the key differences between spleen and LN function is the manner in 
which cells enter the organs. In the spleen, cells and antigens enter via the blood and 
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infiltrate through the marginal zone before leaving via the afferent splenic artery. 
Whereas, in the LN cells enter carried by lymph fluid, which enters the LN via 
multiple afferent lymphatics and permeates through the LN before leaving via the 
efferent lymphatic vessel. Naïve B and T cells are able to enter the LN through 
numerous HEVs, located in the paracortex, in a chemokine dependent manner 
(Mebius and Kraal, 2005; Crivellato et al., 2004). 
 
1.4.2. Structure and Function of Peyer’s Patches 
1.4.2.1. Structure 
Peyer’s Patches (PPs) are organised lymphoid structures located along the 
anti-mesenteric border of the small intestine. PPs contain multiple, distinct large B 
cell follicles, with germinal centres and intervening T cell areas arranged within a 
reticular connective tissue network (Azzali, 2003) (Figure 1.2. C). This structure is 
separated from the intestinal lumen by follicle-associated epithelial cells (FAE), 
within the FAE, specialised microfold (M) cells can be found (Mowat, 2003). M cells 
are specialised enterocytes, lacking microvilli, capable of sampling antigens and 
invasive bacteria from the intestinal lumen (Kraehenbuhl and Neutra, 2000; Pabst et 
al., 2007). Beneath the FAE is the subepithelial dome, stromal cells in this area 
express VCAM-1 and selectively express receptor activator of nuclear factor-κB 
ligand (RANKL) (Taylor et al., 2007). VCAM-1 is expressed by activated endothelial 
cells and is involved in lymphocyte adhesion via it’s ligand α4β1 (also known as very 
late antigen-4, VLA-4) (Osborn et al., 1989; Chen et al., 1999). RANKL is a member 
of the TNF family that plays a major role in osteoclast differentiation and LN 
 13 
development, and is also expressed by activated T cells promoting the survival and 
cytokine production of DCs (Wong et al., 1999; Josien et al., 1999; Blair et al., 2007). 
 
1.4.3. Function 
PPs are an important site for the production of specific IgA antibodies. The M 
cells provide a window for antigen sampling and uptake, allowing for presentation by 
APCs. M cells lack MHCII expression and are therefore unlikely to act as APCs 
(Mowat, 2003). The functional significance of M cells has been demonstrated by 
Knoop, et al, where they revealed a severe reduction or total lack of M cells in the 
PPs of Rankl-/- mice and showed that uptake of immunofluorescent beads from the 
intestinal lumen was reduced. Treatment of Rankl-/-mice with exogenous RANKL 
restored M cells, and immunofluorescent bead uptake. Additionally, PP germinal 
centre formation and faecal IgA production in Rankl-/- mice was reduced compared 
with WT controls (Knoop et al., 2009). This indicates that M cells play a crucial role 
in the uptake of antigens and bacteria from the intestinal lumen and differentiation of 
M cells is dependent on RANKL. 
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Figure 1.2 Secondary and tertiary lymphoid tissue structures 
 
A. Structure of the lymph node (LN). Lymph fluid enters the LN via afferent 
lymphatics and leaves via the efferent lymphatics. The innermost region of the LN is 
the medulla, moving outwards to the paracortex, the location of T cells, recruited by 
CCL21 expression by resident stromal cells, and high endothelial venules (HEVs). 
The outermost region is the cortex, consisting of B cell follicles and CXCL13 
expressing follicular DCs (FDCs). Surrounding these areas is the subcapsular sinus. 
 
B. Structure of the spleen. Blood enters the white pulp of the spleen via the 
MAdCAM-1+ marginal zone, which is inhabited by specialised marginal zone B cells. 
Below this structure is the marginal sinus. The central area of the spleen is the T 
zone, containing stromal cells expressing CCL19/21, required for recruitment and 
retention of T cells. Central arterioles are located in the T zone. B-cell follicles are 
located around the T zone and FDCs in this area express CXCL13, as in the LN. 
 
C. Structure of cryptopatches (CPs), isolated lymphoid follicles (ILFs) and Peyer’s 
patches (PPs). CPs and ILFs are located in the small intestine and colon, PPs are 
located in the small intestine only. CPs consist of a cluster of LTi-like cells and DCs. 
CPs develop into ILFs following the recruitment of B cells. ILFs are made up of a 
central cluster of B cells, surrounded by DCs and interspersed with T cells. PPs have 
a structure similar to that of LNs, with a T zone, containing HEVs, surrounded by B 
cell follicles. The follicle-associated epithelium (FAE) is situated above the PP and 
contains specialised epithelial cells termed M-cells. 
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 Splenic architecture 
 Mouse 
model 
B/T cell 
segregation 
B cell follicles/ 
GCs 
Chemokine 
expression Refs 
Ltα-/-    CXCL13 
 CCL19/21 
(Kuprash et al., 2002; 
Banks et al., 1995; 
Alexopoulou et al., 1998; 
Matsumoto et al., 1997) 
Ltβ-/- ∗  
 CXCL13 
 CCL21 
 CCL19* 
(Alimzhanov et al., 1997; 
Alexopoulou et al., 1998; 
Kuprash et al., 2002; Ngo 
et al., 1999) 
LtβR-/-   - (Fütterer et al., 1998) 
Tnf-/-   B follicles  CXCL13 
 CCL19/21$ 
(Kuprash et al., 2002; Ngo 
et al., 1999) 
Tnfr-/-   B follicles 
 GC**  
 CXCL13 
 CCL19/21$ 
(Neumann et al., 1996; Ngo 
et al., 1999) 
Rankl-/-  +/- B follicles 
 GC - 
(Kim et al., 2000) 
TN
F 
&
 T
N
FR
 su
pe
rf
am
ily
 
Rank-/-   - (Dougall et al., 1999) 
Nfkb2-/-    
 CXCL13 
 CCL21 
 CCL19 
(Franzoso et al., 1998; 
Caamaño et al., 1998) 
p100Δ   
 CXCL13 
 CCL21 
 CCL19 
(Guo et al., 2007; Ishikawa 
et al., 1997) 
Rela-/-
TnfrI-/-   - 
(Alcamo et al., 2002) 
c-rel-/-   - (Weih and Caamaño, 2003) 
Relb-/-   - (Weih and Caamaño, 2003) 
Ikkα-/- $$  B follicles
$$ 
 GC$$ 
 CXCL13 
 CCL21 
 CCL19 
(Dejardin et al., 2002; 
Kaisho et al., 2001a) N
F-
κB
 c
om
po
ne
nt
s 
aly/aly   - 
(Weih and Caamaño, 2003; 
Karrer et al., 2000; 
Miyawaki et al., 1994; 
Koike et al., 1996) 
Cxcl13-/-   B follicles 
 GC**  CXCL13 
(Ansel et al., 2000) 
Cxcr5-/-   B follicles 
 GC** 
 CXCL13 (Förster et al., 1996) 
Plt/plt ££  B follicles  CCL21 
 CCL19 
(Nakano et al., 1998; 
Luther et al., 2000) 
C
he
m
ok
in
es
 &
 
re
ce
pt
or
s 
Ccr7-/- £  B follicles 
 GC£ - 
(Förster et al., 1999) 
 
Table 1.3 Overview of splenic architecture in various mouse models. 
* The segregation of B/T cells in the spleen of Ltβ-/- mice is more pronounced than in 
Ltα-/- but not equivalent to WT. CCL19 mRNA expression slightly increased in Ltβ-/- 
mice compared with Ltα-/-, may contribute to more discrete B/T cell areas. 
$ Splenic CCL19/21 mRNA in Tnf-/- and TnfrI-/-, not reduced as much as Ltα-/- mice. 
** Aberrant location of GC formation in TnfrI-/-, Cxcl13-/- and Cxcr5-/- mice. 
$$ BM chimeras, Rag2-/- host.  
£ Ccr7-/- mice exhibited disorganised spleens, with randomly located T cells and 
aberrantly located B cell follicles and GCs. 
££ Disrupted T cell localisation to white pulp. 
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1.5. Secondary Lymphoid Organ Development 
1.5.1. Lymph Node Development 
Development of SLO occurs during embryogenesis and begins with 
development of the mesenteric LN (mLN), followed by development of the LNs from 
head to tail (Mebius, 2003) (Figure 1.3). LN development proceeds along four main 
stages; i) formation of lymphatic endothelium and differentiation of mesenchymal 
precursors into primed stromal cells, ii) maturation of primed stromal cells into 
lymphoid tissue organiser (LTo) cells, iii) interaction of LTo cells and lymphoid 
tissue inducer (LTi) cells, and iv) recruitment of lymphocytes. 
LTo cells were first identified during the investigation of PP development. At 
embryonic day 15.5 (E15.5), clusters of cells expressing VCAM-1 were identified 
(Adachi et al., 1997) and mice deficient in LTα or IL-7Rα, lacked these structures 
and did not develop PPs (Yoshida et al., 1999; Adachi et al., 1998; Adachi et al., 
1997), indicating that these VCAM-1+ cells were critical to PP development. Various 
studies identified that this population of VCAM-1+ mesenchymal stromal cells also 
expressed ICAM-1, MAdCAM-1, RelB and RANKL, and showed that these cells 
were capable of interacting with LTi cells via expression of LTβR, and following this 
interaction were capable of producing adhesion molecules and chemokines (Adachi et 
al., 1997; Adachi et al., 1998; Yoshida et al., 1999; Hashi et al., 2001; Honda et al., 
2001; Bénézech et al., 2010). Subsequently, LTo cells have been identified in LNs 
and shown to express CXCL13 and CCL19/21, in addition to the markers previously 
described (Cupedo et al., 2004). 
LN development is dependent on the presence of LTi cells. Mebius et al, were 
the first to describe LTi cells, with the following surface marker expression: CD3-
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CD4+LTβ+CXCR5+ (Mebius et al., 1997). Further characterisation of these cells has 
been performed by various studies, demonstrating that LTi cells also express IL-7Rα, 
Integrin α4β7, CCR7, RANK/RANK-L and RORγt (Mebius et al., 1996; Mebius et 
al., 1997; Kim et al., 2000; Dougall et al., 1999) (Table 1.5). Mice lacking LTi cells, 
such as Rorγ-/- mice, fail to develop any peripheral LNs (Kurebayashi et al., 2000). 
 
LTo LTi 
VCAM-1
high
 CD3
-
CD4
+
 
ICAM-1
high
 IL-7Rα
+
 
CXCL13 CXCR5
+
 
MAdCAM-1
+
 Integrin α4β7 
LTβR
+
 LTα1β2 
CCL19/21 CCR7 
RANK-L
high
 RANK/RANK-L 
 
Table 1.4 Surface markers identifying lymphoid tissue inducer (LTi) cells 
and lymphoid tissue organiser (LTo) cells. 
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Figure 1.3 Ontogeny of lymphoid tissue development 
 
Diagram depicting the timing of lymphoid tissue development during embryogenesis. 
The mesenteric lymph node (mLN) is the first to develop, with the inguinal LN 
developing around E16. The PPs develop around E17. 
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Figure 1.4 Lymph node development 
 
LN development proceeds along four main stages; (1) Formation of lymphatic 
endothelium and differentiation of mesenchymal precursors into primed stromal cells, 
(2) maturation of primed stromal cells into LTo, (3) interaction of LTo and LTi cells, 
and (4) recruitment of lymphocytes. 
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1.5.1.1. Formation of Lymphatic Endothelium and 
Differentiation of Mesenchymal Precursors into Primed 
Stromal Cells 
The initial stage of LN development is closely linked to that of the lymphatic 
vasculature and the formation of the lymph sac at the site of future LN development. 
It was proposed in 1902, by Sabin, that the lymph sac forms from endothelial cells 
budding from the blood vasculature during embryogenesis253. More recent studies 
have shown that cells expressing specific lymphatic endothelium markers, such as 
VEGFR3 (Kaipainen et al., 1995), Prox-1 (Wigle and Oliver, 1999) and Lyve-1, bud 
from the cardinal vein to form the lymph sac in response to VEGFC signals 
(Karkkainen et al., 2004). Indeed, mice deficient in Prox-1 were not able to develop 
lymph sacs. Interestingly however, they were able to develop primitive LN anlage and 
further work by Vondenhoff et al, indicated that the earliest stages of lymph node 
development did not depend on lymph sac formation (Vondenhoff et al., 2009). 
It has been proposed that mesenchymal precursors, identified as CD45-ICAM-
1-VCAM-1-MAdCAM-1-LTβR+RelB-PDGFRα+, give rise to LN stromal cells in a 
two-step maturation process (Bénézech et al., 2010) (Figure 1.4). The first step 
involves upregulation of ICAM-1 and VCAM-1 expression giving rise to a ‘primed’ 
stromal cell population, described as CD45-ICAM-1intVCAM-1intMAdCAM-1-
LTβR+RelB+PDGFRα+. This step was shown to be independent of LTβR signalling 
and LTi cell presence, as in LtβR-/- mice, and in Rorγ-/- mice lacking LTi cells, this 
population of cells was still present. The second maturation step involves further 
upregulation of ICAM-1 and VCAM-1, and induced expression of MAdCAM-1, 
producing a unique LTo cell population (see below) (Bénézech et al., 2010). 
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1.5.1.2. Maturation of Primed Stromal Cells into LTo Cells 
Benezech et al, proposed a model for LTo cell maturation in LN development, 
whereby following LTβR engagement, ICAM-1intVCAM-1int ‘primed’ stromal cells 
are able to mature into ICAMhiVCAMhi LTo cells (Bénézech et al., 2010). The 
maturation of LTo cells is dependent on LTβR, as LtβR-/- mice lack this cell 
population. The appearance of LTi cells in the inguinal LN between E15-E17 
corresponds with the maturation of LTo cells, indicating that LTi cells are providing 
the lymphotoxin signal crucial for LTo cell maturation (Bénézech et al., 2010) (Figure 
1.4).  
 
1.5.1.3. Interaction of LTo and LTi Cells 
The interaction of LTo and LTi cells is a critical event in LN development. 
Mice lacking LTi cells, such as the Rorγ-/- mice, do not develop LNs (Sun et al., 2000; 
Kurebayashi et al., 2000) and it is the expression of LTα1β2 by LTi cells that is 
essential for crosstalk with LTβR expressing LTo cells. Interestingly, a recent study 
provided evidence that clustering of LTi cells with LTo cells, via LTo cell expression 
of CXCL13, occurred independently of LT and was instead induced by retinoic acid 
(RA) (van de Pavert et al., 2009). In addition to LTα1β2-LTβR signalling between LTi 
and LTo cells, signalling via the RANKL-RANK axis is also crucial for LN 
development (Randall et al., 2008). Mice lacking RANKL, RANK or TRAF-6, the 
critical component of downstream RANK signalling, do not develop LNs (Naito et 
al., 1999; Kong et al., 1999; Kim et al., 2000; Dougall et al., 1999). It has been well 
described that LTi cells express RANK, as well as, RANKL, and that LTo cells 
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express RANKL. The expression of RANKL on LTo cells promotes differentiation 
and survival of LTi cells, whilst also inducing upregulation of LTα1β2 on the surface 
of LTi cells (Yoshida et al., 2002; Cupedo et al., 2004). These steps initiate a positive 
feedback loop, where more LTi cells are recruited to the LN anlage with subsequent 
further stimulation and maturation of LTo cells. This interaction is likely to be 
important for providing LTo cells with sustained signalling through LTβR, potentially 
leading to activation of the NF-κB transcription factors and induction of Nfkb2 and 
Relb transcription, thus resulting in activation of the alternative NF-κB signalling 
pathway. Activation of this pathway leads to expression of high levels of chemokines 
such as CCL19, CCL21 and CXCL13 (Guo et al., 2007). These chemokines are 
responsible for the recruitment of mature lymphocytes to the LN anlagen. (Figure 1.4) 
 
1.5.1.4. Recruitment of Peripheral Lymphocytes 
After sufficient LTo/LTi cell clustering, differentiation of HEVs occurs within 
mesenteric and peripheral LNs, allowing the influx of lymphocytes. Initially, HEVs 
express the cell addressin molecule MAdCAM-1 (Mebius et al., 1996), allowing 
entrance only of cells expressing Integrin α4β7, such as LTi cells and γδ T cells 
(Mebius et al., 1997; Mebius et al., 1998; Yoshida et al., 2001). From postnatal day 
three, MAdCAM-1 expression is downregulated and PNAd expression is upregulated, 
this allows for the entrance of mature B and T lymphocytes (Mebius et al., 1996). The 
recruitment of lymphocytes to the LN anlage and their role in providing a constant 
source of surface LT, enables further differentiation of stromal cells to form 
specialised B and T cell areas. The molecules responsible for the demarcation of B 
and T zones include, CXCL13, CCL19 and CCL21. LTi cells express the receptors 
for these molecules (CXCR5 and CCR7, respectively), with B lymphocytes 
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expressing CXCR5, and T lymphocytes expressing CCR7. The differential expression 
of chemokines by the stromal cells, and of their receptors on B and T lymphocytes, 
allows organisation into specific B and T cell areas within the developing LN. 
Moreover, in order to sustain LN development and organisation postnatally, LN 
stromal cells require stimulation by newly immigrated IL-7Rα+ T and natural killer 
(NK) cells (Coles et al., 2006). 
 
1.5.2. Peyer’s Patch Development 
The formation of PPs follows a sequence of developmental steps similar to LN 
development, but with several key differences. Three main steps have been identified 
by immunohistochemical analysis (Figure 1.5). 
The first step occurs around E15.5 with clustering of VCAM-1+ICAM-1+ LTo 
cells (Adachi et al., 1997; Yoshida et al., 1999), the phenotype of which is reflected in 
a stromal cell population identified in LN development (Cupedo et al., 2004). The 
differentiation of LTo cells from resident stromal cells is promoted by lymphoid 
tissue initiator cells (LTint). LTint are identified as CD4-CD3-IL7Rα-c-kit+CD11c+, 
they express LT and are present in the gut from E15.5, depletion of these cells results 
in a drastic decrease in PP development (Veiga-Fernandes et al., 2007). In addition to 
the interaction of LTint and LTo cells via LTα1β2/LTβR axis, signalling via the 
tyrosine kinase receptor, RET, expressed on LTint, and its ligand, ARTN, expressed 
on LTo cells, is also thought to play a key role in PP anlagen formation. Interestingly, 
in Ret-/- mice, normal numbers of LTint were observed in the gut at E15.5, but were 
unable to form clusters and PP anlage development was blocked, indicating that 
signalling via RET enables migration and aggregation of LTint (Veiga-Fernandes et 
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al., 2007). Importantly, the identification of LTint in LN anlagen has not been 
described to date. 
The second stage of PP development involves the accumulation of LTi cells 
within the LTo cell clusters at around E17.5. LTi cells express Integrin α4β7, allowing 
them to interact with MAdCAM-1 expressing LTo cells, thereby stimulating further 
clustering of the latter (Adachi et al., 1997; Yoshida et al., 1999). In addition, the 
expression of LTα1β2 on LTi cells is upregulated by exposure to IL-7 inducing further 
recruitment of LTi cells to the PP anlagen (Yoshida et al., 2002). A key difference 
between PP and LN development is the requirement for the IL-7/IL-7Rα axis in PP 
development, which is dispensable for LN formation; Il7rα-/- mice lack PPs but do 
develop most LNs (Adachi et al., 1998). This differs from LN development where 
formation depends on RANK-L/RANK expression, not on IL-7 expression. PP 
development occurs independently of RANK-L/RANK expression (Kim et al., 2000; 
Kong et al., 1999). 
The final stage of PP development occurs around E18.5 and involves 
compartmentalisation and recruitment of mature lymphocytes. This proceeds through 
the same mechanism as for LN development; LTi cell signal via LTβR to LTo cells 
and induction of chemokines and cell adhesion molecules ensues, enabling 
recruitment of mature lymphocytes. Initially, at E18.5 aggregates of CD11c+ cells 
(most likely reflecting the LTint population, described by Veiga-Fernandes (Veiga-
Fernandes et al., 2007)) and LTi cells are present, forming the basis of future B cell 
follicles (Hashi et al., 2001). Mature B and T lymphocytes are present in the PP 
anlagen at this stage but are not organised into distinct areas, this begins from 
postnatal day one onwards. The compartmentalisation of the PP anlagen is not 
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dependent on T lymphocytes, as SCID mice, lacking the latter, still exhibit a degree of 
compartmentalisation in the PP anlagen (Hashi et al., 2001). 
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Figure 1.5 Peyer’s patch development 
 
Peyer’s patch development proceeds through three main steps; (1) LTint promotion of 
LTo cell clustering around E15.5, (2) Interaction of LTo and LTi cells around E17.5, 
as seen in LN development, (3) recruitment of mature lymphocytes around E18.5. 
Finally, B and T cells are organised into specific areas from postnatal day one 
onwards. 
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1.6. Tertiary Lymphoid Organs 
Tertiary lymphoid organs (TLOs) differ from SLOs in that they develop 
postnatally and are inducible, and are located predominately at mucosal sites. 
Induction of TLOs can occur under steady-state, inflammatory or autoimmune 
conditions and formation of TLOs can, to a certain extent, be reversible. Of particular 
importance and interest is the development of intestinal tertiary lymphoid tissues, 
which includes cryptopatches (CPs) and isolated lymphoid follicles (ILFs). The 
formation of these structures involves intricate interactions between haematopoietic 
and stromal cell compartments, in much the same way as in LN and PP development.  
 
1.6.1. Isolated Lymphoid Follicle Structure and Function 
1.6.1.1. Structure 
ILFs are located throughout the small intestine and colon, and consist of 
organised clusters of B and T lymphocytes, and DCs (Figure 1.2. C). Hamada et al, 
were the first to identify murine ILFs and defined them as aggregates of B220+ B cells 
present along the mucosa of the intestine. Accompanying the B cells, various other 
cell types were identified including, c-kit+IL7-Rα+ LTi-like cells, CD3+ T cells, and 
CD11c+ DCs (Hamada et al., 2002). The B cells present within ILFs have been 
characterised by several studies, to be predominately B-2 B cells, based on expression 
of CD23 and lack of CD5 (Hamada et al., 2002; Wang et al., 2006; Lorenz et al., 
2003), and display a mature phenotype, co-expressing IgM and IgD (Wang et al., 
2006). Functionally, ILF B cells preferentially differentiate to produce IgA plasma 
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cells, rather than IgG or IgM, and their cytokine profile demonstrates IL-4 and IL-10 
production, differing from that of splenic and PP B cells (Wang et al., 2006). 
Recruitment of B lymphocytes to the gut utilises various chemokines and cell 
adhesion molecules. ILF B cells express Integrin α4β7 and are able to migrate into the 
intestine in response to MAdCAM-1, expressed on vessels associated with ILFs 
(Wang et al., 2008). Indeed, mice lacking β7 failed to develop the normal number of 
intestinal ILFs and the use of blocking antibodies to α4β7 or MAdCAM-1 resulted in 
ablation of B cell aggregation (Wang et al., 2008). Additionally, ILF B cells express 
CCR6 and expression is increased compared with equivalent B cells from the spleen 
(McDonald et al., 2007). CCR6 is the only receptor for CCL20 (Liao et al., 1997); a 
chemokine expressed by colonic epithelium (Tanaka et al., 1999) and is important for 
the localisation of B cells to the intestine and subsequent aggregation into ILFs 
(McDonald et al., 2007; Williams, 2006). 
Stromal cells play a key role in tertiary lymphoid tissue structure and 
organisation and this is highlighted by several studies investigating the ILF stromal 
cell compartment. The accumulation of VCAM-1+ICAM-1+ LTo cells into clusters 
marks the initial stages of LN and PP development, Taylor et al, identified VCAM-1+ 
cells situated in CPs and ILFs, and proposed these cells to reflect the LTo cells seen in 
LN and PP development. Within the intestine, the expression of FDCM1, CD157 
(BP-3) and VCAM-1 by ILF stromal cells, was dependent on functional NIK, thereby 
requiring activation of the alternative NF-κB pathway for their expression. RANKL is 
also expressed, but independently of NIK (Taylor et al., 2007). Additionally, ILF 
stromal cells express CCL20 (McDonald et al., 2007) and VCAM-1, and vessels 
associated with ILFs express MAdCAM-1 and CD31 (Wang et al., 2008). 
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1.6.1.2. Function 
The organised follicular structure of intestinal ILFs and the presence of B cells 
exhibiting preferential class-switching to IgA plasma cells, along with the presence of 
T cells and antigen-presenting DCs alludes to a role as sites for induction of mucosal 
immunity. The function of PPs as important sites of mucosal immunity is well 
understood, however, a study by Yamamoto et al, demonstrated that mice treated in-
utero with antagonistic LTβR-Ig, to ablate PP development, were still able to produce 
Ag-specific intestinal IgA (Yamamoto et al., 2000). Mice treated this way 
demonstrated a significant increase in intestinal ILF formation, in a potentially 
compensatory mechanism for the loss of PP development (Kweon et al., 2005). This 
data suggests that ILFs are able to function as inductive sites for producing Ag-
specific intestinal IgA.  
 
1.6.2. Isolated Lymphoid Follicle Development 
The formation of ILFs is thought to follow developmental steps similar to 
those of LNs and PPs. LTβR signalling during secondary lymphoid tissue 
development revolves around the expression of LTα1β2 on LTi cells. The initial 
clustering of these cells is critical for LN development and it is suggested that this is 
mirrored in ILF development, by the formation of ILF precursor structures termed 
cryptopatches (CPs) (Eberl, 2005) (Figure 1.6). 
CPs owe their name to the location in the intestinal crypt at the base of villi. 
CPs were first described by Kanamori et al, as being composed of clusters of Lin-c-
kit+ lymphoid cells and DCs (Kanamori et al., 1996) and are distinguished from ILFs 
by their lack of B and T cells (Hamada et al., 2002). It has been shown that Lin-c-kit+ 
 30 
lymphoid cells present in CPs present with LTi cell-like characteristics, including 
expression of IL-7Rα, and RORγt, whilst lacking lineage markers such as CD3, 
B220, CD11b, CD11c and Gr-1 (Saito et al., 1998; Eberl and Littman, 2004). Eberl 
suggested the model of CP development into ILFs (Eberl, 2005), a model that does 
not recognize CPs and ILFs as distinct structures but as structures representative of a 
spectrum of stages in intestinal lymphoid tissue development (Pabst et al., 2005; 
Bouskra et al., 2008; Ivanov et al., 2006). Studies of a variety of mutant mouse 
models have elucidated that CP development is dependent on LTα, LTβ, LTβR and 
RORγt, as mice deficient in any of these molecules fail to develop CPs and 
subsequent ILFs (Taylor et al., 2004; Pabst et al., 2005; Eberl and Littman, 2004; 
McDonald et al., 2010). Thus demonstrating that LTi-like cells and the LTα1β2-LTβR 
signalling axis are essential for the development of intestinal lymphoid tissue, as well 
as for LN and PP development. The development of CPs occurs independently of 
NIK, CCR6, Integrin α4β7 and lymphocytes, as CP structures have been observed in 
aly/aly mice (expressing a non-functional form of NIK), Ccr6-/- mice (Lügering and 
Kucharzik, 2006), β7-/- mice (Wang et al., 2008) and mice lacking lymphocytes, such 
as Rag-/- and SCID mice (Hamada et al., 2002) (Table 1.5). 
The transition of CPs to ILFs is defined by the recruitment of B cells to the 
structure, a process that is dependent on NIK (Hamada et al., 2002), B cell expression 
of CCR6 (Lügering and Kucharzik, 2006), Integrin α4β7 (Wang et al., 2008), and 
CXCR5 (Velaga et al., 2009) and, by definition, lymphocytes, a situation opposing 
that of CP development (Table 1.5). To date there are no mouse models where the 
development of ILFs has been observed in the absence of CP development, 
supporting the theory that ILFs develop from CPs. Moreover, the common 
dependence of CP and ILF development on LTα, LTβ, LTβR and RORγt further 
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supports this hypothesis. In addition, it has been shown that it is LTα-sufficient B 
cells and LTβR expressing stromal cells, that are required for ILF formation, as LTα-
sufficient B cells transferred into LTα-deficient mice results in ILF formation, and in 
LtβR-/- mice receiving WT BM ILFs fail to develop (Lorenz et al., 2003; Taylor et al., 
2004). Interestingly, ILF ontogeny differs from that of PPs in the timing during 
embryogenesis when LTβR signalling is required. PPs require LTβR signalling 
between E14-17, and blockage at this point results in a lack of PP development with a 
corresponding, and potentially compensatory, development of large numbers of ILFs 
(Kweon et al., 2005). 
Additionally, LTβR signalling is important in the formation of other tertiary 
lymphoid tissues such as in aged ApoE-/- mice, where LTβR signalling is responsible 
for the formation of aortic tertiary lymphoid organs and LTβR signal blockage 
disrupted these structures (Gräbner et al., 2009). 
Importantly, it has been shown that ILF formation and maturation is 
dependent on gut flora (Hamada et al., 2002; Lorenz et al., 2003), in a NOD1 
dependent manner (Bouskra et al., 2008). NOD1 binds Peptidoglycan from Gram-
negative bacteria. The number of ILFs present in the colon of WT mice housed under 
Germ-free conditions was severely reduced compared with WT mice residing in 
specific pathogen free (SPF) conditions, a similar reduction of ILFs was observed in 
mice deficient for NOD1 (Bouskra et al., 2008). However, in mice deficient for 
TLR2/4, or MyD88, the molecule involved in downstream signalling of TLRs, 
induction of ILFs was comparable with WT mice (Bouskra et al., 2008). Interestingly, 
in mice lacking AID (activation-induced cytidine deaminase), where the intestinal 
bacterial load is increased due to lack of IgA production in the gut, an increase in 
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number and size of ILFs was observed, a phenotype which was rescued following 
treatment with antibiotics to reduce bacterial load (Fagarasan et al., 2002).  
The interaction of intestinal stromal cells, resident and migratory 
haematopoietic cells and gut commensal bacteria, clearly plays an important role in 
ILF development. Ivanov proposes a model for CP transition to ILFs that follows DC 
activation by intestinal bacteria, resulting in the recruitment of B cells and some T 
cells into CP structures. This recruitment could occur via several mechanisms; direct 
action of CP-derived DCs on B and T cells; the activation of CP stromal cells by DCs; 
the indirect activation of stromal cells via stimulation of LTi-like cells, with all of 
these mechanisms resulting in direct recruitment of B and T cells or alterations in 
chemokine expression allowing B and T migration to the CPs (Ivanov et al., 2006). 
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 Mouse model LNs PPs CPs ILFs Refs 
Ltα-/-     
(Ivanov et al., 2006; De Togni et al., 
1994; Hamada et al., 2002; Banks et 
al., 1995; Taylor et al., 2004; Lorenz 
et al., 2003) 
Ltβ-/-  peripheral LNs ≈75% have mLNs    
(Alimzhanov et al., 1997; Pabst et 
al., 2005) 
LtβR-/-     
(Fütterer et al., 1998; Ivanov et al., 
2006; Taylor et al., 2004; Lorenz et 
al., 2003) 
Tnf-/-     (Pasparakis et al., 1997; Ivanov et al., 2006) 
Tnfr-/-  (small)   (Neumann et al., 1996; Ivanov et al., 2006; Lorenz et al., 2003) 
Rankl-/-   ? ? (Kong et al., 1999; Kim et al., 2000; Ivanov et al., 2006) 
TN
F 
&
 T
N
FR
 su
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Rank-/-   ? ? (Dougall et al., 1999) 
Rela-/- TnfrI-/-   ? ? (Alcamo et al., 2002) 
Nfkb1-/-  No.   (Paxian et al., 2002; Weih and Caamaño, 2003) 
Nfkb2-/-  ∗ ∗ ∗  
(Carragher et al., 2004; Paxian et al., 
2002; Weih and Caamaño, 2003) 
This study 
p100Δ    No. (Ishikawa et al., 1997) This study. 
Rela-/- TnfrI-/-   ? ? (Alcamo et al., 2002) 
Relb-/-   ?  
(Weih et al., 1995; Yilmaz et al., 
2003; Weih and Caamaño, 2003) 
This study. 
c-rel-/-   ? ? (Weih and Caamaño, 2003) 
Ikkα-/- ?  ? ? (Matsushima et al., 2001) 
aly/aly     
(Shinkura et al., 1999; Miyawaki et 
al., 1994; Ivanov et al., 2006; 
Hamada et al., 2002; Taylor et al., 
2004; Karrer et al., 2000) 
N
F-
κB
 c
om
po
ne
nt
s 
Nik-/-   ? ? (Yin et al., 2001) 
Cxcl13-/-   (0-2 formed) 
? ? (Ansel et al., 2000) 
Cxcr5-/-   $ $ (Velaga et al., 2009; Förster et al., 1996; Ansel et al., 2000) 
C
he
m
ok
in
es
 &
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ce
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s 
Ccr6-/-     (McDonald et al., 2007) 
Traf6-/-   ? ? (Kong et al., 1999) 
Plt/plt   ? ? (Nakano et al., 1998) 
Ret-/-   ? ? (Veiga-Fernandes et al., 2007) 
β7-/-     (Wang et al., 2008) 
Il7R-/-    (small) (Ivanov et al., 2006; Adachi et al., 1998; Hamada et al., 2002) 
RORγ-/-     
(Kurebayashi et al., 2000; Sun et al., 
2000; Eberl et al., 2004; Ivanov et 
al., 2006; Eberl and Littman, 2004) 
O
th
er
 
Rag-/-  (small) (large)  (Hamada et al., 2002; Ivanov et al., 2006) 
 
Table 1.5 Overview of the development of secondary and tertiary 
lymphoid tissue in various mouse models. 
 
* The LNs and PPs that develop in Nfkb2-/- mice are reduced in size and number and 
consist of mainly of T lymphocytes with no B cell follicles.
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Figure 1.6 Isolated lymphoid follicle development 
 
The initial clustering of LTi cells is critical for LN development and it is suggested 
that this is mirrored in isolated lymphoid follicle (ILF) development, by the formation 
of ILF precursor structures, termed cryptopatches. Recruitment of B cells to CP 
structures defines the transition from CP to ILF. 
LTi 
clustering 
stromal cell 
LTαβ 
LTα
CCR6 
MAdCAM-1 
Cryptopatch 
Isolated 
Lymphoid 
Follicle 
Chemokines 
Cell adhesion 
molecules 
Lymphoid Tissue Inducer (LTi) Cell 
Dendritic Cell (DC) 
B Cell 
T Cell 
Development of Isolated Lymphoid Follicles 
Figure 1.6 
 35 
1.7. Innate Immunity 
The innate immune system is an evolutionary ancient system for defence 
against pathogenic microorganisms. The innate immune system utilises recognition 
molecules that are germ-line encoded, thus enabling genetic inheritance and these 
molecules have therefore evolved by natural selection to be specific for recognition of 
infectious microorganisms. This contrasts with the adaptive immune system, where B 
and T cell receptors are generated by random somatic mutations to generate a diverse 
repertoire of receptors capable of recognising a vast array of antigens, whether they 
are pathogenic, innocuous or self-antigens. Due to the somatic generation of the B and 
T cell receptors, the range of specificities produced in an individual’s life cannot be 
passed on to offspring, no matter how beneficial they may be (Medzhitov and 
Janeway, 2000; Medzhitov, 2010; Iwasaki and Medzhitov, 2010). 
 
1.7.1. PAMPs and PRRs 
The innate immune system utilises recognition molecules that are designed to 
identify groups of microorganisms, based on pathogen-associated molecular patterns 
(PAMPs). PAMPs are highly conserved invariant structures shared by molecules 
expressed by particular groups of microorganisms, for example LPS is produced by 
all Gram-negative bacteria, and the PAMP Lipoteichoic acid, is produced by Gram-
positive bacteria. Other types of molecules recognised as PAMPs include 
Peptidoglycan, Mannans, bacterial DNA and single/double-stranded RNA. The 
receptors for PAMPs are pattern recognition receptors (PRRs) and are expressed by 
cells of the innate immune system (Medzhitov and Janeway, 2000). 
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There are three main structural groups of PRRs: secreted, cytosolic and 
transmembrane. Secreted PRRs, including collectins and ficolins, act as opsonins, 
binding to microbial surfaces and inducing activation of complement pathways and 
label the microbe for phagocytosis. Cytosolic PRRs include RIG-1-like receptors 
(RLRs), which are capable of recognising ssRNA and dsRNA associated with viral 
pathogens, and nucleotide-binding domain and leucine-rich repeat-containing 
receptors (NLRs), which can detect pathogens and stress signals. Transmembrane 
PRRs include, C-type lectins and Toll-like receptors (TLRs), of which TLRs are the 
most studied and well characterised (Iwasaki and Medzhitov, 2010). 
 
1.7.2. Toll-like Receptors 
TLRs are a family of receptors capable of recognising particular PAMPs 
(Table 1.6). Toll receptors were first discovered in Drosophila before the 
identification of mammalian homologues termed Toll-like Receptors (TLRs). The 
Toll family of receptors in Drosophila were shown to be involved in fly 
embryogenesis (Hashimoto et al., 1988) and, importantly, ligation of Toll receptors 
induced the activation of NF-κB, a transcription factor known to be involved in the 
production of inflammatory molecules (Belvin and Anderson, 1996). Studies of 
Drosophila with a loss-of-function mutation in the Toll gene demonstrated increased 
susceptibility to fungal infections, indicating the need for Toll receptors in innate 
immunity (Lemaitre et al., 1996). The first mammalian TLR identified, later 
designated TLR4, was shown to induce NF-κB signalling and production of cytokines 
and costimulatory molecules involved in adaptive immune responses (Medzhitov et 
al., 1997; Rock et al., 1998). To date, at least ten mammalian TLRs have been 
identified (Table 1.6). 
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TLRs are expressed by various cell types including cells of the innate immune 
system, such as macrophages and DCs. The assessment of TLR expression by such 
cells, has been hindered by the lack of effective antibodies to detect TLRs and by 
differences in expression between freshly isolated cells and in-vitro derived cells 
(Boonstra et al., 2003). However, all freshly isolated murine splenic DCs express 
TLR1, 2, 4, 6, 8 and 9, with plasmacytoid DCs lacking expression of TLR3 and 
CD8a+ DCs lacking expression of TLR5 and TLR7 (Edwards et al., 2003).  
TLR PAMP 
TLR1/TLR2 
TLR2/TLR6 
Lipoteichoic acid 
Lipoproteins 
(Gram+ bacteria) 
TLR4 LPS (Gram- bacteria) 
TLR5 Flagellin 
TLR3 dsRNA 
TLR7 ssRNA 
TLR9 dsDNA 
 
Table 1.6 Toll-like Receptors (TLRs) and their respective 
Pathogen-associated Molecular Patterns (PAMPs). 
 
1.8. Dendritic Cells 
1.8.1. Dendritic Cells in Innate and Adaptive Immunity  
Interaction between the innate and adaptive immune systems is central to the 
promotion of efficient pathogen recognition, leading to initiation of antigen-specific 
immune responses and development of immunological memory. An important aspect 
of this crosstalk is mediated through TLR ligation-induced upregulation of co-
stimulatory molecules on APCs, which then enables interaction and activation of cells 
of the adaptive immune system. 
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The key cells involved in this innate control of adaptive responses are DCs. 
DCs are APCs, involved in presentation of antigenic peptides by MHC molecules to T 
cells. TLR stimulation of splenic DCs induces up-regulation of CCR7 (Sallusto et al., 
1998; Dieu et al., 1998), a receptor critical for migration of DCs to T cell areas in the 
spleen and LNs, this results in interaction of DCs with T cells and subsequent T cell 
activation. Activation of T cells requires two signals: i) recognition of the TCR 
cognate antigen presented by MHC molecules on APCs; ii) co-stimulatory signalling 
via CD28, expressed on T cells, and CD80 or CD86, expressed on activated APCs. 
Ligation of the TCR without the second co-stimulatory signal results is T cell anergy. 
The expression of CD80/CD86 on DCs is upregulated upon activation and 
maturation, and the main pathway controlling this occurs by TLR recognition of 
PAMPs (Medzhitov, 2001; Kaisho et al., 2001b; Michelsen et al., 2001; Weatherill et 
al., 2005). In this way, T cells require signalling through TCR engagement with 
microbe-derived peptide presented on MHC and co-stimulatory signalling from TLR 
activation-induced CD80/CD86 expression on DCs. This is the fundamental link 
between the innate and adaptive immune systems. 
 
1.8.2. Dendritic Cell Origin and Homeostasis 
The origin of the vast heterogenous populations of DCs is complicated. In its 
most basic form, monocyte, macrophage and dendritic cell precursors (MDPs) give 
rise to monocytes and common DC precursors (CDPs) (Figure 1.7). Monocytes are 
able to migrate to areas of inflammation and differentiate into subsets of macrophages 
and inflammatory DCs. CDPs are able to generate plasmacytoid DCs (PDCs) and 
precursors of conventional DCs (pre-cDCs), both of which are released from the BM 
into the blood. The blood-borne pre-cDCs migrate to lymphoid tissues, before 
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undergoing proliferation, differentiation and maturation into mature cDCs (Liu et al., 
2009), a process controlled by regulatory T cells (T regs), Flt3 and LTbR (Geissmann 
et al., 2010). 
Under steady state conditions the peripheral DC pool needs to be maintained 
in order to allow efficient and rapid responses to antigenic challenge. This 
homeostasis of DCs occurs by continual seeding of the periphery by pre-cDCs and by 
local proliferation, a process regulated by LTβR. In mice deficient for LTβR, LTα or 
LTβ, a reduction in splenic DC numbers was observed, with a preferential decrease in 
CD11chighCD8α- DCs (Wu et al., 1999; Abe et al., 2003; De Trez et al., 2008; Wang 
et al., 2005). DC subsets express LTβR and in vitro bone marrow DC cultures 
revealed that DC numbers were increased following treatment with agonist LTβR 
antibody (Kabashima et al., 2005). There are two known ligands for LTβR: LTα1β2 
and LIGHT, these are expressed by B and T lymphocytes and it could be that these 
cell types are responsible for providing the LTβR signalling that DCs require for their 
homeostasis (Kabashima et al., 2005). In addition to this, it has also been shown that 
ligation of RANK expressed on DCs increases survival, but is not necessary for 
maturation (Josien et al., 2000), stimulation of CD40 expressed on DCs contributes to 
their survival and maturation (Caux et al., 1994; Miga et al., 2001; Mackey et al., 
1998) and a component of the signalling pathway downstream of CD40, TRAF6, has 
been shown as necessary for the development of splenic CD8α- cDCs (Ardavín, 2003; 
Kobayashi et al., 2003). 
The involvement of LTβR, RANK and CD40 in DC homeostasis, survival and 
maturation and the fact that activation of the classical and alternative NF-κB 
pathways occurs following ligation of these receptors, indicates that these signalling 
pathways play a significant role in DC biology. Analysis of mice lacking different 
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NF-κB subunits revealed the relative contribution of these pathways. Considering the 
classical pathway, mice deficient in p50, p65 or c-Rel, demonstrate normal 
proportions of CD11chighCD8α+ and CD11chighCD8α- DCs in the spleen (Ouaaz et al., 
2002). In contrast, mice with non-functional NIK (aly/aly) or Relb-/- mice, exhibiting 
a block in alternative NF-κB signalling, a selective defect in splenic CD11chighCD8α- 
DCs is observed (De Trez et al., 2008; Wu et al., 1998). Interestingly however, Ouaaz 
et al, revealed defects in DC maturation and survival in mice doubly deficient in p50-
RelA and p50-cRel (Ouaaz et al., 2002). Furthermore, RANKL deficient mice do not 
exhibit defects in DC development (Kong et al., 1999), suggesting a degree of 
redundancy in the system. Critically, it appears that LTβR signalling through the 
alternative NF-κB pathway maintains splenic CD11chighCD8α- DC homeostasis. 
Regarding the mechanism by which the alternative NF-κB pathway is 
involved in DC biology, Speirs et al, demonstrated that p100 is able to inhibit RelB 
activation in stimulated DCs by acting as a negative regulator of RelB. The 
consequence of removing this control mechanism, as in Nfkb2-/- mice, is that DCs 
present with elevated expression of activation markers, but normal cytokine 
production levels and possess an increased capacity to stimulate CD4+ T cells (Speirs 
et al., 2004). 
Taken together, these studies expose mechanisms by which the alternative NF-
κB pathway is involved in DC homeostasis and activation. 
 
1.8.3. Dendritic Cell Subtypes 
There are many different subtypes of DCs, which vary in their origin, 
migration/recruitment, anatomical location and function. These subsets include 
classical DCs (cDCs), monocyte-derived DCs, resident DCs such as Langerhan cells 
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within the skin, migratory DCs and recruited or inflammatory DCs. Here we focus on 
cDCs which can be identified by their high expression of CD11c. Within the spleen 
the two main subtypes are determined based on CD8α expression: CD11chighCD8α+ 
and CD11chighCD8α- cDCs (Leenen et al., 1998; Shortman and Liu, 2002).  
Within the gut, two significant subsets of DCs are present, with distinct 
functions in intestinal immunity (See Section 1.8.4); non-migratory CX3CR1+ DCs 
(Schulz, Jung et al., 2000; Schulz et al., 2009), and migratory CD103+ DCs (del Rio et 
al., 2010; Schulz et al., 2009). In addition, CD103+ DCs have been identified in mLNs 
and investigation into the origins of this subset revealed that the majority are 
migratory LP-derived CD103+ DCs (Jaensson et al., 2008). 
 
1.8.4. Mucosal Dendritic Cells 
The intestinal mucosa is a pivotal site for defence against potentially pathogenic 
organisms and DCs play an important role in maintaining host defences. Many 
subsets of mucosal DCs have been identified based on surface expression of different 
molecules; of particular interest is expression of CD103 and CX3CR1. 
CD103, also termed Integrin αE, combines with β7 in a heterodimeric complex 
(αEβ7) and is able to interact with E-cadherin, a molecule expressed by mucosal 
epithelial cells (Agace et al., 2000; Cepek et al., 1994). CD103 is a typical marker for 
intraepithelial T cells, but is also expressed on a subset of effector memory CD8+ T 
cells, T regs and lamina propria (LP) T cells (Lehmann et al., 2002; Uss et al., 2006; 
Agace et al., 2000; Annunziato et al., 2006) and, of particular interest, on mucosal 
CD11chigh DCs (Jaensson et al., 2008). CD103+ DCs are present in the mLN, colonic 
LP and PPs (Annacker et al., 2005). Functional analysis has been performed on the 
specific CD11chighCD103+ and CD11chighCD103- DC populations and demonstrated 
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that CD103+ DCs are able to induce expression of gut-homing molecules on T cells, 
such as CCR9 (Annacker et al., 2005) and Integrin α4β7, whereas CD103- DCs do not 
exhibit this capacity (Jaensson et al., 2008). Furthermore, CD103+ LP-DCs are 
capable of migrating to the draining mLN in order to present antigen to T cells 
(Schulz et al., 2009) and are proficient at generating Foxp3+ T regs from naïve T cells 
(Coombes et al., 2007; Siddiqui and Powrie, 2008). Together these studies 
demonstrate that CD103+ DCs play a distinct role in presentation of gut-derived 
antigens to T cells within the mLN, inducing gut-homing capability of the T cells, 
along with induction of Tregs, thereby producing a tolerogenic gut environment. In 
contrast, CD103- DCs promote the generation of IFNγ-producing T cells and secrete 
high levels of IL-6 and TNFα following stimulation, demonstrating enhanced 
phagocytic qualities compared with their CD103+ counterparts (del Rio et al., 2008). 
Therefore, this subset of DCs appears capable of promoting pro-inflammatory 
responses. 
Intestinal CX3CR1+ DCs are a population of non-migratory, tissue resident DCs 
(Schulz et al., 2009), present in the intestine and responsible for extending dendrites 
into the lumen to sample antigens (Chieppa et al., 2006; Niess et al., 2005; Rescigno 
et al., 2001b; Rescigno et al., 2001a). These DCs are not able to migrate to the 
draining mLN to interact with T cells and also have a reduced capacity to induced 
expression of gut-homing molecules on T cells, indicating they play a different role in 
intestinal immunity from CD103+ DCs. 
Together, these studies demonstrate that specific subsets of DCs are present in 
the gut and that each has distinct functions in intestinal immunity. 
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Figure 1.7 Dendritic cell origin 
 
Monocyte, macrophage and dendritic cell precursors (MDPs) give rise to monocytes 
and common DC precursors (CDPs). Monocytes are able to migrate to areas of 
inflammation and differentiate into subsets of macrophages and inflammatory DCs. 
CDPs are able to generate plasmacytoid DCs (PDCs) and precursors of conventional 
DCs (pre-cDCs), both of which are released from the bone marrow into the blood. 
The blood-borne pre-cDCs migrate to lymphoid tissues, before undergoing 
proliferation, differentiation and maturation into mature cDCs, a process controlled 
by regulatory T cells, Flt3 and LTβR. 
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1.9. NF-κB Signalling Pathways 
The family of Rel/NF-κB transcription factors play a role in a wide range of 
immune system processes, including generation of immune responses, lymphocyte 
survival, recruitment and homeostasis, lymphoid tissue development and control of 
cell cycle and transformation. There are two main activation pathways involving 
signal transduction through NF-κB: the Classical and Alternative pathways (Figure 
1.9). 
 
1.9.1.  Rel/NF-κB Family of Transcription Factors 
The Rel/NF-κB family of transcription factors consists of five, structurally 
related, members: RelA, RelB, c-Rel, NF-κB1 (the precursor p105 and the active 
protein p50) and NF-κB2 (the precursor p100 and the active protein p52) (Figure 1.8). 
The five Rel/NF-κB proteins share the highly conserved Rel-homology domain 
(RHD), which enables DNA binding, dimerisation of family members and binding 
with inhibitors of NF-κB (IκBs). The Rel/NF-κB proteins are able to form homo- 
and/or heterodimers with any other member of the family, except for RelB, which can 
only dimerise with p52 and p50. These dimers are retained in the cytoplasm in an 
inactive form often associated with IκBs. Each of the Rel/NF-κB proteins contains a 
nuclear localisation signal (NLS), allowing the translocation of dimers into the 
nucleus following activation. In addition to the NLS, the family members RelA, RelB 
and c-Rel also contain a transcriptional activation domain; therefore only dimers 
containing these proteins are capable of inducing gene transcription. 
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The structure of NF-κB1 (p105/p50) and NF-κB2 (p100/p52) differs from the 
other members of the Rel/NF-κB family. These proteins are transcribed as a precursor 
protein with a series of ankyrin repeats at the C-terminus and in this respect the 
structure resembles that of IκBs, enabling p105 and p100 to act as inhibitors of NF-
κB activation (Basak et al., 2007). Indeed, it is the presence of these ankyrin repeats 
and the accompanying glycine-rich hinge region that allows for folding of the protein 
and concealment of the NLS, resulting in sequestration of p105- and p100-associated 
dimers in the cytoplasm (Ghosh et al., 1998). The carboxy terminal region of p105 
and p100 are degraded by the proteosome to produce the active proteins, p50 and p52 
respectively (See Section 1.9.4). 
 
1.9.2.  Inhibitors of NF-κB and IκB Kinases 
IκBs are capable of masking the NLS exhibited by all five Rel/NF-κB family 
members, thus inhibiting nuclear translocation and induction of gene transcription. 
The IκB family consists of IκBα, IκBβ, IκBε, (Figure 1.8) and Bcl-3 and, as 
previously described, the precursor forms of NF-κB1 and NF-κB2, (p105 and p100, 
respectively) can also act as IκBs. Degradation of IκBs is required in order for signal 
transduction to proceed through the classical and alternative NF-κB pathways. IκB 
degradation requires IκB kinases (IKKs): IKKα, IKKβ and IKKγ (aka NEMO). IKKγ 
is a scaffold protein that forms the structure of the IKK complex (Ghosh and Karin, 
2002). 
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Figure 1.8 Rel/NF-κB family of transcription factors and inhibitors of NF-κB 
 
In mammals there are five members of the Rel/NF-κB family of transcription factors: 
RelA, c-Rel, RelB, NF-κB1 (p105/p50) and NF-κB2 (p100/p52). All five members 
share a highly conserved Rel-homology domain (RHD). Only RelA, c-Rel and RelB 
have transcriptional activation domains. NF-κB1 and NF-κB2 are transcribed as the 
inactive precursors p105 and p100, respectively, with a series of ankyrin repeats at 
the C-terminal. These proteins can act as inhibitiors of NF-κB by dimerising with 
other members of the Rel/NF-κB family and retaining the complex in the cytoplasm. 
Phosphorylation and proteosomal degradation cleaves the ankyrin repeats from p105 
and p100 to produce the active p50 and p52 proteins, respectively. The inhibitors of 
NF-κB (IκBs) possess similar ankyrin repeats as p105 and p100, and are responsible 
for the retention of Rel/NK-κB dimers in the cytoplasm. Three of the five members of 
the IκB family are depicted. 
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1.9.3.  The Classical NF-κB Pathway 
The classical pathway is the most studied Rel/NF-κB activation pathway. It 
occurs downstream of signals such as TNFα and LPS, and revolves around nuclear 
translocation of RelA/p50 and c-Rel/p50 heterodimers (Figure 1.9). These 
heterodimers are retained in the cytoplasm by IκBs and the degradation of IκBs is 
controlled by a trimeric complex of IKKs (consisting of IKKα, IKKβ and IKKγ). The 
IKK complex phosphorylates IκB, thereby labelling it for proteosomal degradation. 
This reveals the NLS enabling the RelA/p50 and c-Rel/p50 heterodimers to 
translocate into the nucleus. 
Activation of the classical NF-κB pathways results in transcription of target 
genes including cytokines, chemokines, cell adhesion molecules and enzymes (Figure 
1.9). The classical NF-κB pathway plays a key role in cell proliferation, apoptosis and 
pro-inflammatory responses (Beinke and Ley, 2004); Ghosh, 1998, p08739}. 
 
1.9.4.  The Alternative NF-κB Pathway 
The alternative NF-κB pathway is focussed on the activation and processing 
of NF-κB2 p100, followed by subsequent nuclear translocation of predominantly 
p52/RelB, but also p52/RelA heterodimers (Dejardin et al., 2002), and this pathway 
occurs downstream of several TNF receptor family members, such as LTβR, BAFF-
R, CD40, RANK and TNF-R2 but not TNF-R1 (Dejardin et al., 2002; Müller and 
Siebenlist, 2003; Claudio et al., 2002; Coope et al., 2002; Weih and Caamaño, 2003) 
(Figure 1.9). Ligation of these receptors induces activation of both the classical and 
alternative NF-κB pathways (Bonizzi and Karin, 2004). The alternative pathway has 
been implicated in various immune processes, including development and 
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organisation of secondary lymphoid organs, lymphocyte survival and proliferation, 
and promotion of adaptive immune responses. 
The central feature of the alternative pathway is the degradation of NF-κB2 
p100 to p52 and this process is dependent on specific IKKs. Several studies have 
investigated the mechanism of NF-κB2 activation using mouse embryonic fibroblasts 
(MEFs) and have revealed that the production of p52 cannot occur in the absence of 
NF-κB-inducing kinase (NIK) or IKKα (Müller and Siebenlist, 2003; Claudio et al., 
2002; Senftleben et al., 2001; Yilmaz et al., 2003), but occurs independently of IKKβ 
and IKKγ (Dejardin et al., 2002; Müller and Siebenlist, 2003; Yilmaz et al., 2003; 
Weih and Caamaño, 2003). NIK is responsible for activation of IKKα, a process that 
is required for the phosphorylation of p100, enabling ubiquitination and proteosomal 
degradation (Xiao et al., 2001; Silverman and Maniatis, 2001; Senftleben et al., 2001; 
Yilmaz et al., 2003). This degradation entails proteolytic cleavage of the p100 C-
terminal ankyrin repeats at the glycine-rich hinge region (Heusch et al., 1999). The 
predominant heterodimers that form in the alternative pathway are p100/RelB 
(Dejardin et al., 1998; Yilmaz et al., 2003) and it is through association with p100 that 
RelB is retained in the cytoplasm (Coope et al., 2002). 
Interestingly, continuous induction of p100 processing requires de novo 
protein synthesis of p100 within 24 hours of receptor ligation, as treatment of MEFs 
with cycloheximide, an inhibitor of protein synthesis, prevented proteolysis of p100 
and generation of p52 (Coope et al., 2002; Müller and Siebenlist, 2003). As 
previously explained the classical pathway is dependent on IKKβ and IKKγ, and in 
MEFs lacking IKKβ or IKKγ, no new p100 protein is produced, but that which is 
present is degraded to p52 following LTβR ligation (Dejardin et al., 2002), indicating 
that the classical pathway is required for de novo p100 synthesis, but not for p100 
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processing. This data correlates with evidence that the classical NF-κB pathway 
induces transcription of Nfkb2 (Liptay et al., 1994). 
Other components involved in activation of the alternative pathway are 
tumour necrosis factor receptor-associated factors (TRAFs), intracellular proteins 
involved in signal transduction downstream of members of the TNF receptor family, 
IL-1 receptor and TLRs (Wajant et al., 2001). It has been demonstrated that TRAF3 
association with BAFF-R and LTβR (Xu and Shu, 2002; Kuai et al., 2003) acts as a 
negative regulator of NIK (Liao et al., 2004). The interaction of TRAF3 and NIK 
induces continuous degradation of NIK, a situation that can be reversed following 
ligation of receptors, such as CD40 and BAFF, inducing degradation of TRAF3, 
thereby ablating NIK degradation and increasing cytoplasmic levels, and allowing 
processing of p100 (Liao et al., 2004). Furthermore, it has been demonstrated that 
TRAF3 acts as a negative regulator of CD40 signalling (Hostager and Bishop, 1999; 
He et al., 2004), which has been shown to proceed via the alternative NF-κB pathway 
(Coope et al., 2002). In addition, it has been postulated that TRAF6 functions 
downstream of RANK, as Rank-/- and Traf6-/- mice exhibit similar phenotypes, with a 
defect in osteoclast differentiation and a lack of peripheral LNs, whilst retaining PP 
development (Dougall et al., 1999; Kim et al., 2000; Naito et al., 1999). 
Expanding on the role of the alternative NF-κB pathway in lymphocyte 
survival and proliferation, truncations of the C-terminal region of p100 have been 
associated with various lymphomas (Rayet and Gélinas, 1999) and the alternative 
pathway has been shown to be involved in cell transformation by oncogenic viruses, 
such as HTLV-1 (human T-cell leukaemia virus type 1) (Lanoix et al., 1994) and the 
LMP-1 (latent membrane protein 1) (Saito et al., 2003; Atkinson, 2003, p13785; 
Eliopoulos et al., 2003; Luftig et al., 2004) from Epstein Barr virus. These two viruses 
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are able to induce p100 processing via different mechanisms; HTLV-1 depends on the 
classical IKK complex (IKKα-IKKβ-IKKγ) and occurs independently of NIK 
(Lanoix et al., 1994); LMP-1 requires presence of a TRAF binding site in it’s 
cytoplasmic tail and induces p100 processing independently of IKKγ (Luftig et al., 
2004). In addition, the alternative NF-κB pathway has been shown to be involved in 
the transcription of various factors involved in cell cycle progression, such as cyclin-
D1 and skp2. Heterodimer complexes of p52/Bcl3 upregulate Cyclin-D1 gene 
expression (Westerheide et al., 2001; Rocha et al., 2003) and p52/RelB complexes 
upregulate Skp2 gene expression (Schneider et al., 2006), thereby promoting 
proliferation. 
1.9.5. κB DNA binding sites 
The nuclear translocation of heterodimers formed during activation of the 
alternative NF-κB pathway, mainly p52/RelB, induce transcription of specific genes. 
Bonizzi et al, demonstrated that RelB containing complexes specifically bind to κB 
binding sites in the promoter regions of genes encoding CXCL13, CCL19 and CCL21 
(Bonizzi et al., 2004). Stimulation of stromal cells and bone marrow-derived DCs 
(BMDCs) with agonistic LTβR antibody resulted in nuclear translocation of p52/RelB 
heterodimers, in an IKKα-depedent manner, and induced upregulation of CXCL13, 
CCL19 and CCL21 chemokine expression (Bonizzi et al., 2004). 
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Figure 1.9 NF-κB activation pathways 
 
The classical NF-κB pathway occurs downstream of receptors such as TNFR and 
TLR4, and revolves around nuclear translocation of RelA/p50 and c-Rel/p50 
heterodimers, by degradation of IκBs which retain these complexes in the cytoplasm. 
Activation of the classical NF-κB pathway results in transcription of target genes 
including cytokines, chemokines, cell adhesion molecules and enzymes. 
 
The alternative NF-κB pathway occurs downstream of receptors such as LTβR, 
CD40, BAFF-R and RANK, and centres around degradation of p100 to p52 and 
subsequent nuclear translocation of predominantly p52/RelB heterodimers. Activation 
of this pathway results in transcription of chemokines, cytokines and cell adhesion 
molecules. 
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1.9.6.  Receptors that Activate the Alternative NF-κB Pathway  
The alternative NF-κB pathway occurs downstream of several TNF receptor 
family members, including LTβR, BAFF-R, CD40 and RANK. These receptors are 
expressed by a variety of cell types and can consequently induce different gene 
expression patterns. 
 
1.9.6.1. LTβR 
The most extensively analysed receptor-induced activation of the alternative 
NF-κB pathway is activation via LTβR. LTβR is expressed by stromal cells, such as 
MEFs and by DCs (Kabashima et al., 2005). Several studies have elucidated the 
mechanism by which p100 processing occurs downstream of LTβR. Treatment of WT 
MEFs with an agonistic LTβR monoclonal antibody induced p100 processing to p52. 
This p100 degradation did not occur in MEFs with a naturally occurring non-
functional mutation in NIK (aly/aly), or in MEFs lacking IKKα, but did occur in 
MEFs lacking RelA, IKKβ, IKKγ or NF-κB1 (Dejardin et al., 2002; Müller and 
Siebenlist, 2003; Yilmaz et al., 2003). These results suggested that p100 processing to 
p52 was dependent on the alternative NF-κB pathway and not the classical pathway. 
In addition, it was shown that LTβR ligation promotes nuclear translocation of p52, 
RelB and RelA and that at six hours post ligation the predominant heterodimers 
located in the nucleus are p52/RelB dimers and this nuclear translocation was 
dependent on IKKα, but not IKKβ (Dejardin et al., 2002). However, LTβR 
stimulation does not only induce the alternative NF-κB pathway, but also activates the 
classical pathway and the gene expression patterns differ depending on the pathway 
activated (Dejardin et al., 2002; Lo et al., 2006). When WT MEFs were stimulated 
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with agonistic LTβR, expression of VCAM-1 mRNA was upregulated, this was not 
observed in MEFs lacking a component of the classical pathway, such as RelA or 
IKKβ, but was present in aly/aly and Ikkα-/- MEFs (Dejardin et al., 2002). Conversely, 
expression levels of the chemokines CCL19/21 and CXCL13, and BAFF, were 
increased in splenocytes from WT mice treated with agonistic LTβR antibody. This 
increase was inhibited in mice with a non-degradable form of IKKα, therefore with 
no alternative NF-κB signalling. Together this data demonstrates that LTβR 
signalling proceeds through the classical and alternative pathways and in support of 
this Müller et al, demonstrated that following LTβR ligation DNA binding of 
complexes containing RelA were observed initially, with subsequent DNA binding of 
RelB containing heterodimers (Müller and Siebenlist, 2003). Thus indicating that 
LTβR engagement initially activates the classical pathway, followed later by 
prolonged activation of the alternative pathway. 
 
1.9.6.2. BAFF-R 
The B cell activating factor (BAFF) is a member of the TNF family and is 
required for proliferation and survival of mature B cells (Schneider et al., 1999). 
BAFF is present as a membrane-bound and secreted protein and binds to three 
receptors: BAFF-R, BCMA (B cell maturation antigen) and TACI (transmembrane 
activator and CAML interactor). Two of these receptors, BCMA and TACI, are also 
able to bind the proliferation-inducing ligand, APRIL (Do and Chen-Kiang, 2002). 
APRIL does not bind to BAFF-R, therefore the only known ligand for BAFF-R is 
BAFF (Thompson et al., 2001). Claudio et al, investigated the involvement of NF-κB 
pathway components on the survival, proliferation and maturation of B cells in 
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response to BAFF. They showed that treatment of mature splenic B cells and 
immature BM B cells with BAFF induced processing of p100 to p52 and that this 
processing was ablated in B cells from aly/aly mice and in B cells expressing a 
mutated BAFF-R (A/WySnJ mice (Thompson et al., 2001)) (Claudio et al., 2002). It 
was also shown that BAFF induced nuclear translocation of p52/RelB heterodimers 
and DNA binding occurred in splenic B cells in a NIK-dependent manner. This data 
shows that BAFF is able to induce p100 degradation and nuclear translocation of 
p52/RelB heterodimers, dependent on NIK and this process occurs downstream of 
BAFF-R. 
In vivo, the two NF-κB activation pathways have been shown to be involved 
in B cell maturation and survival, by evidence that mice doubly deficient for NF-κB1 
and NF-κB2 showed increased apoptosis of splenic B cells, due to decreased 
expression of anti-apoptotic genes, such as Bcl2. The effect in single Nfkb1-/- and 
Nfkb2-/- mice revealed that B cell development was dependent on NF-κB2 and not 
NF-κB1. Moreover, in aly/aly mice and mice expressing a mutated form of BAFF-R, 
maturation of bone marrow B cell precursors was not markedly impaired (Claudio et 
al., 2002). 
 
1.9.6.3. CD40 
CD40 is a member of the TNFR superfamily and is involved in B cell 
activation and differentiation. CD40 is expressed on B cells, as well as other APCs, 
and it’s ligand, CD40-L, is expressed on activated T cells (Grewal and Flavell, 1998). 
The potential for involvement of the alternative NF-κB pathway in signalling 
downstream of CD40 was postulated following the observation that aly/aly mice 
present with defects in B cell function (Karrer et al., 2000; Yamada et al., 2000). 
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Coope et al, demonstrated, using CD40-transfected 293 cells, that CD40 engagement 
by either anti-CD40 antibody or CD40-L induced processing of p100 to p52 and that 
this processing did not occur following treatment with TNFα or IL-1α (stimulators of 
the classical, but not the alternative NF-κB pathway). Subsequent nuclear 
translocation of p52 was observed and the entire process was dependent on functional 
NIK. Furthermore, CD40 treatment of splenic B cells induced p100 degradation and 
nuclear translocation of p52/RelB heterodimers (Coope et al., 2002). 
 
1.9.6.4. RANK 
RANK is a member of the TNFR superfamily and is involved in osteoclast 
differentiation and LN development (Wong et al., 1999; Dougall et al., 1999; Kong et 
al., 1999). RANK is the receptor for RANKL (also known as TRANCE). RANKL is 
expressed by activated T cells (Josien et al., 1999; Anderson et al., 1997; Wong et al., 
1999), whereas RANK is expressed by DCs (Josien et al., 1999; Anderson et al., 
1997; Wong et al., 1999; Wong et al., 1997), and osteoclast progenitors (Wong et al., 
1999; Lacey et al., 1998). RANK plays a role in the promotion of DC survival 
following lgation with RANK-L (Josien et al., 2000). In addition, RANK signalling is 
required for osteoclastogenesis and LN development, but is dispensable for the 
development of PPs; Rank-/- and Rankl-/- mice exhibit a block in osteoclast 
differentiation and lack peripheral LNs, whilst retaining development of PPs (Dougall 
et al., 1999; Kong et al., 1999). Importantly, LTi cells express both RANK and 
RANKL (Kim et al., 2000). Additionally, mice lacking TRAF6 present with a 
phenotype similar to Rank-/- and Rankl-/- mice, indicating that signalling downstream 
of RANK involves TRAF6 (Naito et al., 1999). 
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1.9.7. The alternative NF-κB pathway and lymphoid tissue 
development 
The alternative NF-κB pathway is activated downstream of several TNFR 
family members known to be important in lymphoid tissue development and 
organisation of the spleen, therefore indicating a significant role for alternative NF-
κB signalling in these processes. Several mouse models with deficiencies in 
components of the NF-κB pathway have been developed and analysed for the 
formation of lymphoid tissue and splenic architecture (Table 1.5). 
Of the classical pathway, three models are of interest: Nfkb1-/-, c-rel-/- and 
Rela-/-TnfrI-/-. Nfkb1-/- and c-rel-/- mice both develop LNs and PPs, although PP 
numbers in Nfkb1-/- are decreased (Paxian et al., 2002; Weih and Caamaño, 2003). 
The normal development of lymphoid tissues in these mice suggests a non-essential 
role for the classical NF-κB pathway. Deletion of RelA is embryonic lethal at E15 
(Beg et al., 1995), due to TNFα-induced liver degeneration, therefore, Rela-/- mice 
were crossed with TnfrI-/- mice to allow full term survival (Alcamo et al., 2001). 
Interestingly, Rela-/-TnfrI-/- mice do not develop LNs or PPs and lack demarcation of 
B and T zones in the spleen, contrary to TnfrI-/- mice (Alcamo et al., 2001). This 
phenotype is similar to that seen in LtβR-/- (Fütterer et al., 1998) and Relb-/- (Weih et 
al., 2001) mice, and considering that LTβR signalling initially activates nuclear 
translocation of p52/RelA heterodimers, followed by p52/RelB heterodimers, this is a 
possible explanation for the defects in lymphoid tissue development and splenic 
organisation associated with RelA deficiency (Dejardin et al., 2002). 
The key components of the alternative NF-κB pathway are NF-κB2/p100, 
RelB, NIK and IKKα. The phenotype of Nfkb2-/- mice differs from that of Relb-/- and 
aly/aly (non-functional NIK) mice in that the former develops LNs and PPs, whereas 
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the latter do not (Paxian et al., 2002; Weih et al., 1995; Carragher et al., 2004; 
Shinkura et al., 1999; Miyawaki et al., 1994). Ordinarily, RelB is retained in the 
cytoplasm in association with p100, in Nfkb2-/- mice no p100 is present, therefore 
there is no negative control of RelB-induced gene transcription suggesting a possible 
explanation for LN and PP development. However, the LNs and PPs that do develop 
are disorganised, with few B cells present and no B cell follicles. In the LN, this is 
linked to a defect in CXCL13 expression and a decrease in CCL19/21 expression 
(Carragher et al., 2004). In addition, B/T cell segregation in the spleen can be 
observed, but no B cell follicles form (Caamaño et al., 1998; Franzoso et al., 1998). In 
contrast to Nfkb2-/- mice, Relb-/- and aly/aly mice lack all LNs and PPs, and when the 
spleen is analysed, no B/T cell segregation can be seen and, similar to Nfkb2-/- mice, a 
defect in B cell follicle formation is observed (Weih et al., 2001; Karrer et al., 2000; 
Miyawaki et al., 1994). 
Removal of p100 as a negative regulator of RelB-induced gene transcription 
results in a decrease in lymphocyte homing chemokines, the reverse situation involves 
constitutive activation of p100 (p100Δ mouse model), resulting in increased p52/RelB 
heterodimerisation and nuclear translocation. In p100Δ mice, an increase in splenic 
CXCL13 and CCL21 can be observed, with ectopic MAdCAM-1 expression in the 
red pulp and increased VCAM-1 and ICAM-1 expression. The splenic architecture is 
not disrupted with regards to B/T cll segregation, but an increase in MZ B cells has 
been shown (Guo et al., 2007) (Table 1.5). 
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1.10. Aims 
The LTα1β2-LTβR axis is critical for the development of clearly demarcated B 
and T cell areas in the spleen through the expression of area-specific chemokines. The 
spleens of LTβR and LTα deficient mice show no organisation of B and T zones due 
to a lack of homing chemokines, such as CXCL13 and CCL19/21. We aim to analyse 
the affect of introducing constitutively active NF-κB2 p100 into an LTα-deficient 
environment with the hypothesis that this will mimic continuous LTβR signalling and 
therefore rescue expression of homing chemokines and recovery of splenic 
organisation.  
It is well established that the alternative NF-κB pathway plays a significant role 
in SLO development through its involvement in signalling downstream of various 
TNFR superfamily members. This thesis aims to expand on this area by investigating 
the role of this pathway in the development of TLOs, by utilising a mouse model 
where NF-κB2/p100 is constitutively active, the p100Δ mouse model. The tertiary 
lymphoid tissue system we focus on is the formation of colonic ILFs. With the aim to 
address the following points: 
 
o The affect of constitutively active NF-κB2/p100 on the formation of colonic 
lymphoid aggregates and the similarity of these aggregates to ILFs within the 
following parameters: 
• Cellular composition and organisation, and stromal structure 
• Investigation into which cellular compartment constitutively active 
NF-κB2/p100 plays a significant role: haematopoietic or stromal 
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• Assessment of alterations in proportion and cell number for cell 
subtypes such as B and T cells, and dendritic cells. 
• Alterations in activation or maturation status seen in the lymphoid 
organs (spleen, mLN) and colon of p100Δ mice. 
 
The LTα1β2-LTβR axis is critical for the development of clearly demarcated B 
and T cell areas in the spleen through the expression of area-specific chemokines. The 
spleens of LTβR and LTα deficient mice show no organisation of B and T zones due 
to a lack of homing chemokines, such as CXCL13 and CCL19/21. We aim to analyse 
the affect of introducing constitutively active NF-κB2/p100 into an LTα-deficient 
environment with the hypothesis that this will mimic continuous LTβR signalling. 
With the view to analyse the following areas: 
o Demarcation of B and T cell areas in the spleen 
o Expression of homing chemokines and stromal markers (e.g. CCL21, CXCL13, 
Gp38) 
o Recovery of aspects of splenic micro-architecture, such as the marginal zone. 
o Development of lymph nodes 
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2.  Materials and Methods 
2.1. Mice 
Details of all mouse strains are found in Table 2.1. These strains were bred 
and maintained under specific pathogen-free (SPF) conditions in the Biomedical 
Service Unit at the University of Birmingham according to Home Office and local 
ethics committee regulations.  
 
Strain Background CD45 Isotype 
C57Bl/6 (WT) C57Bl/6 CD45.2 
p100Δ C57Bl/6 CD45.2 
LTα-/- C57Bl/6 CD45.2 
p100ΔLTα-/- C57Bl/6 CD45.2 
Relb-/- C57Bl/6 CD45.2 
p100ΔRelb-/- C57Bl/6 CD45.2 
Rag-/- (BoyJ) C57Bl/6 CD45.1 
 
Table 2.1 Mouse strains. 
 
2.1.1. Generation of p100Δ  Mouse Model 
Ishikawa, et al, generated the p100Δ mouse model (Ishikawa et al., 1997). The 
Nfkb2 gene was disrupted by the introduction of a stop sequence, KpnI and SalI at 
amino acid 451, located between the glycine rich region and the first ankyrin repeat. 
This resulted in transcription of the p52 molecule that is only 450 amino acids in 
length and no production of the full-length p100 precursor protein (Figure 2.1). The 
p100Δ mice have high levels of p52/RelB heterodimers in the nucleus of many 
different cell types. 
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Figure 2.1 Generation of p100Δ  mouse model 
 
Ishikawa et al, (1997) J. Exp. Med. 
 
A. Targeting strategy of the ankyrin-encoding region of the nfkb2 gene. 
The relevant part of the mouse nfkb2 gene structure is shown at the top. Exons 13–19, 
encoding residues 332–690, are indicated by closed boxes. Targeting vector 
pPNT/IκBδ and the targeted allele are shown at the middle and bottom, respectively. 
Open boxes indicate the SV40 polyadenylation recognition sequences, PGK-neo and 
PGK-tk cassettes. The position of KpnI and SpeI sites are indicated by K and S, 
respectively. The diagnostic restriction fragments used for Southern blot analysis are 
indicated at the top (wild-type allele) and bottom (targeted allele). The DNA 
fragments used as 5′ external (H) and internal (B) probes are indicated at the bottom. 
 
B. Genotype analysis of mice generated from p100+/− heterozygote intercrosses. 
Tail DNAs were digested with KpnI and SpeI, and subjected to Southern blot analysis 
using the 5′ external probe H indicated in A. The 8.5-kb band indicates the wild-type 
allele, while the 7.2-kb band represents the targeted allele. 
 
C. Absence of p100 in homozygous mutant mice. 
Protein extracts from control (+/+) and homozygous (−/−) mutant thymocytes 
labeled with [35S]methionine for 8 h in the presence of PMA (20 ng/ml) and PHA (5 
µg/ml) were immunoprecipitated with an anti-p52 antiserum. p100 and p52 proteins 
are indicated by the arrows.  
 
 
Ishikawa H et al. J Exp Med 
1997;186:999-1014 © 1997 Rockefeller University Press 
Figure 2.1 
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2.1.2. Genotyping 
Heterozygous p100Δ mice (p100Δ+/ki) were bred due to postnatal lethality of 
p100Δki/ki at three weeks of age. p100Δki/ki are designated p100Δ within this thesis. 
When crossing the p100Δ strain with Relb-/- the parents were heterozygous for p100Δ 
(p100Δ+/ki) and either heterozygous or knockout for RelB (Relb+/- or Relb-/-). Once 
established the p100ΔLTα stain bred parents heterozygous for p100Δ (p100Δ+/ki) and 
knockout for LTα (LTα-/-). Ear clippings from the p100Δ,  p100ΔRelb and p100ΔLTα 
colonies were taken at ten days of age, providing tissue for genotyping. The tissue 
was digested in 100µl DNA extraction buffer (Table 2.2) for 20 minutes at 95oC on a 
thermoshaker (Eppendorf, Thermomixer). Following this incubation 100µl 40mM 
Tris HCl was added to precipitate out the DNA. The extracted DNA solution could 
then be used directly in the PCR reaction mix. 
 
2.1.2.1. PCR Reaction Mix 
The primers used to genotype the p100Δ and p100ΔRelb colonies are listed in 
Table 2.3. The PCR reaction mix per sample was as follows: 1µl each primer, 16µl 
ReddyMix (containing inert red dye, Taq DNA polymerase, 1.5mM MgCL2 and 
dNTPs) (Thermo Scientific, UK) and 2µl sample DNA solution. 
 
2.2. Medium and Supplements 
All dissected tissues and cells were handled in RF10 medium, prepared as 
shown in Table 2.5. 
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DNA Extraction Buffer 10x 
Reagents Conc Volume Supplier 
NaOH 10N 1M 1,250µl Sigma-Aldrich, UK 
EDTA 500mM 200µl AccuGENE (BioWhittaker) 
H2O - 48,550µl - 
 
Table 2.2 Reagents required for DNA extraction buffer 10x. 
Solution is used at 1x concentration. 
 
 
 
  Primer Name Primer Sequence 
p100 Forward ATCAATAAACACGACCGGAG 
p100 Reverse CAACTAACAGATCCAGGCAC 
SV40 
Forward 
ATGAATGGGAGCAGTGGTGG Primers 
SV40 Reverse GGTGTAAATAGCAAAGCAAGCAAG 
p100 
Cycle 45 seconds 94oC; 45 seconds 60oC; 1 minute 72oC: 33x 
 
Table 2.3 p100Δ  primers and PCR cycle details. 
 
 
 
  Primer 
Name Primer Sequence 
RelB 
273 
GTGGTGCCCGGGAATAGGATTGCTG 
RelB 
106 
CCATTTTGCTCTGGGTCTGTGTCTG 
RelB 4 CATCGACGAATACATTAAGGAGAACGG 
Primers 
HHNEO AAATGTGTCAGTTTCATAGCCTGAAGAACG 
RelB 
Cycle 1 minute 95oC; 1.5 minutes 60oC; 1 minute 72oC: 35x 
 
Table 2.4 RelB primer and PCR cycle details. 
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RF10 Medium 
Medium and 
supplements Volume 
Final 
concentration Supplier 
RPMI 500ml - Sigma-Aldrich, UK 
L-glutamine 5ml 1% Sigma-Aldrich, UK 
Penicillin 
Streptomycin 10ml 2% Sigma-Aldrich, UK 
Heat-inactivated 
foetal bovine serum 50ml 10% Hyclone 
 
Table 2.5 Supplements required for RF10 medium. 
 
 
 
 
 
Digestion Buffer 
Reagents Concentration Supplier 
Collagenase/Dispase 2.5 mg/ml R&D Systems, Minneapolis, MN 
DNase I 100 µg/ml Sigma- Aldrich, UK 
RPMI - Sigma- Aldrich, UK 
 
Table 2.6 Reagents required for enzyme digestion buffer 1x. 
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Dilution Conjugate Antibody Clone Conc. 
Confocal FACs 
Supplier 
CD3ε 145-2C11 
0.5mg/ml 1/100 1/100 e-bioscience 
CD8α 53-6.7 0.5mg/ml - 1/200 e-bioscience 
CD11c N418 0.5mg/ml 1/150 1/100 e-bioscience 
CD31 N418 0.5mg/ml 1/100 - e-bioscience 
CD45.2 104 0.5mg/ml 1/100 - e-bioscience 
CD103 2E7 0.5mg/ml 1/100 1/100 e-bioscience 
CD169 3D6.112 0.1mg/ml 1/50 - AbD Serotec 
F4/80 BM8 0.5mg/ml 1/100 - e-bioscience 
FDCM1 4E3 0.5mg/ml 1/100 - e-bioscience 
FoxP3 FJK-16s 0.5mg/ml 1/50 1/200 e-bioscience 
IgD 11-26c 0.5mg/ml 1/300 - e-bioscience 
Ki67 SP6 0.2mg/ml 1/400 - Abcam 
FITC 
VCAM-1 429 0.5mg/ml 1/100 - e-bioscience 
CD3ε 145-2C11 
0.2mg/ml - 1/50 BD Pharmingen PE 
CD86 GL1 0.2mg/ml - 1/200 e-bioscience 
PE Cy5.5 B220 RA3-6B2 
0.2mg/ml - 1/200 e-bioscience 
PerCP 
Cy5.5 CD11b M1/70 
0.2mg/ml - 1/3500 e-bioscience 
CD4 GK1.5 0.2mg/ml - 1/400 e-bioscience APC 
CD11c N418 0.2mg/ml - 1/300 e-bioscience 
B220 RA3-6B2 
0.5mg/ml 1/200 - e-bioscience 
CD69 H1-2F3 0.5mg/ml - 1/500 e-bioscience Biotin 
MAdCAM-
1 
MECA-
367 
0.5mg/ml 1/100 - e-bioscience 
CCL21 polyclonal 
0.1mg/ml 1/100 - R&D Systems 
CXCL13 polyclonal 
0.1mg/ml 1/50 - R&D Systems Purified 
IgA C10-1 o.5mg/ml 1/200 - BD Pharmingen 
CD4-647* GK1.5 0.5mg/ml 1/200 - e-bioscience 
Gp38/Podo
planin 8.1.1 
Supernatant 
1/2 - ** 
Other 
IgM- 
Rhodamine 
Red 
- 
1.5mg/ml 
1/400 - 
Jackson 
ImmunoResearch 
Laboratories 
Table 2.7 Primary antibodies for immunofluorescent staining for 
confocal microscopy and FACs analysis. 
 
* CD4 was directly conjugated using the Alexa Fluor 647 mAb Labeling Kit 
(Invitrogen, Carlsbad, CA). 
** (Supernatant) Kind gift from A. Farr, University of Washington, Seattle, WA. 
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2.3. Isolation of Spleen, mLN and Colon 
Spleen, mLN and colon were dissected from mice of varying ages from 
postnatal day 10 (P10) to P21 and all the attached fat was removed. The fat attached 
to the mLN and colon was removed by microdissection. All dissected tissues were 
stored in RF10 medium (Table 2.5) during handling.  
 
2.3.1. Freezing of Tissues 
To freeze the spleen, the tissue was placed on a section of aluminium foil and 
place on a Petri dish on dry ice. Once frozen the spleen was wrapped in the foil and 
transferred to -80oc freezer for storage. 
To freeze the colon, the tissue first had all luminal contents removed. This was 
done carefully to avoid damaging the tissue. Once cleaned the tissue was placed on 
aluminium foil with the cecum in the centre and the rest of the colon coiled around 
the outside. The tissue was frozen on dry ice and stored at -80oc. 
 
2.3.1.1.  Cryostat Sectioning of Frozen Tissues 
The tissue was removed from storage (-80oC) and placed in the cryostat. A 
circle of wet filter paper (Whatman) was placed on a chuck and left to freeze followed 
by a large drop of OCT compound (Tissue Tek). The tissue was added to the 
compound with the flat side facing upwards. The chuck was then placed in the chuck 
holder and 5µm sections were cut and collected onto either a 4-spot microscope slide 
(C.A Hendley Lts, Essex, UK) for the spleen or an extra-adhesive microscope slide 
(Surgipath, UK) for the colon. The slides were left to air dry for at least 40 minutes 
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then fixed in cold (4oC) acetone (Sigma-Aldrich, Poole, UK) for 20mins at 4oC. Fixed 
slides were stored at -20oC. 
 
2.3.1.2.  Immunofluorescent Staining of Cryostat Sections 
 Slides were removed from -20oC and air-dried for approximately 30 
minutes. After hydration in PBS (Sigma-Aldrich, Poole, UK) for 5 minutes, a 
blocking solution of 10% goat serum (Sigma-Aldrich, Poole, UK) in 1% BSA/PBS 
was added to each section and incubated for 10 minutes. The antibodies used are 
listed in Table 2.7. The blocking solution was aspirated and the primary antibody 
solution was added and incubated for one hour. The secondary antibodies were cross-
absorbed with 10% normal mouse serum (NMS) (Sigma-Aldrich, Poole, UK) in 1% 
BSA/PBS. After primary antibody incubation, the slides were washed in PBS for 10 
minutes, and then the secondary antibody solution was added and incubated for 30 
minutes. If tertiary and quaternary antibodies were used then the same process was 
followed as for the secondary antibodies. All secondary and tertiary antibodies are 
listed in Table 2.8. After all antibody incubations and a final wash in PBS, the slides 
were mounted using Vectashield (VectorLaboratories) with or without the nuclei stain 
DAPI. A cover slip was added, excess Vectashield was blotted off and the slides were 
sealed with nail varnish. Finally, all stained slides were stored at -20oC. Confocal 
images were acquired using a Zeiss LSM 510 laser scanning confocal head with a 
Zeiss Axio Imager Z1 microscope (Zeiss, Oberkochen, Germany). Digital images 
were recorded in four separately scanned channels with no overlap in detection of 
emissions from the respective fluorochromes. Confocal micrographs were stored as 
digital arrays of 2048 x 2048 pixels with 8-bit sensitivity; detectors were routinely set 
so that intensities in each channel spanned the 0–255 scale optimally. 
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Dilution Antibody Conc. 
Confocal FACs 
Supplier 
Streptavidin Alexa Fluor 488 1mg/ml 1/300 - Invitrogen 
Streptavidin Alexa Fluor 555 1mg/ml 1/300 - Invitrogen 
Streptavidin Alexa Fluor 647 1mg/ml 1/300 - Invitrogen 
Streptavidin Alexa Fluor APC 1mg/ml - 1/600 Invitrogen 
Donkey anti Goat IgG 555 2mg/ml 1/100 - Invitrogen 
Rabbit anti FITC 1mg/ml 1/200 - R & D Systems 
Goat anti Rabbit IgG FITC 1mg/ml 1/200 - Southern Biotech 
Goat anti Hamster IgG- biotin 1.5mg/ml 1/100 - Vector Labs 
Goat anti Rat IgG- biotin 1mg/ml 1/100 - Southern Biotech 
 
Table 2.8 Secondary and tertiary antibodies. 
 
2.3.1.3. Assessment of Colonic B cell Aggregate Number and Size 
Colonic B cell aggregates were enumerated following immunofluorescence 
staining of colon sections with anti-IgM and visualisation on a fluorescence 
microscope. Three separate sections of colon where assessed for at least three mice of 
each genotype in each age group (WT postnatal day 10, n=2). 
Quantification of B cell aggregate size was performed following 
immunofluorescence staining of colon sections with anti-IgM. Pictures of at least six 
aggregates per colon section were collected using fluorescence microscopy and image 
software ImageJ was used to measure aggregate size. Three mice per genotype were 
analysed. 
 
2.3.1.4. Assessment of B and T cell Segregation in the Spleen 
Confocal images of spleen sections were analysed using LSM software. The 
Region of Interest (ROI) was highlighted and the software calculated the area in µm2. 
The ROI in this instance was the T cell area, marked by positive staining of anti-CD4. 
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At least six images were taken for each section of spleen, for three individual mice for 
each genotype was assessed. 
Assessment of B and T cell segregation was determined by calculation of the 
number of B220+ pixels present in the T cell area; the number of B220+ pixels 
corresponding with the number of B cells.  Between each confocal image the same 
settings were used for each fluorescence channel. Saturated pixels were excluded 
from the analysis. This data was presented as the mean number of B220+ pixels per 
µm2 of T zone area. 
 
2.4. Preparation of Single Cell Suspensions 
2.4.1. Spleen 
The spleen was isolated and placed in RF10 medium. The spleen was cut into 
small fragments and mechanically forced through a nylon cell strainer (70µm, BD 
Falcon). The cell suspension was transferred to a falcon tube in 15 ml RF10 and 
centrifuged (7 minutes, 1400rpm, 4oC). The supernatant was removed and 5 ml of red 
cell lysis buffer was added and incubated on ice for 5 minutes. After this time, 5 ml 
RF10 medium was added to prevent further action of the lysis buffer and centrifuged 
(7 minutes, 1400rpm, 4oC). The supernatant was discarded and the cell pellet was 
resuspended in 5 ml RF10. Cell counts were performed using a haemocytometer. 
 
2.4.2. Mesenteric lymph node and colon 
The mLN was dissected and all fat was removed using a dissecting 
microscope. The mLN was then placed in 1 ml RF10 and roughly teased apart. The 
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colon was isolated and placed in RF10 media on ice. The luminal contents were 
removed and the colon was cut longitudinally and into small pieces, using a dissecting 
microscope. 
The treatment of mLN and colon for enzymatic digestion was the same, as 
follows. Samples were centrifuged (7 minutes, 1400rpm, 4oC) and resuspended in 
500µl collagenase/Dispase and DNase solution (Table 2.6) and incubated at 37oC on a 
thermocycler for 20 minutes, agitated frequently with pipetting. Following this 
incubation, 100µl 0.02% EDTA (Sigma-Aldrich, Poole, UK) was added to each 
sample before centrifugation, followed by addition of 500µl RF10 (7 minutes, 
1400rpm, 4oC). The supernatant was removed and the pellet resuspended in 1 ml 
RF10, each sample was then filtered through a 70µm cell strainer. Filtered samples 
were centrifuged as before and the cell pellets were resuspended in 1 ml RF10. Cell 
counts were performed using a haemocytometer. 
 
2.4.2.1. Immunofluorescent staining of single cell suspensions 
A 96-well v-bottomed plate was used to stain cells for flow cytometric 
analysis with approximately 500,000 cells per well. The cells were washed in 180µl 
0.1% BSA/PBS and centrifuged (1 minute, 2500rpm, 4oC), supernatant discarded.  
The cells were then resuspended in 50µl 0.1% BSA/PBS plus the required primary 
antibodies and incubated (20 minutes, in the dark, at 4oC). After the primary antibody 
incubation, the cells were washed twice with 180µl 0.1% BSA/PBS. If secondary 
antibodies were used, they were added in 50µl 0.1% BSA/PBS and incubated for 20 
minutes in the dark at 4oC. The samples were then washed twice with 180µl 0.1% 
BSA/PBS and resuspended in 100µl PBS ready for flow cytometric analysis. 
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In the case of staining for DC and macrophages populations the single cell 
suspensions were first incubated with Fc block (supernatant of 2.4G2 hybridoma) for 
30 minutes before addition of primary and secondary antibodies. In addition, the 
incubation time for primary antibodies was extended to 30 minutes to allow optimal 
DC staining. 
Four-color flow cytometric analysis was performed using a FACSCalibur (BD 
Biosciences, San Jose, CA) with forward/side scatter gates set to exclude non-viable 
cells. Gates were applied appropriately according to the expression profile of the 
molecules being assayed. Data were analysed with FlowJo software (Tree Star, 
Ashland, OR). 
 
2.5. Preparation of cDNA from Tissue Samples 
The preparation of cDNA from spleen samples involved the acquisition of 
20mm thick cryostat sections from frozen tissues. The samples were collected in 
DNase/RNase free eppendorfs (BioSphere® Micro Tube, SARSTEDT) and stored at -
80oC. High-purity cDNA was generated from purified mRNA using µMacs One-Step 
cDNA synthesis kit, according to the manufacturer’s instructions (Miltenyi Biotec, 
Auburn, CA).  
 
2.5.1. Real time RT-PCR 
 Real-time PCR was performed using IQ SYBR Green Supermix (Bio-
Rad, Hercules, CA) with primers specific for β-actin, Ccl21, Ccl19, Cxcl13, and 
Madcam-1 (Table 2.9). PCRs were conducted in triplicate in 10µl volumes containing 
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200nM primers. After an initial denaturation step (95˚C for 10 min), cycling was 
performed at 95˚C for 15 seconds, 60˚C for 20 s, and 72˚C for 5 seconds (45 cycles). 
Specific amplification was verified by melt curve analysis. mRNA transcript levels of 
each gene were analyzed using Applied Biosystem’s SDS software (Applied 
Biosystems, Foster City, CA) by setting thresholds determining the cycle number at 
which the threshold was reached (Ct). The Ct of the β-actin was subtracted from the 
Ct of the target gene, and the relative amount was calculated as 2-ΔCt. Means of 
triplicate reactions (multiplied 1000-fold) are represented, data shown are 
representative of two separate experiments. 
 
 Primer Sequence 
Gene Forward Reverse 
β-actin CGTGAAAAGATGACCCAGATCA TGGTACGACCAGAGGCATACAG 
Cxcl13 CATAGATCGGATTCAAGTTACGCC TCTTGGTCCAGATCACAACTTCA 
Ccl21 CTTCCTCAGGGTTTGCACAT GCTGCCTTAAGTACAGCCAGAA 
Ccl19 CCTTAGTGTGGTGAACACAACA GGGGTCTAATGATGCGGAA 
Madcam-1 CTCCTTTGCCCTGCTACTGG ACAGTGGTGTGCCCTCAGC 
 
Table 2.9 Primers used for real time RT-PCR. 
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2.6.  Preparation of Blood Serum Samples 
Cardiac punctures were performed on anaesthetised mice by qualified 
technicians in the Biomedical Services Unit, University of Birmingham. Blood 
samples were collected into 1.5ml eppendorf tubes and the blood was allowed to clot. 
Samples were then centrifuged at 4000rpm for 5 minutes. The serum supernatant was 
removed and placed in a clean eppendorf and stored at -20oC. 200µl of each sample 
was sent to RBM Inc, USA, where the test, Rodent MAP v2.0 – Antigens (Multi-
Analyte Profile of 58-biomarkers, Table 2.10) performed. 
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Apo A1 (Apolipoprotein A1)  IP-10 (Inducible Protein-10) (aka CXCL10) 
CD40  KC/GROalpha (Melanoma Growth Stimulatory Activity Protein) 
CD40 Ligand  LIF (Leukemia Inhibitory Factor) 
CRP (C Reactive Protein)  Lymphotactin 
EGF (Epidermal Growth Factor)  M-CSF (Macrophage-Colony Stimulating Factor) 
Endothelin-1  MCP-1 (Monocyte Chemoattractant Protein-1) (aka CCL2) 
Eotaxin  MCP-3 (Monocyte Chemoattractant Protein-3) (aka CCL7) 
Factor VII  MCP-5 (Monocyte Chemoattractant Protein-5) 
FGF-9 (Fibroblast Growth Factor-9)  MDC (Macrophage-Derived Chemokine) 
FGF-basic (Fibroblast Growth Factor-basic)  MIP-1alpha (Macrophage Inflammatory Protein-1alpha) (aka CCL3) 
Fibrinogen  MIP-1beta (Macrophage Inflammatory Protein-1beta) (aka CCL4) 
GCP-2 (Granulocyte Chemotactic Protein-
2)  
MIP-1gamma (Macrophage Inflammatory Protein-
1gamma) (aka CCL9) 
GM-CSF (Granulocyte Macrophage-
Colony Stimulating Factor)  
MIP-2 (Macrophage Inflammatory Protein-2) (aka 
CXCL14) 
GST-alpha (Glutathione S-Transferase 
alpha)  
MIP-3beta (Macrophage Inflammatory Protein-
3beta) (aka CCL19) 
Haptoglobin  MMP-9 (Matrix Metalloproteinase-9) 
IFN-gamma (Interferon-gamma)  MPO (Myeloperoxidase) 
IgA (Immunoglobulin A)  Myoglobin 
IL-10 (Interleukin-10)  OSM (Oncostatin M) 
IL-11 (Interleukin-11)  RANTES (Regulation Upon Activation, Normal T-Cell Expressed and Secreted) 
IL-12p70 (Interleukin-12p70)  SAP (Serum Amyloid P) 
IL-17 (Interleukin-17)  SCF (Stem Cell Factor) 
IL-18 (Interleukin-18)  SGOT (Serum Glutamic-Oxaloacetic Transaminase) 
IL-1alpha (Interleukin-1alpha)  TIMP-1 (Tissue Inhibitor of Metalloproteinase Type-1) 
IL-1beta (Interleukin-1beta)  Tissue Factor 
IL-2 (Interleukin-2)  TNF-alpha (Tumor Necrosis Factor-alpha) 
IL-3 (Interleukin-3)  TPO (Thrombopoietin) 
IL-4 (Interleukin-4)  VCAM-1 (Vascular Cell Adhesion Molecule-1) 
IL-5 (Interleukin-5)  VEGF (Vascular Endothelial Cell Growth Factor) 
IL-6 (Interleukin-6)  vWF (von Willebrand Factor) 
IL-7 (Interleukin-7)   
 
Table 2.10 Table of biomarkers in Rodent MAP v2.0 – Antigens (RBM Inc, USA) 
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2.7. Foetal Liver Cell Reconstitution Studies 
2.7.1. Preparation of Foetal Liver Cells 
Owing to the fact that p100Δ mice survive to around 3 weeks of age, 
harvesting of bone marrow cells was difficult, therefore to increase the number of 
cells recovered, foetal liver cells (FLCs) from E15 embryos were used instead. At E15 
the liver is the major site for haematopoiesis. 
Female mice at day 15 of gestation were sacrificed and the embryos removed. 
The livers of each embryo were dissected using a dissecting microscope and kept 
individually in RF10. Each liver was passed through a 70µm cell strainer into 5 ml 
RF10 to produce a single cell suspension of FLCs. The samples were centrifuged (7 
minutes, 2500rpm, 4oC) and washed once in 5 ml 1% BSA/PBS. The supernatant was 
removed and the cell pellets were resuspended gently in 1 ml 10% DMSO/FCS, 
avoiding generation of air bubbles. The samples were then transferred quickly to a 
pre-cooled (-80oC) container lined with isopropanol (Sigma-Aldrich, Poole, UK). The 
container plus samples was placed back in the -80oC freezer until the following day, 
when the samples were transferred to liquid nitrogen for storage. 
When the FLC samples were ready for use they were thawed by addition of 
500µl RF10, with gentle agitation using a 1ml pipette. Once thawed the cell 
suspensions were placed in 30ml RF10 in a falcon tube and left on ice for 20 minutes, 
followed by centrifugation (7 minutes, 2500rpm, 4oC) and resuspension in 1ml RF10 
ready for cell counting. Cell counts were performed using a haemocytometer, with the 
addition of Trypan Blue (Sigma-Aldrich, Poole, UK) to identify dead cells. 
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2.7.2. Foetal Liver Cell Reconstitutions 
WT mice (age 8-11wks) were lethally irradiated and reconstituted with either 
100% p100Δ, 50:50 WT:p100Δ or 100% p100Δ FLCs. Three months following 
reconstitution the mice were sacrificed and tissues were isolated and frozen. This 
work was carried out in collaboration with Dr Elena Vigorito at the Babraham 
Institute, Cambridge. 
 
2.8. Statistical Analysis 
All experiments were analysed using nonparametric, two-tailed Mann-
Whitney U-test, unless otherwise indicated. Confidence interval was set at 95%. 
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3. NF-κB2 Involvement in Tertiary Lymphoid Tissue 
Development in the Colon 
 
3.1. Introduction 
Isolated lymphoid follicles (ILFs) are located throughout the small intestine 
and colon, and consist of an organised cluster of B and T lymphocytes, and DCs. ILFs 
develop postnatally and can be identified in C57Bl6 mice from around postnatal day 
25 (P25) (Hamada et al., 2002). It has been proposed that ILFs develop from 
precursor structures termed cryptopatches (CPs) (Eberl, 2005). CPs are composed of a 
cluster of LTi-like cells (CD3-CD4+IL-7Rα+RORγt+) (Saito et al., 1998; Eberl and 
Littman, 2004) and DCs (Kanamori et al., 1996). The transition of a CP to an ILF is 
defined by the recruitment of B cells to the structure and this process is dependent on 
B cells expressing CCR6 (McDonald et al., 2007), CXCR5 (Velaga et al., 2009), and 
Integrin α4β7 (Wang et al., 2008). The expression of these receptors allows B cells to 
migrate to the intestine in response to CCL20 (ligand for CCR6), expressed by 
epithelial cells (Tanaka et al., 1999), CXCL13 (ligand for CXCR5), expressed by a 
subtype of DCs, and MAdCAM-1 (ligand for Integrin α4β7), expressed by ILF-
associated vessels (Wang et al., 2008). Furthermore, it has been shown that ILF B 
cells are predominately B-2 B cells, based on expression of CD23 and lack of CD5 
expression (Hamada et al., 2002; Wang et al., 2006; Lorenz et al., 2003), and display 
a mature phenotype, co-expressing IgM and IgD (Wang et al., 2006). 
Eberl suggested subdivision of ILFs into two types: immature and mature, the 
difference being that mature ILFs possess germinal centres (GCs) (Eberl and Sawa, 
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2010). Essentially, the formation of GCs allows for B cells to undergo Ig class-
switching and it has been shown that ILF B cells preferentially differentiate into IgA 
producing plasma cells (Wang et al., 2006). Work by Yamamoto et al, demonstrated 
that mice treated in-utero with antagonistic LTβR-Ig, to ablate PP development, were 
still able to produce Ag-specific intestinal IgA (Yamamoto et al., 2000) and later it 
was discovered that in this model, increased numbers of ILFs developed in a 
potentially compensatory mechanism for the loss of PP development (Kweon et al., 
2005). 
The LTα1β2-LTβR signalling axis is indispensable for SLO development and 
it has been postulated that it plays a similar role in tertiary lymphoid tissue 
development. In mice where LT expression is compromised, such as Ltα-/- or LtβR-/- 
mice, or in mice lacking LTi cells (RORγt-/- mice), CPs and ILFs fail to develop 
(Ivanov et al., 2006; De Togni et al., 1994; Hamada et al., 2002; Taylor et al., 2004; 
Lorenz et al., 2003). Moreover, signalling downstream of LTβR activates the 
alternative NF-κB pathway (Dejardin et al., 2002; Müller and Siebenlist, 2003). The 
p100Δ mouse model exhibits constitutive alternative pathway activation and the 
development of secondary lymphoid tissue in this model has previously been 
investigated (Ishikawa et al., 1997; Guo et al., 2007). In a novel approach to studying 
tertiary lymphoid tissue development, we utilise the p100Δ model to investigate the 
role of the alternative NF-κB pathway in the development of colonic ILFs. 
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3.2. Results 
3.2.1. Early postnatal death of p100Δ  mice 
Previous studies have described the reduced body weight and early postnatal 
death of p100Δ mice (Ishikawa et al., 1997). Ishikawa et al, attributed this phenotype 
to gastric hyperplasia of the stomach epithelial layer, with occlusion of the lumen. We 
confirm this published data showing that p100Δ mice appear smaller than WT 
littermates at two weeks of age (Figure 3.1. A) and after birth they gain weight at a 
slower rate (Figure 3.1. B). The survival of p100Δ mice is noticeably reduced 
compared with WT littermates, with 100% death rate by four weeks of age (Figure 
3.1. C). Constitutive activation of the alternative NF-κB pathway leads to early 
postnatal death. 
 
3.2.2. Augmented formation of colonic B cell aggregates in p100Δ  
mice 
Within the intestine tertiary lymphoid tissues encompass CPs and ILFs. 
Intestinal ILFs are inducible structures, which occur postnatally and are defined as a 
cluster of B lymphocytes. In C57Bl6 mice, ILFs remain largely absent until P25 
(Hamada et al., 2002). 
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Figure 3.1 Reduced survival and body weight of p100Δ  mice 
 
A Reduced size and body weight of p100Δ mice in comparison to WT littermates. 
(Postnatal day 15 and 18 n≥17, day 21 n≥8, for each genotype). B Limited postnatal 
survival of p100Δ mice (n=17 for each genotype). 
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Cryostat sections of colon were stained with immunofluorescently labelled 
antibodies to identify B cell aggregates. Figure 3.2, shows tilescan images (acquired 
using confocal microscopy) of WT and p100Δ colons stained with IgM (red) to 
identify B cell aggregates; sections were counterstained with nuclei dye DAPI (grey). 
p100Δ mice present with an increase in B cell aggregates in the colon (Figure 3.2. A). 
B cell aggregates were enumerated following immunofluorescence staining of 
colon sections with anti-IgM and visualisation on a fluorescence microscope (Leica 
DM6000). Three separate sections of colon where assessed for each individual 
animal. A significant increase in colonic B cell aggregates in p100Δ mice was 
observed at P15 (WT, n=4, mean=4.9±2.8, p100Δ, n=4, mean=20.9±8.7, p=0.013) 
and P21 (WT, n=3, mean=1.5±1.3, p100Δ, n=6, mean=41.2±17.9, p=0.003) with 
respect to WT mice (Figure 3.2. B). Quantification of B cell aggregate size was 
performed following immunofluorescence staining of colon sections with anti-IgM 
and measurement of the IgM foci. At P21, p100Δ mice exhibit larger colonic B cell 
aggregate size compared with WT littermate controls (WT, n=3, mean=15611±2270, 
p100Δ, n=3, mean=37328±9031, p=0.100) (Figure 3.2. C).  
Constitutive activation of NF-κB2 p100 leads to a significant increase in B 
cell aggregates in the colon. The structure and organisation of these aggregates was 
then assessed for their similarity to WT ILFs. 
 
 
 
 
 
 
 82 
Figure 3.2 Augmented formation of colonic B cell aggregates in p100Δ  mice 
 
A Immunofluorescence staining of colon sections showing DAPI nuclei staining 
(grey) and B cells stained with anti-IgM antibody (red). p100Δ mice display increased 
numbers of colonic B cell aggregates. Representative tilescans shown. Scale bar 
indicates 1mm. 
 
B B cell aggregates per colon section were enumerated following 
immunofluorescence staining for IgM (as in A) and viewed by fluorescence 
microscopy. P10: WT n=3, p100Δ n=3. P15: WT n=4, p100Δ n=4. P21: WT n=4, 
p100Δ n=6. Graph shows mean number of B cell aggregates per colon, errors bars 
indicate standard deviation. Students T-test * p≤ 0.05, ** p≤ 0.02. 
 
C The B cell aggregates in p100Δ colon at P21 show a trend to be larger in area than 
in WT littermates (n=3 for each genotype). Bar indicates mean. 
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Figure 3.3 Organisation of haematopoietic cells within p100Δ  colonic B cell 
aggregates closely resembles WT ILFs 
 
WT ILFs (A and B, left panel) typically consist of a B220+ core (red) surrounded by 
CD11c+ dendritic cells (green, 2nd line), interspersed with CD3+ T cells (green, 3rd 
line). F4/80+ macrophages (green, 4th line) are located throughout the colonic tissue, 
but not within the ILF. The structure of p100Δ colonic B cell aggregates (A and B, 
right panel) closely resembles that of WT ILFs. Representative immunofluorescent 
confocal images are shown. 
 
A, x10 magnification. Scale bar denotes 200µm. 
B, x40 magnification. Scale bar denotes 50µm. 
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Figure 3.4 B cells constituting WT ILFs and p100Δ  B cell aggregates display a 
mature phenotype and are capable of class switching 
 
The phenotype of the B cells present was determined by staining with anti-IgM 
antibody (red), anti-IgD (green), anti-B220 (blue) and the nuclei stain DAPI (grey). 
 
A Characteristically the B cells constituting WT ILFs exhibit a mature phenotype, 
B220+IgM+IgD+ (A, merge, left panel, pale blue). In addition, B220-IgM+, B220-IgD+ 
(A, merge left panel, red and green respectively) and B220-IgA+ (B, left panel) cells 
are also present. This phenotype is mirrored in the p100Δ colon (A, right panel). 
Representative immunofluorescent confocal images are shown (x40 magnification). 
Scale bar denotes 50µm. 
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Figure 3.5 Presence of LTi-like cells and Tregs, and normal proliferation of 
colonic aggregate cells in p100Δ  mice 
 
A Staining with anti-B220 (blue), anti-CD3 (green) and anti-CD4 (red) allows 
identification of CD3+CD4+ T cells (yellow cells) and CD3-CD4+ LTi-like cells (red, 
white circles) in both WT ILFs and p100Δ B cell aggregates. 
 
B Regulatory T cells (white circles) were identified in both WT ILFs and p100Δ B cell 
aggregates by co-staining of anti-Foxp3 (green, nuclear stain) and anti-CD4 (red). 
Representative immunofluorescent confocal images are shown (x40 magnification).  
 
C Ki67 staining identifies proliferating epithelial cells in the WT and p100Δ colon 
(dotted line), as well as proliferating cells within the WT ILFs and p100Δ B cell 
aggregates (arrow heads). B cells stained with anti-B220 (red) and T cells stained 
with anti-CD4 (blue). 
 
D Close-up images of C (upper row). 
 
Scale bar represents 50mm. Top panel of A, B and C counterstained with DAPI. 
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3.2.3. Organisation of haematopoietic cells within p100Δ  colonic B 
cell aggregates closely resembles WT ILFs 
Intestinal WT ILFs consist of a central core of B220+ B lymphocytes, 
surrounded by a ring of CD11c+ DCs and interspersed with CD3+ T cells (Hamada et 
al., 2002) (Figure 3.3. A & B, left panel). The B cell aggregates observed in the colon 
of p100Δ mice displayed a structure that closely resembles this phenotype (Figure 3.3. 
A & B, right panel). Interestingly, despite this normal cellular organisation within the 
B cell aggregates, areas adjacent to these regions display differences in cellular 
presence. A clear increase in CD45+ haematopoietic cells can be seen in p100Δ mice 
and this increase is attributable to an increase in CD11c+ DCs and, to a lesser extent, 
CD3+ T cells (Figure 3.3. A, x10 magnification). In addition, CD11c+ DCs and CD3+ 
T cells appeared to be spread throughout the tissue in the p100Δ colons instead of 
being in and around the B cell aggregates, as in WT colons (Figure 3.3. A). 
This data provides the first piece of evidence that the colonic B cell aggregates 
observed in p100Δ mice share characteristics analogous with ILFs. 
 
3.2.4. B cells constituting WT ILFs and p100Δ  B cell aggregates 
display a mature phenotype and are capable of class-switching 
The defining characteristic of an ILF is the presence of B lymphocytes. 
Characterisation of these B cells was performed by confocal microscopy by staining 
sections of colon with anti-B220 to identify B cells and with anti-IgD and anti-IgM to 
define maturity. Mature peripheral B cells are B220+IgD+IgM+ (Norvell and Monroe, 
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1996) and are able to undergo class switching, during which expression of B220 is 
lost, as is either IgM, IgD or both, resulting in their differentiation into antibody 
producing plasma cells (for example B220-IgD-IgM+ or B220+IgD+IgM-). The 
majority of B lymphocytes within WT ILF display a mature phenotype, 
B220+IgD+IgM+ (individually blue, green and red respectively, coexpression: pale 
blue.) (Figure 3.4. A, left panel). The B cells constituting p100Δ B cell aggregates 
also display this mature phenotype (Figure 3.4. A, right panel). In addition, B220-
IgD+ (green) and B220-IgM+ (red) plasma cells can be seen in both mice indicating 
that class switching is not affected in the colon of p100Δ mice. 
The production of IgA antibody is crucial to effective gut immunity and there 
are several possible mechanisms explaining the presence of IgA secreting plasma 
cells in the intestine. Firstly, there is evidence that chemokines such as CCL25, 
CCL28 and MAdCAM-1 are key to IgA plasma cell localisation to the intestine 
(Bowman et al., 2002; Hieshima et al., 2004). Secondly, several groups have shown 
that in situ class switching of B220+IgM+ B cells to B220-IgA+ plasma cells and the 
presence of ILFs are an important source of IgA production in the gut (Fagarasan et 
al., 2001; Lorenz and Newberry, 2004; Eberl, 2005). In Figure 3.4, B220-IgA+ plasma 
cells (green) can be seen in WT and p100Δ mice in the vicinity of ILFs (Figure 3.4. 
B). It would be interesting and useful to investigate the origins and functional 
capabilities of these cells. 
This data demonstrating that the mature B cell phenotype seen in WT ILF B 
cells is reflected in p100Δ B cell aggregates provides the second piece of evidence 
that the lymphoid structures in the colon of p100Δ mice are ILFs. 
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3.2.4.1. Presence of LTi-like cells and Tregs, and normal 
proliferation of colonic lymphoid aggregate cells in p100Δ  
mice 
The critical role for and presence of LTi-like cells in ILF development has 
been well described (Eberl and Littman, 2004; Ivanov et al., 2006). Staining of colon 
sections with immunofluorescent antibodies against B220 (blue) to show B cell 
aggregates, CD3 (green) to label T cells and CD4 (red), allowed identification of LTi-
like cells expressing high levels of CD4, but not CD3 or B220 (Figure 3.5. A. Red 
cells, bottom panel). These cells are clearly present in both WT ILFs and p100Δ B 
cell aggregates. To rule out the chance of these cells being CD4 expressing DCs, 
staining was performed with CD3 and CD11c combined in the FITC channel 
alongside staining for CD4 and B220 and clear LTi-like cells were observed in both 
WT ILFs and p100Δ B cell aggregates (Figure 9.5). 
Regulation of immune responses in the gut is critical due to the exposure of 
intestinal cells to a broad range of commensal and pathogenic bacteria and the 
incidence of CD4+ regulatory T cells within the gut is indispensible for this 
regulation. T regulatory cells are identifiable by their expression of the transcription 
factor Foxp3 (Hori et al., 2003). Figure 3.5, shows the presence of CD4+Foxp3+ T 
regulatory cells, with characteristic punctate nuclear Foxp3 staining, within WT ILFs 
and p100Δ B cell aggregates (Figure 3.5. B). This data demonstrates that regulatory T 
cells are present in the colon of p100Δ mice, as they are in WT mice. In this figure the 
number of Tregs appears reduced in p100Δ B cell aggregates, therefore assessment of 
Treg numbers in the colon would be beneficial to expand this study.  
The question of whether the increase in the number of B cell aggregates and 
their size (P21) in p100Δ mice is a result of increased homing of B cells to the colon 
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or due to increased proliferation of B cells in situ was assessed by 
immunofluorescence staining for the proliferation marker Ki67. Ki67+ staining of 
epithelial villus cells can be seen in the colon of both WT and p100Δ mice (Figure 
3.5. C. Dotted line). In addition, Ki67+ lymphocytes can be seen in the B cell 
aggregates (Figure 3.5. C. Arrows). There was no difference in Ki67 expression in 
p100Δ aggregates compared with WT ILFs. This indicates that the large number of B 
cell aggregates in the colon of p100Δ mice is not due to an increase in B cell 
proliferation in situ, but more likely due to enhanced homing/recruitment of B cells to 
the colon. With respect to the T cell population within the WT ILFs and p100Δ B cell 
aggregates, there is no obvious difference in proliferation. 
The identification of LTi-like cells and Tregs within WT ILFs and the presence 
of analogous populations in the p100Δ B cell aggregates provides the third piece of 
evidence supporting the hypothesis that these aggregates are ILFs. 
 
3.2.5. Stromal cells of p100Δ  colonic B cell aggregates express the 
same markers as WT ILF stromal cells 
The micro-architecture of secondary lymphoid tissues relies heavily on the 
expression of chemokines and cell adhesion molecules by stromal cells to orchestrate 
lymphocyte recruitment and organisation. CXCL13 is responsible for homing of 
CXCR5+ B cells to B cell follicles in the white pulp of the spleen. In mice lacking 
NF-κB2, expression of CXCL13 is downregulated in secondary lymphoid tissues, 
resulting in disrupted micro-architecture (Carragher et al., 2004) and in the p100Δ 
mouse model it has been previously described that CXCL13 mRNA is slightly but not 
significantly increased (Guo et al., 2007). With regards to tertiary lymphoid tissue 
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development, CXCL13 and expression of its receptor CXCR5 on B cells is essential 
for ILF formation (Velaga et al., 2009). In addition, the cell adhesion molecule, 
VCAM-1, has been shown to be expressed by ILF stroma (Taylor et al., 2007). 
Immunofluorescence staining was used to assess the expression of CXCL13 and 
VCAM-1 by intestinal stromal cells. CXCL13+ and VCAM-1+ stromal cells can be 
seen localised within the WT ILFs and p100Δ B cell aggregates, and there are no 
obvious differences in the localisation of these markers between the two genotypes 
(Figure 3.6. A). However, with respect to CXCL13 expression, there is a potential 
increase in staining intensity, indicating an increase in protein expression, in the 
colonic B cell aggregates in p100Δ mice, corresponding with previously published 
data that Cxcl13 is a downstream gene target of NF-κB2 (Liptay et al., 1994). 
In order for lymphocytes to migrate to secondary and tertiary lymphoid tissue 
organogenesis, a suitable vascular network is required. The vascular structures 
associated with ILFs express MAdCAM-1 and CD31 (Wang et al., 2008). Several 
studies have demonstrated the requirement for MAdCAM-1 expression and that of its 
receptor, Integrin α4β7, in the development of ILFs (Miles et al., 2008; Wang et al., 
2008; Gorfu et al., 2009). In Figure 3.6, expression of MAdCAM-1+ and CD31+ 
vascular structures can be A consistent increase in CD31 staining was visible across 
different sections of colon from individual p100Δ mice and across all p100Δ mice 
investigated. 
The data presented here shows clearly that intestinal stromal cells within and 
around the colonic B cell aggregates in p100Δ mice possess all the defining features 
observed in WT ILFs, further supporting the hypothesis that these structures are ILFs. 
 91 
Figure 3.6 Stromal cells of p100Δ  colonic B cell aggregates express markers 
comparable to WT ILF stroma 
 
A Stromal cells present in WT ILFs and p100Δ B cell aggregates express the B cell 
homing chemokine CXCL13 (green, top panel) and the adhesion molecule VCAM-1 
(green, bottom panel). B cells stained with anti-B220 (red). 
 
 B Staining for tissue vasculature with anti-CD31 (green) and anti-MAdCAM-1 (blue) 
shows co-expression of these markers on vascular endothelium (pale blue cells, 
merge, white circles). B cells stained with anti-IgM (red). 
 
Tissue counterstained with DAPI (grey). Representative immunofluorescent confocal 
images are shown (x40 magnification). Scale bar denotes 50µm. 
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3.2.6. WT and p100Δ  foetal liver cell reconstitutions  
In order to dissect the haematopoietic versus stromal cell contribution to the 
increase in colonic ILF formation observed in p100Δ mice, foetal liver cell (FLC) 
reconstitutions were performed. Host WT mice were used to provide a normal stromal 
environment and following lethal irradiation, these mice were injected with either 
50:50 mix of WT and p100Δ FLCs or 100% p100Δ FLCs, to reconstitute their 
immune system (positive control mice received 100% WT FLCs). In this way the 
development of colonic ILFs was assessed in a situation where haematopoietic cells 
express constitutively active NF-κB2 in a normal stromal environment. Three months 
post-transfer the colons of the reconstituted mice were harvested and ILF formation 
was assessed by confocal microscopy. 
Figure 3.7, shows enumeration of B cell aggregates, as previously described 
(Chapter 3.2.2, Materials and Methods 2.2.1.3). Mice receiving 100% p100Δ FLCs 
presented with a significant increase in colonic B cell aggregates compared with those 
receiving 100% WT FLC (100% WT, n=4, mean=10.3±10.9, 100% p100Δ, n=3, 
mean=73.8±44.1, p=0.004) (Figure 3.7. A). Interestingly, mice receiving 50:50 
WT:p100Δ FLCs developed B cell aggregates in similar numbers to that seen in mice 
receiving 100% WT FLC (50:50 WT:p100Δ, n=5, mean=13.3±6.6, p=0.617). The 
organisation of the B cell aggregates formed in these chimeric mice resembles WT 
ILF structures (Figure 3.7. B). The aggregates consist of a B220+ B cell core (red), 
surrounded with CD11c+ DCs (green, middle panel) and interspersed with CD3+ T 
cells (green, lower panel). LTi-like cells (CD3-CD4+, blue cells, bottom panel) can be 
seen within these structures and there is no obvious difference between the different 
chimeric animals. In addition, the majority of B cells present with a mature 
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phenotype, B220+IgD+IgM+ (Figure 3.7. C, pale blue cells, bottom panel). 
Furthermore, B220-IgD+ (green) and B220-IgM+ (red) plasma cells can be seen in 
both mice indicating that class switching is not affected in the colons of the 
reconstituted animals. 
This data demonstrates that haematopoietic cells with constitutive activation 
of NF-κB2 p100 are able to significantly increase ILF formation in the colon of WT 
host mice. The observation that mice receiving 50:50 WT:p100Δ FLC developed ILFs 
in similar numbers to that seen in mice receiving 100% WT FLC, may be due to a 
reduction in cell survival of p100Δ derived lymphocytes when in competition with 
WT derived cells (Appendix, Figure 9.4), or due to a competitive defect in 
lymphocyte homing to the intestine. 
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Figure 3.7 Mice receiving 100% p100Δ  foetal liver cells show an increase in 
colonic B cell aggregates with ILF characteristics 
 
WT mice were lethally irradiated and reconstituted with either 100% WT foetal liver 
cells (FLC), 50:50 WT:p100Δ FLC or 100% p100Δ FLC. 
 
A Colonic B cell aggregates were enumerated by staining colon sections with 
fluorescently labelled anti-B220 and visualised using fluorescence microscopy. Graph 
shows number of B cell aggregates per colon. Bar indicates mean. Students T-test, ** 
p≤0.02, ns= not significant. 
 
B Colon sections were stained for CD11c+ DCs (green, upper panel), CD3+ T cells 
(green, lower panel), B220+ B cells (red) and CD4+ T cells (blue). Scale bar denotes 
50µm. 
 
C The phenotype of the B cell present in the aggregates was determined by staining 
with anti-IgM antibody (red), anti-IgD (green), anti-B220 (blue) and the nuclei stain 
DAPI (grey). The majority of B cells present within the aggregates have a mature 
phenotype, B220+IgM+IgD+ (A, merge, left panel, pale blue). In addition, B220-IgM+, 
B220-IgD+ (A, merge left panel, red and green respectively) and B220-IgA+ (B, left 
panel) plasma cells are also present. Scale bar denotes 50µm. 
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Figure 3.8 The B cell aggregate stroma in mice receiving 100% p100Δ  FLC 
express ILF stromal markers 
 
A Stromal cells present in WT ILFs and p100Δ B cell aggregates express the B cell 
homing chemokine CXCL13 (green, top panel) and the adhesion molecule VCAM-1 
(green, bottom panel). B cells stained with anti-B220 (red). 
 
B Staining for tissue vasculature with anti-CD31 (green) and anti-MAdCAM-1 (blue) 
shows co-expression of these markers on vascular endothelium (pale blue cells, 
merge, white circles). B cells stained with anti-IgM (red) and tissue counterstained 
with DAPI (grey). 
 
Representative immunofluorescent confocal images are shown (x40 magnification). 
Scale bar denotes 50µm. 

 96 
3.2.6.1. Expression of stromal markers in colonic ILFs in mice 
receiving 100% p100Δ  foetal liver cells 
Following analysis of the presence of ILFs in chimeric mice, the 
characteristics of the ILF stroma was assessed using confocal microscopy. CXCL13 
and VCAM-1 expression can be seen in the colonic B cell aggregates found in mice 
receiving 100% WT, 50:50 mix of WT and p100Δ or 100% p100Δ FLCs (Figure 3.8. 
A) and there are no obvious differences in the expression of these markers. 
In Figure 3.8, expression of MAdCAM-1+ and CD31+ vascular structures can 
be seen in the vicinity of B cell aggregates in 100% WT FLC, 50:50 mix of WT and 
p100Δ and 100% p100Δ FLCs reconstituted colon (Figure 3.8. B). 
This data demonstrating the ability of p100Δ haematopoietic cells to drive an 
increase in colonic ILF formation, does not completely rule out a role for the stroma. 
The ILF formation in these reconstitution experiments was assessed three months post 
transfer, whereas p100Δ mice develop augmented ILF formation from two weeks of 
age. It would be interesting and useful to perform further reconstitution experiments 
for analysis at 2-3 weeks post transfer to evaluate this further. Nevertheless, the 
important role of haematopoietic cells in augmenting ILF development is clear and 
therefore further characterisation of this cell compartment was undertaken. 
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3.2.7. Characterisation of lymphocyte subsets in p100Δ  mice 
3.2.7.1. Differences in spleen, mLN and colon absolute cell 
number in p100Δ  mice 
When absolute cell counts were performed following digestion of the spleen, 
mLN and colon of WT and p100Δ mice, a reduction in splenic cell numbers was 
observed in p100Δ mice (WT n=9, median=46.4 x106, p100Δ n=9, median=9.1 x106, 
p=0.001) and no difference was seen in total mLN cell numbers (WT n=7, 
median=5.2 x106, p100Δ n=7, median=6.5 x106, p=0.535), when compared with WT 
mice (Figure 3.9). Compared to WT, there is an increase in the size of mLN of p100Δ 
mice size relative to their reduced size/weight.  Importantly, an approximate two-fold 
increase in total colonic cell numbers was observed in p100Δ mice compared with 
WT mice (WT n=9, median=650,000, p100Δ n=9, median=1.35 x106, p=0.0009) 
(Figure 3.9). This increase correlates with the observation of a significant increase in 
colonic ILF formation in p100Δ mice.  
 
3.2.7.2. Assessment of B and T cell populations in the spleen, 
mLN and colon of p100Δ  mice 
The significant increase in ILF formation observed in the colon of p100Δ mice 
prompted an investigation of lymphocyte populations within this tissue and in 
comparison with the draining lymph node of the gut, the mLN, and the spleen. 
Single cell suspensions of WT and p100Δ splenocytes were prepared and 
stained with immunofluorescently labelled anti-B220, to identify B cells, and anti-
CD3, to identify T cells, and analysed by flow cytometry. Within the spleen there was 
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no significant difference in the proportion of B cell (WT n=9, median=65.3, p100Δ 
n=9, median=62.9, p=0.34) and T cell (WT n=9, median=10.9, p100Δ n=9, 
median=17.7, p=0.09) populations between WT and p100Δ mice (Figure 3.10. A). 
However, due to the reduced total cell number in the spleen, the B and T cell counts 
were significantly lower in the spleen of p100Δ mice compared with WT mice (B 
cells: WT n=9, median=30.3 x106, p100Δ n=9, median=5.7 x106, p=0.008. T cells: 
WT n=9, median=5.4 x106, p100Δ n=9, median=1.9 x106, p=0.001) (Figure 3.10. B.). 
Similar to the spleen, there was no difference in the proportion of B cells (WT 
n=10, median=32.6, p100Δ n=9, median=38.3, p=0.100) or T cells (WT n=7, 
median=42.9, p100Δ n=7, median=46.0, p=0.620) in the mLN of p100Δ mice 
compared with WT mice (Figure 3.10. A). In contrast to the spleen, there was also no 
difference in B cell (WT n=7, median=2.4 x106, p100Δ n=7, median=2.6 x106, 
p=0.867) or T cell (WT n=7, median=2.4 x106, p100Δ n=7, median=2.9 x106, 
p=0.383) number in the mLN (Figure 3.10. B). 
With respect to the colon, the proportion of B and T lymphocytes was not 
altered between p100Δ mice and WT mice (B cells: WT n=7, median=47.1, p100Δ 
n=7, median=47.9, p=0.243. T cells: WT n=7, median=13.9, p100Δ n=7, 
median=16.4, p=0.356)  (Figure 3.10. A). Due to the overall increase in cells isolated 
from the colon of p100Δ mice, a significant increase in the number of B cells (WT 
n=7, median=166,640, p100Δ n=7, median=484,110 p=0.010) and T cells (WT n=7 
median=75,498, p100Δ n=7, median=225,000 p=0.002) was observed in p100Δ mice 
compared with WT mice (Figure 3.10. B). 
In summary, this data demonstrates an increase in lymphocytes in the colon in 
p100Δ mice and that the majority of these infiltrating cells are B220+ B cells, 
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approximately 40%, with a small but significant population of CD3+ T cells, 
approximately 15%. 
 
3.2.7.3. Profile of T cell subsets in the spleen, mLN and colon of 
WT and p100Δ  mice 
To further characterise the T cell population in the tissues of p100Δ mice, 
CD3+ T cells were analysed for their CD4/CD8 profile. Typically, in the WT mouse, 
peripheral T cells are skewed towards a CD4+ instead of a CD8+ phenotype. Within 
the spleen of p100Δ mice there is a decrease in the proportion of CD8+ T cells (WT 
n=3, median=24.0, p100Δ n=6, median=19.0, p=0.024), with a slight, but not 
significant, reciprocal increase in CD4+ T cells (WT n=3, median=57.0, p100Δ n=6, 
median=63.0, p=0.095), compared with WT (Figure 3.12. A). When considering cell 
counts, total CD4+ and CD8+ T cell numbers are reduced in p100Δ spleen compared 
with WT (CD4+: WT n=3, median=7.7 x106, p100Δ n=6, median=580,685, p=0.024. 
CD8+: WT n=3, median=3.3 x106, p100Δ n=6, median=128,505, p=0.024)  (Figure 
3.12. B). In the mLN of p100Δ mice, the proportion of CD4+ T cells was increased 
compared with WT (WT n=3, median=62.6, p100Δ n=6, median=68.8, p=0.024), but 
no difference was seen in the CD8+ T cell population (WT n=3, median=28.8, p100Δ 
n=6, median=22.3, p=0.095) (Figure 3.12. A).  
Importantly, when proportions of CD4+ and CD8+ T cells were analysed in 
the colon of p100D mice, the T cell population was skewed in favour of a CD4+ T 
cell phenotype, with a slight, but not significant, reduction in CD8+ T cells (WT n=3, 
median=17.1, p100D n=6, median=10.7, p=0.381) and a significant, reciprocal 
increase in CD4+ T cells (WT n=3, median=23.8, p100D n=6, median=53.8, 
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p=0.024) compared with WT (Figure 3.12. A) When considering cell counts, CD4+ T 
cells (WT n=3, median=19,087, p100D n=6, median=124,666, p=0.046), but not 
CD8+ T cells (WT n=3, median=16,531, p100D n=6, median=35,002, p=0.548), were 
greatly increased in number in p100D mice compared with WT (Figure 3.12. B).
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Figure 3.9 Differences in absolute cell number from spleen, mLN and colon of 
WT and p100Δ  mice 
 
Isolation of total cells from WT (o) and p100Δ (Δ) mice, show that p100Δ mice 
display a reduction in spleen cellularity, an increase in colonic cell number and no 
difference in mLN cell number. Data from five independent experiments. *** p≤ 0.01, 
ns= not significant. 
Spleen
0
2.0x107
4.0x107
6.0x107
8.0x107
**
mLN
0
2.0x106
4.0x106
6.0x106
8.0x106
1.0x107
1.2x107
ns
Colon
0
5.0x105
1.0x106
1.5x106
2.0x106
**
C
el
l N
o.
 
C
el
l N
o.
 
C
el
l N
o.
 
WT p100Δ
WT p100Δ
WT p100Δ
Figure 3.9 
 102 
Figure 3.10 Evaluation of B and T lymphocyte proportions and cell numbers in 
the spleen, mLN and colon 
 
A Single cell suspension from spleen, mLN and colon were stained for flow cytometry 
with anti-B220 (B cells) and anti-CD3 (T cells). Representative FACs plots are 
shown. Graphs showing proportion of B and T lymphocytes, in the spleen, mLN and 
colon of WT and p100Δ mice. 
 
B Graphs showing the total cell count for B220+ B cells and CD3+ T cells (data from 
at least three independent experiments, total n≥7 for each genotype). 
 
* p≤0.05, ** p≤ 0.02, ns= not significant. Bar indicates median. 
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Figure 3.11 Analysis of activation status of B and T lymphocytes 
 
Single cell suspensions from spleen, mLN and colon were stained with fluorescently 
labelled CD3 and B220 antibodies, to identify T and B cell populations, respectively. 
The marker CD69 was used to assess the activation status of these cells. Graph shows 
percentage of cells expressing CD69, bar indicates median. Results from at least two 
independent experiments. ns= not significant, * p≤0.05. 
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Figure 3.12 Evaluation of CD4+/CD8+ T lymphocyte proportions and cell 
numbers in the spleen, mLN and colon 
 
A Single cell suspension from spleen, mLN and colon were stained for flow cytometry 
with anti-CD3 (T cells), anti-CD4 and anti-CD8. The CD4/CD8 profile of the CD3+ 
gate is shown. Representative FACs plots are shown. Graphs showing proportion of 
CD4+ and CD8+ T cells, in the spleen, mLN and colon of WT and p100Δ mice. 
 
B Graphs showing the total cell count for CD3+CD4+ and CD3+CD8+ T cells (data 
from two independent experiments, total n≥3 for each genotype). 
 
* p≤0.05, *** p≤ 0.01, ns= not significant. Bar indicates median. 
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3.2.8. RelB-dependent, p52-independent development of ILFs  
Previous data in this study has shown that p100Δ mice exhibit a dramatic 
increase in ILF formation in the colon. Downstream signalling analysis of the 
alternative NF-κB pathway by other groups has shown that p100 predominately 
heterodimerises with the RelB subunit within the cytoplasm. In addition, RelB is also 
able to heterodimerise with NF-κB1/p50. Following receptor ligation and degradation 
of p100 to p52, this p52/RelB heterodimer is able to translocate to the nucleus and 
induce transcription of target genes, such as Ccl19 and Cxcl13. In order to assess the 
relative contribution of p52 and RelB to the expression of their target genes and 
subsequently to the colonic phenotype observed in p100Δ mice, these mice were 
crossed with Relb-/- mice and ILF formation was analysed. 
 
3.2.8.1. Further manipulation of the NF-κB2 activation pathway 
and ILF development 
Figure 3.13 A, shows enumeration of B cell aggregates in the colon of WT, 
p100Δ, Relb-/-, Nfkb2-/-, p100ΔRelb+/- and p100ΔRelb-/- mice, by immunofluorescence 
staining with anti-B220 to identify the B cells. In mice deficient in RelB, no ILF 
structures could be found and, conversely, in mice lacking NF-κB2, normal levels of 
ILF formation were seen. In the p100Δ mouse model, it could be expected that due to 
the presence of excessive p52 in the cytoplasm, an increase in p52/RelB heterodimers 
would be formed and translocate to the nucleus and induce transcription of genes 
controlling the colonic phenotype observed. When one allele of Relb is removed from 
this system, the number of ILFs formed was similar to that observed in WT mice. 
When both Relb alleles are removed, ILF formation was prevented (Figure 3.13. A). 
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Figure 3.13 B, illustrates the lymphocyte aggregates formed within the colon of the 
mice indicated. A small number of B cells are observed within the colon of 
p100ΔRelb-/- mice and within CPs (clusters of CD3-CD4+ LTi-like cells (blue)), 
however, no organised B cell follicle is formed. 
In conclusion, Relb-/- mice lack colonic ILFs, whereas Nfkb2-/- mice develop 
ILFs in similar numbers to WT mice, therefore ILF formation is dependent on RelB, 
but independent of NF-κB2. Removal of RelB from the p100Δ mouse model ablates 
ILF formation, indicating that constitutive activation of NF-κB2 p100 alone is not 
sufficient to drive ILF development; the p52 protein must be able to dimerise with 
RelB to elicit an effect. 
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Figure 3.13 ILF formation is dependent on RelB but independent of p52 
 
A Colonic ILFs were enumerated by staining colon sections with fluorescently 
labelled anti-B220 and visualised using fluorescence microscopy. WT n=4, p100Δ 
n=6, p100ΔRelb+/- n=4, p100ΔRelb-/- n=4, Relb-/- n=2, Nfkb2-/- n=3. 
 
B Colon sections were stained for haematopoietic cells (anti-CD45, green, 1st line), 
dendritic cells (anti-CD11c, green, 2nd line), T cells (anti-CD3, green, 3rd line), 
macrophages (anti-F4/80, green, 4th line), B cells (anti-B220, red) and CD4+ cells 
(anti-CD4, blue). 
 
Representative immunofluorescent confocal images are shown (x40 magnification). 
Scale bar represents 50µm. ND= Not Detected. 
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Figure 3.14 Characterisation of B cell phenotype and the stromal cell 
compartment of colonic lymphoid tissue in different NF-κB mouse models 
 
A Colon sections from p100ΔRelb+/-, p100ΔRelb-/- and Nfkb2-/- mice were frozen and 
cryostat sections were stained with fluorescently labelled antibodies to B220 (blue), 
IgM (red) and IgD (green), counter stained with nuclei stain DAPI. Mature B cells 
express B220, IgM and IgD (pale blue cells, bottom panel).  
 
B Staining with fluorescent antibodies to CXCL13 (green, left panel), VCAM-1 
(green, right panel) and B220 (red) show minimal expression of CXCL13 in the three 
mouse strains, with slightly stronger staining for VCAM-1. 
 
C Staining for tissue vasculature with anti-CD31 (green) and anti-MAdCAM-1 (blue) 
shows co-expression of these markers on vascular endothelium (pale blue cells, 
merge, white circles). B cells stained with anti-IgM (red) and tissue counterstained 
with DAPI (grey). 
 
Representative immunofluorescent confocal images are shown (x40 magnification). 
Scale bar denotes 50 µm. 
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3.2.8.2. Haematopoietic cell organisation in colonic lymphoid 
tissues of Nfkb2-/-, p100ΔRelb+/- and p100ΔRelb-/- mice 
The cellular organisation of the ILFs seen was evaluated by confocal 
microscopy. The ILFs present in the colon of Nfkb2-/- mice exhibit the expected 
structure, a B220+ B cell core, surrounded by CD11c+ DCs and interspersed with 
CD3+ T cells (Figure 3.13. B, left column). The ILFs observed in p100ΔRelb+/- varied 
in size (data not shown), and although the ILF pictured is small it still shows an 
organised structure as previously described (Figure 3.13. B, second column). The 
lymphoid structures in p100ΔRelb-/- colon resemble cryptopatches in their cellular 
composition and structure. A cluster of CD3-CD4+ LTi-like cells can be seen (Figure 
3.13. B, right column, third row, blue cells), along with CD11c+ DCs (Figure 3.13. B, 
right column, second row, green cells). A few B220+ B cells can be seen within the 
cryptopatch, but they are not arranged into an organised structure. 
The majority of B lymphocytes within ILFs display a mature phenotype, 
B220+IgD+IgM+. When considering the Nfkb2-/- mice, the majority of the B cells 
within ILFs display this mature phenotype (Figure 3.14. A, left panel). However, 
there appears to be more B220-IgD+ (green) and B220-IgM+ (red) plasma cells when 
compared with WT ILF (Figure 3.14. A, and Figure 3.3. A. WT ILF). The majority of 
B cells present in p100ΔRelb+/- ILFs also display a mature phenotype (Figure 3.14. A, 
second column). Assessment of the few B cells present in p100ΔRelb-/- CPs shows 
that nearly all possess a mature phenotype and that fewer B220-IgD+ and B220-IgM+ 
plasma cells can be seen (Figure 3.14. A, third column). 
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3.2.8.3. Expression of stromal cell markers in colonic lymphoid 
tissues of Nfkb2-/-, p100ΔRelB+/- and p100ΔRelB-/- mice 
To check the phenotype of the stromal cells constituting the lymphoid tissues 
present in the colon of Nfkb2-/-, p100ΔRelb+/- and p100ΔRelb-/- mice, 
immunoflorescence staining was used to assess the expression of CXCL13 and 
VCAM-1. Carragher et al, have published that Nfkb2-/- mice show a reduction in 
CXCL13 expression, but normal levels of VCAM-1, in lymph nodes at P7-14 
(Carragher et al., 2004). Consistent with this data, P14 colon from Nfkb2-/- mice show 
reduced CXCL13 expression within ILFs (Figure 3.14. B, left column). In addition, 
the expression of CXCL13 and VCAM-1 in p100ΔRelb+/- and p100ΔRelb-/- colon was 
low and difficult to detect by confocal microscopy (Figure 3.14. B, middle and right 
column, respectively).  
Carragher et al, further showed that MAdCAM-1 expression is reduced by 
postnatal day seven in Nfkb2-/- LN. In contrast to this data, Figure 3.14, shows 
expression of MAdCAM-1+ vasculature in Nfkb2-/- colon (Figure 3.14. C, left 
column). Furthermore, co-localisation of CD31 with MAdCAM-1 within the colon 
can be observed in these mice (Figure 3.14. C, left column, merge).  
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3.3. Discussion 
The dependence of secondary and tertiary lymphoid tissue development on 
LTβR signalling and the subsequent involvement of the alternative NF-κB pathway 
downstream of LTβR, has been well documented (Fütterer et al., 1998; Ivanov et al., 
2006; Taylor et al., 2004; Lorenz et al., 2003; Alimzhanov et al., 1997; Pabst et al., 
2005; De Togni et al., 1994; Hamada et al., 2002; Banks et al., 1995; Weih et al., 
1995; Yilmaz et al., 2003; Weih and Caamaño, 2003; Shinkura et al., 1999; Miyawaki 
et al., 1994; Fagarasan et al., 2000; Karrer et al., 2000). Studies investigating the 
effect of constitutive activation of this pathway on secondary lymphoid tissue, namely 
the spleen, have previously been published (Ishikawa et al., 1997; Guo et al., 2007) 
and this chapter expands on this by studying the effects on the development of tertiary 
lymphoid tissue, in particular the formation of colonic ILFs. 
This chapter presents the striking finding that in the colon of p100Δ mice there 
is a significant increase ILF formation by two weeks of age, with supporting data 
confirming that these structures are indeed ILFs. The augmented development of ILFs 
in these mice is dependent on constitutive activation of p100 in haematopoietic cells, 
but the contribution of stromal cells is not excluded. p100Δ mice present with 
increased absolute cell numbers in the colon, with an increase in both the B and T cell 
compartments and within the T cell population an increase in the proportion of CD4+ 
T cells was observed. We also show that ILF development is dependent on RelB and 
that removal of RelB from p100Δ mice abrogates of ILF formation. 
The development of ILFs in C57/Bl6 mice has been described to commence at 
around P25 (Hamada et al., 2002). There are inevitable variations on this timescale 
from one animal facility to the other, as the resident commensal bacteria will likely 
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differ. It is demonstrated in this chapter that small numbers of ILFs were present in 
the colon of C57/Bl6 mice from P10 and that by P15 a significant increase in B cell 
aggregates in the colon of p100Δ mice was observed (Figure 3.2. B). 
Several pieces of evidence are presented indicating that the p100Δ colonic B 
cell aggregates are ILFs. The first is that the cellular organisation of p100Δ B cell 
aggregates closely resembles that of WT ILFs, with a core of B220+ B cells, 
surrounded by CD11c+ DCs and interspersed with CD3+ T cells (Figure 3.3). 
Secondly, the majority of B cells constituting WT ILFs present with a mature 
phenotype, B220+IgM+IgD+, a comparable profile is seen in p100Δ B cell aggregates 
(Figure 3.4). Thirdly, identification of LTi-like cells and Tregs within WT ILF and 
p100Δ B cell aggregates was observed (Figure 3.5. A and B) and enumeration and 
functional analysis of these cell populations would be beneficial in understand the 
phenotype observed. Finally, the presence of similar chemokine and cell adhesion 
molecule expression, namely that of CXCL13, VCAM-1 and MAdCAM-1, between 
WT ILFs and p100Δ B cell aggregates was observed (Figure 3.6). Together these 
findings provide extensive evidence that p100Δ colonic B cell aggregates are ILFs 
and that p100Δ mice present with a significant increase in colonic ILF numbers. 
 
The significant increase in ILF formation in the colon of p100Δ mice could 
arise due to various phenomena. Two main explanations revolve around the 
development of cryptopatches and their transition into ILFs. Eberl, et al, suggested 
the link between CP development and subsequent formation into ILFs following the 
recruitment of B cells (Eberl, 2005; Eberl and Sawa, 2010). One possible explanation 
for the increase in ILF development in p100Δ mice could stem from augmented CPs 
development. The presence and enumeration of CPs in the colon of p100Δ mice was 
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attempted by confocal microscopy, however this proved difficult to accurately assess. 
CPs consist of a cluster of CD3-CD4+ LTi-like cells, and CD11c+ DCs, but lacking 
presence of B220 expressing B cells (Kanamori et al., 1996; Hamada et al., 2002). 
The CD4 antibody used was conjugated to a fluorochrome emitting in the far-red 
range and therefore not visible by eye, thus CD4+ clusters could not be counted. 
CD11c+ cells were visible by eye (antibodies were conjugated to FITC), however DCs 
are located throughout the colon and clusters of DCs were hard to define and 
therefore not reliable for CP enumeration. In an attempt to address these issues, 
p100Δ mice were crossed onto the Rag-/- background to remove the complication of 
lymphocyte presence. It has been reported that Rag-/- mice develop CPs as normal 
(Hamada et al., 2002; Ivanov et al., 2006). Initial data from p100ΔRag-/- and Rag-/- 
mice indicated no difference in colonic CP number, however the p100ΔRag-/- mice 
suffered from a failure to thrive that was more severe than p100Δ mice complicating 
the phenotype observed (data not shown). As a result, it is currently unclear whether 
p100Δ mice exhibit normal or increased numbers of CPs in their colon; if more CPs 
were present this could go some way to explain the increase in ILFs. Conversely, if 
there were normal numbers of CPs, then it may be that a higher proportion of the CPs 
present are induced to develop into ILFs. The increased CP transition into ILFs would 
be dependent on increased haematopoietic cell recruitment and this could be driven 
by the haematopoietic cells themselves preferentially migrating to the colon, by 
colonic stromal cells expressing chemokines and cell adhesion molecules, or by a 
combination of both. Additionally, commensal bacteria and TLR stimulation may also 
have an affect by inducing upregulation of chemokines for example, or by stimulation 
DCs. 
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The migration of B cells to the intestine involves various chemokine and cell 
adhesion molecules, such as CCL20 (McDonald et al., 2007; Williams, 2006), 
CXCL13 (McDonald et al., 2010) and MAdCAM-1 (Wang et al., 2008). The presence 
of CXCL13 and MAdCAM-1 can be observed in the colon of p100Δ mice (Figure 
3.6), but the level of expression has not been assessed. The presence of CCL20 has 
not been confirmed in this study. Guo, et al, have shown that in the spleen of p100Δ 
mice the expression of CXCL13 is slightly increased and MAdCAM-1 expression is 
significantly increased compared to levels in WT mice (Guo et al., 2007). If this were 
reflected in the colon, it may be that increased levels of these chemokines could result 
in accumulation of B cells. Interestingly however, Guo et al, also demonstrated that 
p100Δ splenic B cells show reduced localisation to CXCL13 in vitro (Guo et al., 
2007). Peripheral B cells may not reflect this defect but if they did it is possible that B 
cell recruitment to the colon is influenced more by migration towards chemokines 
such as CCL20. There is a positive increase in expression of CCR6, the receptor for 
CCL20, by p100Δ T cells from the spleen, mLN and colon. However, this shift is not 
seen in the B cell population  (Appendix Figure 1. A). 
The role of chemokine/cell adhesion molecule expression by stromal cells and 
the expression of reciprocal receptors on haematopoietic cells is clearly important in 
ILF development. The contribution of stromal and haematopoietic cells to the colonic 
phenotype observed in p100Δ mice was investigated using FLC transfers. 
Mice receiving 100% p100Δ FLCs developed more colonic ILFs than those 
receiving WT FLCs or a 50:50 mix (Figure 3.7. A). This data points to a 
predominately haematopoietic cell driven phenotype, but does exclude a role for the 
stroma. The mice in the FLC transfer experiments were sacrificed three months post-
transfer and no earlier time points were investigated. There are at least two possible 
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scenarios; i) it could have taken three months for the difference in ILF numbers to 
become significant or, ii) it was significant from an earlier age, potentially equivalent 
to the age at which p100Δ mice exhibit significantly more ILFs. In the first scenario, a 
role for stromal cells and haematopoietic could be envisaged; the recruitment or 
preferential migration of p100Δ lymphocytes to the colon, could have induced 
priming and activation of the stroma thereby allowing more CP transition to ILFs, 
generating a positive feedback loop, the ‘activation’ of the stroma being the potential 
reason for the delay in increased ILF formation. In the second scenario, if increased 
ILF formation was occurring soon after FLC transfer, the role of the stroma is much 
diminished and the haematopoietic cells could be considered the major contributor. 
Earlier time points post-FLC transfer would need to be investigated to ascertain which 
of these two scenarios is occurring. Interestingly, transfer of whole splenocytes from 
p100Δ mice, and the harvesting of host mice six weeks post-transfer, no increased ILF 
formation is seen (data not shown), this could be for two reasons: i) mice were 
harvested too early to see significant differences, ii) a cell population present in the 
foetal liver but not in the adult spleen is responsible for inducing increased ILF 
formation. 
In order to clarify the relative contribution of stromal and haematopoietic cells 
to the induction of augmented ILF formation in p100Δ mice, a time course 
experiment following FLC transfer may elucidate differences in the onset and 
development of ILFs. An additional, and similar, time course following splenocyte 
transfer would help narrow down the potential cell type responsible for driving 
augmented p100Δ ILF formation. 
An additional explanation for the increase in ILF formation in p100Δ mice is 
the potential contribution of commensal bacteria and subsequent stimulation of TLRs 
 116 
and NLRs (NOD-like receptors). Bouskra, et al, demonstrated that TLRs and NOD2 
are most likely required for the maturation of ILFs, but not for induction, while 
NOD1 is required for the induction of ILFs (Bouskra et al., 2008). A possible scenario 
could be envisaged where the intestinal APCs of p100Δ mice are hyper-reactive to 
commensal bacteria. This development of ILFs in response to gut flora is 
recapitulated in the DSS-induced colitis model, where an increase in ILF formation 
was observed (Spahn et al., 2002; Jungbeck et al., 2008), the same occurred in the T 
cell transfer model of murine colitis (Leithäuser et al., 2001) and in human Crohn’s 
disease and colitis (Sitohy et al., 2008; Nascimbeni et al., 2005; Yeung et al., 2000). It 
is possible that the increase in ILF development in p100Δ mice reflects the initial 
stages of colitis but that the early postnatal death limits disease progression and by the 
time of death p100Δ mice do not exhibit symptoms of colitis such as diarrhoea or 
intestinal epithelial hyperplasia.  
 
Corresponding to the increase in colonic ILFs in p100Δ mice, an increase in 
the number of B and T lymphocytes was observed in the colon (Figure 3.10). 
Interestingly, there was no difference in proportion of these cell populations, 
indicating that they were increased by similar levels, i.e. it is not just an influx of B 
cells into the colon to form ILFs, but also an increase in T cells. Flow cytometric 
analysis does not take into account the location of the cells present. Colonic B cells 
are located predominately in ILFs, but the T cells can be located within the epithelium 
or lamina propria, not just within ILFs. Interestingly, within the colon of p100Δ mice, 
the proportion of CD4+ and CD8+ T cells was altered, with an increase in the 
proportion of CD4+ T cells and no change in the proportion of CD8+ T cells when 
compared to WT counterparts (Figure 3.12). It could be that the CD4+ cells in the 
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colon are activated and therefore proliferate to expand the population or that there is 
increased recruitment of CD4+ T cells from the periphery, via altered chemokine 
expression by colonic stromal cells or receptors levels on the T cells. Flow cytometric 
analysis revealed a positive, but non-significant, shift in CD69 expression by CD3+ T 
cells isolated from the colon of p100Δ mice relative to WT colonic T cells (Figure 
3.11). This analysis would need to be repeated and expanded to include other 
activation markers in order to verify the results. 
 
The alternative NF-kB pathway centres around activation of predominately 
p52/RelB heterodimers (Dejardin et al., 1998; Yilmaz et al., 2003). ILF formation is 
dependent on RelB, and therefore dependent on the alternative NF-κB pathway, as 
demonstrated in this chapter by the lack of ILF formation in Relb-/- mice. Moreover, 
the removal of RelB from p100Δ mice, as in p100ΔRelb-/- mice, results in a lack of 
ILF formation, presumably through alteration of heterodimer formation. When there 
is no alternative NF-κB pathway activation there is no ILF development, when there 
is constitutive activation of this pathway there is augmented ILF formation. In 
p100ΔRelb-/- mice, with a lack of RelB and excess p52 available, the compensatory 
heterodimers that form could be p52/RelA, p52/c-Rel and p52/p52. p52 homodimers 
would operate as transcriptional repressors due to their lack of transcriptional 
activation domains, unless they are bound to Bcl-3 (Ghosh et al., 1998; Brown et al., 
1994; Bours et al., 1993). The relative formation of these different complexes has not 
been assessed but it would be of importance to investigate this in order to assess the 
contribution to gene expression and ILF development. 
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In summary, p100Δ mice present with a significant increase in the number of 
colonic ILFs, it is currently unclear whether this increase stems from augmented 
development of CPs or from an increase in the number of CPs transitioning into ILFs. 
This colonic phenotype is dependent on RelB containing complexes, as in p100ΔRelb-
/- mice development of ILFs is inhibited. It is clear that the migration of lymphocytes 
to the colon of p100Δ mice is dramatically enhanced compared with WT mice, and 
the presence of CXCL13, VCAM-1 and MAdCAM-1 has been established but the 
relative levels of expression have not. FLC transfer experiments indicate that 
constitutive activation of NF-κB2 p100 in haematopoietic cells is sufficient to drive 
the increase in ILF formation, however possible involvement of stromal cells in this 
phenotype has not been excluded. 
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4. Characterisation of Dendritic Cell Populations in p100Δ  Mice 
4.1. Introduction 
The role of DCs and macrophages in intestinal immunity is not fully 
understood, with diverse subpopulations eliciting differential effects and producing 
various combinations of chemokines and cytokines. cDCs are identified by their high 
expression of CD11c and within the spleen, the two main subtypes are determined 
based on CD8α and CD11b expression: CD11chighCD8α+(CD11b-) and 
CD11chighCD8α-(CD11b+) cDCs (Leenen et al., 1998). cDCs are also present in non-
lymphoid tissues, particularly at mucosal sites. Within the intestine a subpopulation of 
lamina propria (LP) DCs express CD103 and these CD11chighCD103+ LP-DCs are 
capable of migrating to the draining LN of the gut (mLN) (Schulz et al., 2009) and 
inducing expression of gut homing markers on T cells (Annacker et al., 2005; 
Jaensson et al., 2008), as well as stimulating the generation of Treg cells (Coombes et 
al., 2007; Siddiqui and Powrie, 2008). This anti-inflammatory phenotype is contrasted 
by CD11chighCD103- intestinal DCs, which induce a pro-inflammatory response by 
secreting IL-6 and TNFα, and by influencing T cells to generate IFNγ (Coombes et 
al., 2007). mLN populations of DCs include CD11chighCD8α+ and CD11chighCD8α- 
DCs, as well as CD11chighCD103+ and CD11chighCD103- DCs (Coombes et al., 2007; 
Iwasaki and Kelsall, 2001). The assessment of these DC subpopulations in p100Δ 
mice was performed to gain insight into the nature of the altered colonic phenotype in 
these mice, demonstrated by the augmented development of ILFs. 
The importance of LTβR signalling in the regulation of DC homeostasis can 
be shown by the fact that i) DC subsets express LTβR and in vitro bone marrow DC 
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cultures revealed that DC numbers were increased following treatment with agonist 
LTβR (Kabashima et al., 2005), ii) splenic CD11chighCD8α- DCs are preferentially 
decreased in mice deficient for LTβR, LTα or LTβ, indicating that LTβR is involved 
in the regulation of this subset of DCs (Wu et al., 1999; Abe et al., 2003; De Trez et 
al., 2008; Wang et al., 2005), iii) ligation of LTβR induces signalling through both the 
classical and the alternative NF-κB activation pathways. Mice deficient in individual 
components of the classical pathway, such as Rela-/- cRel-/- and p50-/- mice, 
demonstrated intact populations of splenic cDCs (Ouaaz et al., 2002). Additionally, 
mice deficient in NF-κB2 also displayed normal splenic DC development (Kobayashi 
et al., 2003). Conversely, mice with ineffective alternative pathway signalling, either 
due to a lack of LTβR signalling (De Trez and Ware, 2008; Kabashima et al., 2005), 
or due to a lack of RelB (Wu et al., 1998; Kobayashi et al., 2003) have a selective 
defect in development of splenic CD11chighCD8α- DCs. Interestingly however, Ouaaz 
et al, revealed defects in DC maturation and survival in mice doubly deficient in p50-
RelA and p50-cRel (Ouaaz et al., 2002).  
Considering the effect of LTβR signalling on the homeostasis of DCs and the 
critical contribution of this cell type to mucosal immunity, analysis of populations of 
DCs was undertaken in p100Δ mice to understand what affect constitutive activation 
of the alternative NF-κB pathway has on their development, mobilisation and 
activation. 
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4.2. Results 
4.2.1. Increase in dendritic cells and CD11c-CD11b+ cells in p100Δ  
mice 
During the characterisation of ILFs in the colon of p100Δ mice, an apparent 
increase in the numbers of CD11c+ DCs was noted throughout the colon. Flow 
cytometric analysis was performed in order to verify and enumerate this observation. 
Classical DCs (cDCs) are defined by high expression of CD11c and myeloid 
cells, including monocytes and granulocytes are classified as CD11c-CD11b+, and 
both are visible in the spleen, mLN and colon of WT and p100Δ mice (Figure 4.1. A). 
In the spleen of p100Δ mice, a significant increase in the proportion of CD11chigh DCs 
(WT n=5, median=1.06, p100Δ n=5, median=1.95, p=0.008) and CD11c-CD11b+ 
cells (WT n=5, median=4.15, p100Δ n=5, median=8.32, p=0.008) was observed when 
compared with WT spleen (Figure 4.1. B). Taking into account the decrease in total 
splenocyte numbers in p100Δ mice, a decrease in cDC cell numbers was observed 
compared with WT (WT n=5, median=585,297, p100Δ n=5, median=430,920, 
p=0.008) and no difference in cell numbers was observed for the CD11c-CD11b+ 
population (WT n=5, median=2.2 x106, p100Δ n=5, median=1.7 x106, p=0.222) 
(Figure 4.1. C). In contrast, the cDC and CD11c-CD11b+ proportions (cDC: WT n=5, 
median=2.18, p100Δ n=6, median=1.65, p=0.537. CD11c-CD11b+ cells: WT n=5, 
median=1.57, p100Δ n=6, median=1.85 p=0.792) and cell numbers (cDC: WT n=5, 
median=73,828, p100Δ n=6, median=18,195, p=0.247. CD11c-CD11b+ cells: WT 
n=5, median=58,729, p100Δ n=6, median=38,801 p=0.178) were similar in the mLN 
of WT and p100Δ mice (Figure 4.1. B and C). 
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When the colon is considered, p100Δ mice exhibited an increase in proportion 
and total cell number for cDCs with respect to WT mice (Proportions of cDCs: WT 
n=5, median=0.53, p100Δ n=6, median=1.74, p=0.004. cDC Cell Number: WT n=5, 
median=615, p100Δ n=6, median=7,225, p=0.004) (Figure 4.1. B and C). For CD11c-
CD11b+, no difference in proportion was observed (WT n=5, median=1.01, p100Δ 
n=6, median=4.17, p=0.662) (Figure 4.1. B), but due to increased total colon cell 
number, a significant increase in CD11c-CD11b+ cell numbers was seen (WT n=5, 
median=1,852, p100Δ n=6, median=17,543, p=0.004) (Figure. 4.1. C). 
When the cDC population is divided based on the expression of CD11b, two 
distinct populations can be observed; CD11chighCD11b- and CD11chighCD11b+. In the 
spleen and colon the proportion of CD11chighCD11b- (Spleen: WT n=5, median=0.58, 
p100Δ n=5, median=1.13, p=0.008. Colon: WT n=5, median=0.23, p100Δ n=5, 
median=0.89, p=0.009) and CD11chighCD11b+ DCs (Spleen: WT n=5, median=0.48, 
p100Δ n=6, median=0.65, p=0.030. Colon: WT n=5, median=0.22, p100Δ n=6, 
median=0.72, p=0.004) is elevated in p100Δ mice compared with WT counterparts 
(Figure 4.2. A). The reduction in absolute splenic cell number in p100Δ mice 
correlates with a reduction in CD11chighCD11b- (WT n=5, median=336,378, p100Δ 
n=6, median=284,760, p=0.032) and CD11chighCD11b+ (WT n=5, median=248,919, 
p100Δ n=5, median=124,461, p=0.004) DC cell number despite the increase in 
proportion (Figure 4.2. B). In the colon, the cell number for both these cDC 
subpopulations is elevated in p100Δ mice with respect to WT mice (CD11chighCD11b- 
DCs: WT n=5, median=307, p100Δ n=6, median=3,718, p=0.004. CD11chighCD11b+ 
DCs, WT n=5, median=297, p100Δ n=6, median=3,000, p=0 
.004) (Figure 4.2. B). 
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In summary, the spleen and colon of p100Δ mice exhibit an increase in cDC 
and macrophage populations, and within the cDCs, both CD11b- and CD11b+ DCs are 
increased. 
 
4.2.2. Expression of CD103 by dendritic cells in the spleen, mLN and 
colon 
Expression of CD103 on DCs allows identification of functionally distinct DC 
populations. CD11chighCD103+ LP-DCs, and not CD11chighCD103- LP-DCs, are 
capable of migrating from the intestine to the draining mLN, to prime naïve T cells 
and induce expression of gut-homing receptors on these T cells (Jaensson et al., 2008; 
Schulz et al., 2009; Johansson-Lindbom et al., 2005). CD11chighCD103+ LP-DCs have 
been shown to derive from proliferating precursors that circulate in the blood and 
continually migrate into the gut (Jaensson et al., 2008). The observation that p100Δ 
mice have an increase in colonic cDCs prompted investigation of CD103 expression 
by this population.  
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Figure 4.1 Analysis of dendritic cell and CD11b+ populations in the spleen, mLN 
and colon of WT and p100Δ  mice 
 
A Preparations of single cell suspensions from spleen, mLN and colon of WT and 
p100Δ mice were stained with fluorescently labelled antibodies to CD11c and 
CD11b, and analysed by flow cytometry. Classical dendritic cells (cDCs) were 
classified as CD11chigh. Within the spleen, CD11c- cells were subdivided based on 
intermediate or high expression of CD11b. Representative FACs plots of two 
independent experiments are shown. Graphs depict proportion of indicated cell 
populations, from two independent experiments (n≥5 for each genotype). Lower 
graph shows separation of CD11c-CD11b+ splenic cells into CD11bintermedate and 
CD11bhigh populations. 
 
B Graphs depicting cDC and macrophage cell number for the different tissues, from 
two independent experiments (n≥5 for each genotype). 
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Figure 4.2 Analysis of CD11b expression by CD11chigh dendritic cells in the 
spleen and colon of WT and p100Δ  mice 
 
Flow cytometric analysis of single cell suspensions of cells isolated from the spleen 
and colon from WT and p100Δ mice. Classical DCs were defined as CD11chigh and 
subdivided according to CD11b expression, revealing two populations: 
CD11chighCD11b- and CD11chighCD11b+. 
 
A Representative FACs plots. Graphs depicting proportion of CD11chigh CD11b-/+ 
dendritic cells. 
 
B Graphs depicting cell number of CD11chigh CD11b-/+ dendritic cells. 
 
Results of two independent experiments, bar indicates median. (n≥5 for each 
genotype). ** p<0.02, * p<0.05. 
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CD103+ DCs are normally found in mucosal-draining LNs, such as the mLN, 
however, we observed CD11chighCD103+ DCs in the spleen of WT (≈0.2% of total 
splenocytes) and the proportion of this population was significantly increased in 
p100Δ mice (≈0.7% of total splenocytes, p=0.004) (Figure 4.3. B). The proportion of 
CD11chighCD103- DCs in the spleen of p100Δ mice did not differ significantly from 
that observed in WT mice (WT n=5, median=0,78, p100Δ n=6, median=0.96, 
p=0.052) (Figure 4.3. B). The majority of splenic CD11chighCD103+ DCs in both WT 
and p100Δ mice were CD11b- (≈90%) (Appendix, Figure 8.2). The cell numbers for 
splenic CD11chighCD103- DCs in p100Δ mice was reduced by approximately half, 
compared with WT (WT n=5, median=428,076, p100Δ n=6, median=177,117, 
p=0.004) and due to the reduction in p100Δ absolute splenocyte number, no 
difference in cell numbers for CD11chighCD103+ DCs was observed (WT n=5, 
median=129,210, p100Δ n=6, median=151,250, p=0.177) (Figure 4.3. C). Within the 
mLN, the only difference seen between WT and p100Δ mice was the three-fold 
decrease in CD11chighCD103- DC cell number (WT n=5, median=35,323, p100Δ n=6, 
median=7,785 p=0.017) (Figure 4.3. B and C). The proportion of CD11chighCD103+ 
DCs co-expressing CD11b in the mLN was lower than in the spleen, for both WT and 
p100Δ mice (≈70% in WT, ≈50% in p100Δ) (Appendix, Figure 9.2). However, it is 
important to note that there is much variation in the proportions and cell numbers in 
this population between individual animals, as well as between WT and p100Δ mice, 
due to variations in digestion of tissues and extraction of cells. 
When considering the colon, p100Δ mice displayed an approximate two-fold 
increase in the proportion of CD11chighCD103- (WT n=5, median=0.11, p100Δ n=5, 
median=0.5 p=0.008) and CD11chighCD103+ (WT n=5, median=0.27, p100Δ n=5, 
median=0.84 p=0.032) DCs when compared with WT mice. This is reflected in the 
 127 
cell counts where few, if any, CD11chighCD103- DCs are found in the colon of WT 
mice, with an approximately 10-fold increase in this population in p100Δ mice (WT 
n=5, median=120, p100Δ n=5, median=1632, p=0.008) (Figure 4.3. C). Compared 
with CD11chighCD103- DCs, a greater number of CD11chighCD103+ DCs are found in 
the colon of WT mice (n=5), an increase from 120 to 400 cells, but in p100Δ mice 
(n=5) this population expands from 1,300 to around 3,000 cells (p=0.008) (Figure 4.3. 
C). Approximately 60% of colonic CD11chighCD103+ DCs co-express CD11b, in WT 
and p100Δ mice (Appendix, Figure 9.2). 
To summarise, there is a significant increase in CD11chighCD103- and 
CD11chighCD103+ DCs in the colon of p100Δ mice, as well as an increase in these 
two populations in the spleen. CD103 is used as a marker for cDCs capable of 
migrating from the intestine to the draining mLN and spleen, the increase in colonic 
CD11chighCD103+ DCs and their subsequent potential migration to the spleen may 
account for the expansion of this population in the latter. Additionally, although the 
proportion of CD11chighCD103+ DCs in the mLN of p100Δ mice is not significantly 
higher than in WT mLN, an increase is observed nonetheless, potentially equating to 
increased migration of these cells from the intestine. 
 
4.2.3. Activation of dendritic cell subsets in the spleen, mLN and 
colon of WT and p100Δ  mice 
Due to the increase in proportion of DC populations in the spleen and colon of 
p100Δ mice, the activation status of DC populations from p100Δ mice was 
investigated to assess potential functional differences. Following antigen stimulation, 
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DCs upregulate co-stimulatory molecules, such as CD86, thereby allowing CD86 to 
be used as a useful marker for DC activation. 
Within the splenic cDC population in p100Δ mice an increase in CD86 MFI 
was seen with respect to WT mice (WT n=4, mean=48.3±8.0, p100Δ n=4, 
mean=105.6±37.6, p=0.02). Within the colon no difference was observed (WT n=4, 
mean=102.5±36.6, p100Δ n=4, mean=115.3±34.7, p=0.63). Strikingly, in the mLN, 
cDCs from p100Δ mice displayed a marked upregulation of CD86 (WT n=4, 
mean=138.5±45.7, p100Δ n=4, mean=344.8±41.2, p=0.0005) (Figure 4.4).  
The cDC population was further subdivided into CD11b+ or CD11b- cDCs. 
The increased expression of CD86 by splenic cDCs from p100Δ mice is accounted for 
by upregulation of CD86 by CD11chighCD11b+ DCs (WT n=4, mean=21.6±5.5, 
p100Δ n=4, mean=128.5±71.8, p=0.03), rather than CD11chighCD11b- DCs (WT n=4, 
mean=70.7±11.4, p100Δ n=4, mean=91.5±18.2, p=0.10) (Figure 4.4). The CD86 
expression of these two cDC populations in the colon was similar between WT and 
p100Δ mice (CD11chighCD11b+ DCs: WT n=4, mean=123.0±40.1, p100Δ n=4, 
mean=124.2±48.4, p=0.970. CD11chighCD11b- DCs: WT n=4, mean=101.9±34.7, 
p100Δ n=4, mean=117.9±34.6, p=0.539). Finally, in the mLN, the majority of CD86 
expression in the cDC population in p100Δ mice is accounted for by increased CD86 
expression in the CD11chighCD11b- DC (WT n=4, mean=166.0±33.3, p100Δ n=4, 
mean=454.0±98.7, p=0.002), with a less dramatic upregulation of CD86 by 
CD11chighCD11b+ DCs (WT n=4, mean=116.5±60.6, p100Δ n=4, mean=263.0±42.5, 
p=0.007) (Figure 4.4). 
When the cDC profile is switched to assess CD103 expression, a slight, but 
not significant, upregulation of CD86 was seen in the CD11chighCD103+ (Spleen: WT 
n=4, mean=105.6±35.1, p100D n=4, mean=150.2±43.1, p=0.160. Colon: WT n=4, 
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mean=121.6±41.0, p100D n=4, mean=161.0±41.7, p=0.226) and CD11chighCD103- 
(Spleen: WT n=4, mean=35.1±8.1, p100D n=4, mean=60.7±26.3, p=0.112. Colon: 
WT n=4, mean=39.9±29.1, p100D n=4, mean=70.3±11.4, p=0.101) DC populations 
in the spleen and colon of p100Δ mice, when compared with WT mice. The largest 
difference, was again observed in the mLN, where p100Δ mice demonstrated 
upregulation of CD86 in both subpopulations of DCs (CD103+ cDCs: WT n=4, 
mean=237.0±64.8, p100D n=4, mean=472.0±78.5, p=0.004. CD103- cDCs: WT n=4, 
mean=56.7±8.2, p100D n=4, mean=153±43.5, p=0.007) (Figure 4.4). Others markers 
of activation which would be useful to assess with regards to DC biology include 
CD80 and MHCII. 
In summary, the largest differences in DC activation status can be seen in the 
mLN, with all of the DC subsets investigated expressing higher levels of CD86 in 
p100Δ mice when compared with WT counterparts. 
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Figure 4.3 Analysis of CD103+/CD103- dendritic cell populations in the spleen, 
mLN and colon of WT and p100Δ  mice 
 
 
A Preparations of single cell suspensions from spleen, mLN and colon of WT and 
p100Δ mice were stained with fluorescently labelled antibodies to CD11c and CD103 
and analysed by flow cytometry. Classical dendritic cells (cDCs) were classified as 
CD11chigh and this population was subdivided according to CD103 expression, 
revealing two distinct populations; CD11chiCD103- and CD11chiCD103- cDCs. FACs 
plots representative of two independent experiments are shown. 
 
B Graphs depicting proportion of CD11chiCD103- and CD11chiCD103- cDCs for the 
different tissues, from two independent experiments (n≥5 for each genotype). 
 
C Graphs depicting CD11chiCD103- and CD11chiCD103- cDC cell number for the 
different tissues, from two independent experiments, bar indicates median (n≥5 for 
each genotype). 
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Figure 4.4 Activation of dendritic cell subsets in the spleen, mLN and colon of 
WT and p100Δ  mice 
 
Single cell suspensions of spleen, mLN and colon were stained with fluorescently 
labelled antibodies against CD11c, CD11b, CD103, CD3, and the activation marker 
CD86 was used to assess DC activation. Graphs show mean fluorescence intensity 
(MFI) and standard deviation error bars for CD86 expression by the DC populations 
described. Classical dendritic cells (cDCs), defined as CD11chigh. The cDC 
population was further sub-divided into CD11chighCD11b+ and CD11chghiCD11b- 
DCs. Two additional DC populations were identified as CD11chighCD103+ and 
CD11chighCD103-. Results of two independent experiments (n=4 for each tissue and 
genotype). ***p<0.001  ** p<0.02, * p<0.05, ns= not significant. 
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4.2.4. Analysis of CD103 expression by non-cDC populations 
CD103 expression is not restricted to DC populations, particular subsets of T 
cells also express CD103 (Uss et al., 2006), such as intraepithelial T cells 
(Annunziato et al., 2006) and LP T cells (Agace et al., 2000). The CD11c-CD103+ 
population of cells visible in spleen, mLN and colon, were investigated further. 
In the spleen there is a 2.5-fold increase in the proportion of CD11c-CD103+ 
cells in p100Δ mice over that seen in WT mice (WT n=5, median=1.0, p100D n=6, 
median=2.6, p=0.004), although no change in absolute cell numbers was documented 
(WT n=5, median=656,708, p100D n=6, median=515,650, p=0.247), as p100Δ mice 
have a lower splenocyte count compared with WT (Figure 4.5. B). Within the mLN, 
the proportion of CD11c-CD103+ cells in p100Δ mice (n-6) was increased to 15%, 
compared with 7% in WT mice (n=5) (Figure 4.5. B, p=0.004). However, this did not 
correspond to an increase in absolute cell number (WT n=5, median=250,947, p100D 
n=6, median=316,758, p=0.691) (Figure 4.5. C). 
Interestingly, when investigating the colon, a decrease of 30% was observed in 
the proportion of CD11c-CD103+ cells in p100Δ mice compared with WT mice (WT 
n=5, median=70.5, p100D n=6, median=43.1, p=0.028) (Figure 4.5. B). However, 
when converted to cell numbers, a significant increase in CD11c-CD103+ cells was 
seen in p100Δ mice compared with cells isolated from the colon of WT mice (WT 
n=5, median=84,600, p100D n=6, median=171,314 p=0.016) (Figure 4.5. C). 
Within the colon the CD11c-CD103+ population can be subdivided based on 
level of expression of CD103 (Figure 4.5. D). In the colon of p100Δ mice an increase 
in the proportion of CD11c-CD103high cells with a concomitant decrease in CD11c-
CD103int cells when compared with WT mice. In addition, the side scatter (SSC) and 
forward scatter (FSC) plots for the individual CD11c-CD103high and CD11c-CD103int 
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populations differ. The CD11c-CD103high cells exhibit a profile similar to 
lymphocytes and the CD11c-CD103int cells exhibit a wider SSC/FSC profile, 
demonstrating larger size and granularity. This data suggests that these two 
populations are unique and further investigation into their phenotype and function 
would be advantageous. 
In summary, an increase in the proportion of CD11c-CD103+ cells was seen in 
the spleen and mLN of p100D mice compared with WT mice and an increase in 
CD11c-CD103+ cell number was observed in the colon of p100D mice. Further flow 
cytometric analysis was performed to characterise this population. 
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Figure 4.5 Analysis of CD103 expression on non-cDC populations 
 
A Single cell suspensions from spleen, mLN and colon of WT and p100Δ mice were 
stained with fluorescently labelled antibodies to CD11c and CD103 and analysed by 
flow cytometry. This figure focuses on the CD11c-CD103+ cell population. FACs 
plots representative of two independent experiments are shown. 
 
B Graph depicting proportion of CD11c-CD103+ for the different tissues, from two 
independent experiments (n≥5 for each genotype). 
 
C Graph depicting CD11c-CD103+ cell number for the different tissues, from two 
independent experiments (n≥5 for each genotype). 
 
D Within the colon the CD11c-CD103+ population can be divided based on the level 
of CD103 expression. Two populations can be observed: CD11c-CD103int and 
CD11c-CD103high. The side scatter (SSC) and forward scatter (FSC) profile for each 
subpopulation is shown. 
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4.2.5. Characterisation of CD11c-CD103+ cells in the spleen, mLN 
and colon of WT and p100Δ  mice 
In order to analyse any differences in CD11c-CD103+ subpopulations between 
WT and p100Δ mice, single cell suspensions from spleen, mLN and colon where 
stained with fluorescently labelled antibodies to CD11c, CD11b, CD103 and CD3, 
and analysed by flow cytometry. 
In Figure 4.6, it can be seen that within the spleen approximately 60% of 
CD11c-CD103+ cells are CD3+ T cells (CD11b-) in both WT (n=5) and p100Δ (n=6) 
mice (Figure 4.6. A). Interestingly, when the CD11c-CD11b-CD3+ T cell population is 
gated on, a larger proportion of T cells are CD103+ in p100Δ mice with respect to WT 
mice (increased from 20% in WT, to 36% in p100Δ) (Figure 4.6. C). Within the mLN, 
approximately 90% of the CD11c-CD103+ cells are CD3+ T cells (CD11b-) in both 
WT (n=5) and p100Δ (n=6) mice (Figure 4.6. A). Similar to the spleen, when the 
CD11c-CD11b-CD3+ T cell population is gated on, a larger proportion of T cells are 
CD103+ p100Δ mice compared with WT mice (increased from 23% in WT, to 44% in 
p100Δ) (Figure 4.6. B). 
In the colon the CD11c-CD103+ population is subdivided into CD11c-
CD103int and CD11c-CD103high cells. Consistent with the SSC/FSC profile reflecting 
that the classical lymphocyte profile, the CD11c-CD103high cells from WT and p100Δ 
mice consist mainly of CD3+CD11b- T cells (Figure 4.6. C). Whereas, the CD11c-
CD103int cells represent a heterogeneous population with regards to CD3 and CD11b 
expression. This is consistent between WT and p100Δ mice (Figure 4.6. C). A greater 
proportion of CD3+ colonic T cells from p100Δ mice express CD103 when compared 
to CD3+ colonic T cells isolated from WT mice (Figure 4.6. D). 
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4.2.6. Blood serum levels of monocyte and macrophage chemotactic 
factors and IL-10 
Monocytes and macrophages response to chemotactic gradients in the same 
way lymphocytes respond to chemokines such as CXCL13 and CCL21. There are 
many chemotactic proteins able to promote mobilisation and recruitment of 
monocytes and macrophages and they can be secreted into the blood under steady-
state and inflammatory conditions, such as monocyte chemotactic protein (MCP) -1, 
MCP-3 and MCP-5, and macrophage inflammatory protein (MIP) -1γ. Blood serum 
levels of MCP-1, MCP-5 and MIP-1γ were increased in p100Δ mice, as was the level 
of IL-10, when compared to WT blood serum levels (Figure 4.7). 
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Figure 4.6 Characterisation of CD11c-CD103+ cells in the spleen, mLN and colon 
of WT and p100Δ  mice 
 
Preparations of single cell suspensions from spleen, mLN and colon of WT (n=3) and 
p100Δ (n=2) mice were stained with fluorescently labelled antibodies to CD11c, 
CD11b, CD103 and CD3, and analysed by flow cytometry. Representative FACs plots 
are shown. 
 
A Spleen and mLN: Cells were gated on CD11c-CD103+ and the CD11b/CD3 profile 
was analysed. 
 
B Spleen and mLN: CD103 histogram for T cells (gated on CD11c-C11b-CD3+). 
 
C Colon: Cells were gated on CD11c-CD103- CD11c-CD103int and CD11c-
CD103high. The CD11b/CD3 profile was analysed for these populations. 
 
D Spleen and mLN: CD103 histogram for T cells (gated on CD11c-C11b-CD3+). 
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Figure 4.7 Serum levels of monocyte and macrophage chemokines 
 
Blood serum collected from WT and p100Δ mice. Graph shows serum levels of MCP-
1, MCP-3 and MCP-5 (monocyte chemotactic protein), IL-10 and MIP-1γ 
(macrophage inflammatory protein) (WT n=4, p100Δ n=2). Results from one 
experiment. Mean values are shown, bars represent standard deviation. Students T-
test, *p≤0.05, **p≤0.01, ns=not significant. 
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4.3. Discussion 
Two distinct populations of splenic DCs that have been well characterised in 
the spleen: CD11chighCD8α-CD11b+ and CD11chighCD8α+CD11b- DCs (Leenen et al., 
1998; Shortman and Liu, 2002), and the proportion of both of these DC subsets was 
increased in the spleen and colon of p100Δ mice (Figure 4.1). Within the mLN, the 
expression of CD103 on gut-derived CD11chigh cells identifies DCs capable of 
migrating from the intestine to the mLN (Annacker et al., 2005; Schulz et al., 2009), 
and this population of DCs was increased in the colon of p100Δ mice (Figure 3.3). 
Intraepithelial and LP-T lymphocytes also express CD103 (Lehmann et al., 2002; Uss 
et al., 2006; Agace et al., 2000; Annunziato et al., 2006) and in the colon of p100Δ 
mice an increase in expression of CD103 was observed on CD3+ T cells, as well as on 
CD3+ T cells from the spleen and mLN (Figure 3.6). In addition to the identification 
of these DC subsets, the activation status of each was analysed and revealed increased 
CD86 expression by all the aforementioned DC subsets in the mLN of p100Δ mice 
and by CD11chighCD11b+ DCs from the spleen (Figure 4.4). Finally, blood serum 
levels of chemoattractant proteins, MCP-1, MCP-5 and MIP-1γ, in addition to the 
regulatory cytokine, IL-10, were elevated in p100Δ mice (Figure 4.7). 
The subdivision of cDCs based on CD8α/CD11b expression denotes two 
distinct populations within the spleen. Within the CD11chigh cDC population, both 
these subsets are increased in proportion in the spleen and colon of p100Δ mice 
(Figure 4.2), with no preferential increase in either class. If both sets are functioning 
normally, it is unlikely that any alteration in the cytokine milieu has occurred, 
although it is not known if the populations of CD8α+CD11b- and CD8α-CD11b+ DCs 
in the colon posses the same functional characteristics as the respective populations in 
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the spleen. Although functional studies have not been performed, the maturation 
phenotype has been assessed by expression of CD86. In this regard, both CD11b- and 
CD11b+ cDCs from the mLN of p100Δ mice demonstrated an increased activation 
status (Figure 4.4). This data suggests that an immune response is occurring in this 
tissue and as the mLN is the draining LN of the gut this implies that stimulation of 
DCs has occurred at this location, with subsequent migration to the draining LN. 
Conversely, it is the CD11b+ DC population, not the CD11b- population, in the spleen 
of p100Δ mice where an increased maturation status can be seen (Figure 4.4), 
implying that the phenotype in this tissue may be skewed towards a pro-inflammatory 
environment. Providing further complication to the situation, the proportion of 
CD11b- and CD11b+ cDCs was increased in the colon of p100Δ mice to a similar 
extent (Figure 4.2), but no alteration in activation status was observed (Figure 4.4). To 
fully understand the contribution of these DC subtypes to the p100Δ phenotype, 
expansion of activation markers investigated, such as CD80 and MHCII, as well as 
functional DC analysis is critical. 
LTβR is involved in the homeostasis of CD11chighCD11b+CD8α- DCs, but not 
CD11chighCD11b-CD8α+ DCs (Kabashima et al., 2005; Geissmann et al., 2010), 
therefore constitutive activation of signalling downstream of LTβR could account for 
the increase in CD11chighCD11b+CD8α- cDCs, but not for CD11chighCD11b-CD8α+ 
DCs. This indicates that in this situation alternative processes may be giving rise to 
the increase in CD11chighCD11b-CD8α+ DCs. 
Similar to CD11b+CD8α- and CD11b-CD8α+ cDCs, the subpopulations of 
CD103- and CD103+ intestinal cDCs present with differing functions, with CD103- 
cDCs driving a pro-inflammatory response and CD103+ cDCs inducing a tolerogenic 
environment (Annacker et al., 2005; Jaensson et al., 2008; Schulz et al., 2009; 
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Coombes et al., 2007; Siddiqui and Powrie, 2008). The proportion of both CD103- 
and CD103+ cDC populations were increased in the colon of p100Δ mice (Figure 3.3), 
suggesting that the balance between a tolerogenic and pro-inflammatory environment 
is not disturbed. Whereas, in the spleen of p100Δ mice, only the CD11chighCD103+ 
DCs population was increased in proportion (Figure 3.3). The majority of splenic 
CD103+ cDCs do not express CD11b and therefore correlate with the CD11b- DC 
subset (Appendix Figure 2), data that is supported by Annacker et al (Annacker et al., 
2005). Therefore, the CD103+ and CD11b- splenic DC populations presented in this 
chapter should not be regarded as distinct populations. The activation status of 
CD103- and CD103+ cDCs was increased only in the mLN of p100Δ mice and both 
populations demonstrate similar relative increases in CD86 expression (Figure 4.4). 
Therefore no individual population was preferentially affected by constitutive 
activation of p100. As with the CD8α+CD11b- and CD8α-CD11b+ DC subsets, 
functional analysis would need to be performed to determine whether this is altered.  
In compliance with the observed increases in cDC and CD11c-CD11b+ cell 
populations in the tissues of p100Δ mice, increased blood serum levels of 
chemoattractant proteins for monocytes, macrophages and DCs were detected (Figure 
4.7). Despite the fact that these analyses need to be repeated, this suggests a possible 
explanation for the augmented mobilisation of these cell types. It is important to note 
that the serum levels of these chemoattractant proteins may not reflect the levels 
present within specific tissues. In addition, increased serum IL-10 levels were 
observed (Figure 4.7) and may be associated with expansion of the macrophages 
CD11c-CD1b+ cell population in the colon of p100Δ mice, even though this expansion 
is not statistically significant (Figure 4.1). The population of CD11c-CD11b+ cell 
could include granulocytes and macrophages. Recent work investigating colonic 
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lamina propria macrophages demonstrates that they exhibit an anti-inflammatory M2-
like phenotype, expressing increased IL-10 and MCP-1 compared with splenic 
macrophages (Takada et al., 2010). Indeed, serum levels of not only IL-10 but also 
MCP-1 are increased in p100Δ mice (Figure 3.7). In contrast, splenic macrophages 
present with a pro-inflammatory M-1 phenotype, producing more TNFα than lamina 
propria counterparts (Takada et al., 2010). The population of splenic macrophages 
CD11c-CD1b+ cells in p100Δ mice is significantly increased (Figure 4.1), and if this 
population consisted of predominately splenic macrophages capable of producing 
TNFα this may correlate with data published by Ishikawa et al, where they showed 
increased TNFα mRNA in the spleen of p100Δ mice (Ishikawa et al., 1997). 
The majority of IELs are CD8+, and approximately 90% express CD103, 
whilst greater than 50% of LP-lymphocytes are CD4+ and only around 40-50% 
express CD103 (Agace et al., 2000). Analysis of CD103+ non-DCs in this chapter 
revealed that in the spleen and mLN, of WT and p100Δ mice, the majority of CD11c-
CD103+ cells were CD3+, whereas in the colon only around 40-50% were CD3+, with 
a potential increase in the proportion of CD11c-CD103+CD3+ cells in p100Δ mice 
(Figure 4.6).  Importantly, in Chapter 3 the proportions of CD4+ and CD8+ T cells in 
the colon of WT and p100Δ mice showed an increase only in the CD4+ T cell 
population in p100Δ mice, leaving the proportion of CD8+ T cells unchanged (Figure 
3.12). Together this data suggests that the increase in CD103+CD3+ T cells in the 
colon of p100Δ mice is likely to occur within the CD4+ lamina propria T cell 
population as opposed to the CD8+ IEL. Further flow cytometric analysis would 
confirm the phenotype of this colonic CD103+CD3+ T cell population and parallel 
immunofluorescence staining of colon sections would provide data on the in situ 
localisation. 
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5. Constitutive NF-κB2 Signalling in LTα-deficient Mice 
5.1. Introduction 
The importance of LTα1β2/LTβR signalling in the development and 
organisation of the spleen has been well described. The chemokines responsible for 
localisation of B and T lymphocytes to their respective areas include CXCL13, 
responsible for B cell recruitment (Förster et al., 1999; Cyster et al., 1999) and 
produced by FDCs (Ansel et al., 2000) in the B cell follicles, and CCL19/21, 
responsible for T cell and DC localisation and produced by T zone stromal cells and 
DCs (Luther et al., 2000). In addition to expression of CCL19/21, stromal cells of the 
T zone also express the transmembrane mucin-type protein, Gp38/Podoplanin, 
expression of which is dependent on LTβR signalling (Ngo et al., 2001; Withers et 
al., 2007). Cxcl13 and Ccl19/21 are target genes of the alternative NF-κB pathway 
(Bonizzi et al., 2004),(Dejardin et al., 2002) and without signalling via this pathway 
efficient organisation of B and T cell areas in the spleen cannot be achieved (Franzoso 
et al., 1998; Caamaño et al., 1998; Weih and Caamaño, 2003; Dejardin et al., 2002; 
Kaisho et al., 2001a; Karrer et al., 2000; Miyawaki et al., 1994; Koike et al., 1996). 
Ltα-/- mice present with a disorganised splenic architecture, with absence of 
B/T cell segregation, failure of B cell follicle formation and a lack of expression of 
chemokines associated with migration of B and T cells to their correct locations 
(Alexopoulou et al., 1998; De Togni et al., 1994; Matsumoto et al., 1996; Kuprash et 
al., 2002; Koni et al., 1997; Ngo et al., 1999). Moreover, mice deficient in alternative 
NF-κB signalling, such as Relb-/- or aly/aly mice, B/T segregation in the spleen is 
ablated as a result of reduced or absent CXCL13 and CCL19/21 expression (Weih et 
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al., 2001; Fagarasan et al., 2000).  Corroborating this, constitutive activation of the 
alternative pathway, as in the p100Δ mouse model, results in increased expression of 
CXCL13 and CCL21, and no defects in splenic B/T segregation (Guo et al., 2007). 
We hypothesised that introduction of constitutive activation of the alternative 
NF-κB pathway into an LTα-deficient environment, with subsequent recovery of 
chemokine expression, could rescue the disorganised splenic phenotype observed in 
Ltα-/- mice.  
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5.2. Results 
5.2.1. Similar body weight for p100Δ  and p100ΔLtα -/- mice 
The body weight of p100Δ and p100ΔLtα-/- mice at approximately three weeks 
of age does not differ (p=0.471) and the body weight of Ltα-/- mice at the same age is 
slightly increased compared with WT mice (Figure 5.1. A, p=0.013). 
Ligation of LTβR activates both the classical and alternative NF-κB pathways. 
The major ligand of LTβR is LTα1β2, with LIGHT being the minor ligand. In the 
p100ΔLtα-/- mouse model, signalling via the alternative pathway is constitutively 
active, but membrane bound LTα1β2 ligation of LTβR does not occur and therefore 
only minimal classical pathway activation is assumed to take place. The absence of 
LTα ligation of LTβR does not rescue the reduced body weight observed in p100Δ 
mice, indicating that this phenotype is controlled mainly through the alternative NF-
κB pathway.  
 
5.2.2. Rescue of splenic B and T cell segregation in Ltα -/- mice with 
constitutive activation of NF-κB2 p100 
The effect of introducing constitutive activation of the alternative NF-κB 
pathway into Ltα-/- mouse background was investigated by the generation of 
p100ΔLtα-/- mice. Cryostat sections of the spleens from these mice were stained and 
analysed by confocal microscopy. 
Analysis of spleen sections from WT, p100Δ, Ltα-/- and p100ΔLtα-/- mice 
demonstrated normal B and T cell organisation in WT and p100Δ mice, but a lack of 
 147 
B/T cell segregation in the white pulp of Ltα-/- mice. In the spleen of p100ΔLtα-/- mice 
the segregation of B and T cells was clearly restored in 100% of mice analysed 
(Figure 5.1. B). 
In order to enumerate the extent of B/T cell segregation in the spleen, the T-
zone in the confocal images was highlighted for further analysis. Initially, the 
measurement of T-zone size (µm2) was recorded. There was no difference in T-zone 
size between WT and p100Δ mice (p=0.229), a significant decrease in size was 
observed between WT and Ltα-/- mice (p=0.004) (Figure 5.1. C). Considering that the 
T-zone in Ltα-/- mice constitutes the entire white pulp, it can be said that a reduction 
in total white pulp area was observed in Ltα-/- mice. No significant difference in T-
zone size was seen between WT and p100ΔLtα-/- mice (Figure 5.1. C, p=0.060). 
Following assessment of T-zone size, the segregation of B and T cells was 
ascertained. This was evaluated by calculating the mean number of B220+ pixels 
within the T cell area, with B220+ pixels corresponding to the presence of B cells. The 
higher the value, the more B cells present and thus correlating to reduced segregation 
of B and T cells. p100Δ mice exhibited a similar number of B220+ pixels in the T-
zone as WT mice (p=0.629), demonstrating normal B/T cell segregation (Figure 5.1. 
C). Ltα-/- mice had significantly more B220+ pixels in the T-zone when compared 
with WT mice (Figure 5.1. C, p=0.021), indicating a reduction in B/T cell 
segregation, this is supported by the confocal images of spleen sections (Figure 5.1. 
B). Analysis of p100ΔLtα-/- mice showed a significant reduction in B220+ pixels in 
the T-zone compared with WT mice (p=0.007) and compared with Ltα-/- mice 
(p=0.004), indicating a more organised splenic organisation with respect to B and T 
cell areas (Figure 5.1. C). 
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In summary, p100Δ mice demonstrated normal demarcation of B and T cell 
areas in the spleen, whereas Ltα-/- mice showed no segregation of these two areas. 
Importantly, the introduction of constitutively active NF-κB2 p100 into Ltα-/- mice, as 
p100ΔLtα-/- mice, appears to rescue the formation of proper of B- and T- cell areas 
within the spleen. 
 
5.2.3. Expression of T-zone chemokines in Ltα -/- and p100ΔLtα -/- 
spleen 
The expression of chemokines by specialised splenic stromal cells is necessary 
for recruitment of B and T lymphocytes to their specific areas. Stromal cells in the T 
zone express Gp38/Podoplanin and CCL21 (Ngo et al., 2001; Withers et al., 2007), 
and Ccl21 is a target gene for the alternative NF-κB pathway (Bonizzi et al., 
2004),(Dejardin et al., 2002). To further dissect the differences in splenic 
microarchitecture and organisation, chemokine expression was assessed by confocal 
microscopy.  
Identification of T-zone stroma was achieved by staining for Gp38/Podoplanin 
and CCL21. Gp38/Podoplanin staining was observed in 100% of WT and p100Δ 
mice, but not in Ltα-/- mice, as expected (Figure 5.2 A and B, first colomn). 
Importantly, Gp38/Podoplanin staining was detectable in p100ΔLtα-/- mice, indicating 
recovery of expression of this glycoprotein by T-zone specific stromal cells (Figure 
5.2. B first column). CCL21 staining was observed in 100% of WT and p100Δ mice, 
but absent from Ltα-/- mice (Figure 5.2. A and B, second column). Interestingly, 
CCL21 expression was recovered in some, but not all, p100ΔLtα-/- mice: 60% of mice 
demonstrated positive CCL21 staining (Figure 5.2. A). 
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Splenic mRNA levels of Ccl21 were relatively similar in WT and p100Δ mice, 
reduced in Ltα-/- mice and restored in p100ΔLtα-/- mice. Surprisingly, the relative 
mRNA levels of Ccl19 in the spleen of p100Δ mice was elevated compared with WT, 
contrary to that published by Guo, et al, where they showed a reduction in Ccl19 
mRNA in the spleen (Guo et al., 2007). Levels in Ltα-/- mice were reduced compared 
with WT, and p100ΔLtα-/- mice demonstrated slightly elevated levels with respect to 
WT mice (Figure 5.3). 
 
5.2.4. Development of B cell follicles in Ltα -/- and p100ΔLtα -/- spleen 
The development of B cell follicles is dependent on LT, TNF and the 
expression of the chemokine CXCL13, which is produced by FDCs. In mice lacking 
TNF or LTα, few FDCs are found in the spleen and subsequently CXCL13 
expression is severely reduced (Ngo et al., 1999) and in mice lacking CXCL13, FDCs 
and B cell follicles fail to develop (Ansel et al., 2000). Figure 5.2, shows CXCL13 
expression (green, third column) and presence of FDCM1+ FDCs (green, fourth 
column) in WT and p100Δ mice. Ltα-/- and p100ΔLtα-/- mice lack both these markers 
(Figure 5.2. B). Splenic mRNA levels of Cxcl13 were elevated in p100Δ mice 
compared with WT mice and as expected levels were reduced in Ltα-/- mice. The level 
in the spleen of p100ΔLtα-/- mice was similar to that observed in Ltα-/- mice (Figure 
5.3). Surprisingly, there was one p100ΔLtα-/- mouse in which B cell follicle formation 
was restored, as was the expression of CXCL13 (Figure 5.4. C). 
Constitutive signalling through the alternative NF-κB pathway in Ltα-/- mice 
results in the rescue of B/T cell segregation in the spleen, but does not restore the 
formation of B cell follicles, except in one p100ΔLtα-/- mouse. 
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Figure 5.1 Rescue of splenic B and T cell segregation in Ltα -/- mice with 
constitutive activation of NF-κB2 p100 
 
A Body weights of WT, p100Δ, Ltα-/- and p100ΔLtα-/- mice at approximately 3 weeks 
of age. Black line represents median. 
 
B Cryostat sections of spleen from WT, p100Δ, Ltα-/- and p100ΔLtα-/- mice were 
stained with fluorescently labelled antibodies to B220 (blue) and CD4 (red) to 
visualise the T cell zone and B cell follicles using confocal microscopy. 
Representative images are shown. The T cell zone of the white pulp was extracted and 
the area measured using LSM image software. At least six T cell areas per animal, for 
three individual animals were quantified. 
 
C Using LSM image software the mean number of B220+ pixels present in the T cell 
area was counted. Black line represents mean. Statistical analysis: Student’s T-test.  
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Figure 5.2 Rescue of CCL21 and Gp38/Podoplanin expression in p100ΔLtα -/- 
mice 
 
A Overview of immunofluorescence analysis of p100ΔLtα-/- spleen. At least four 
individual animals per genotype were assessed. Consecutive cryostat sections of 
spleen were stained with fluorescent antibodies to CCL21 (T-zone chemokine), 
FDCM1 (marker for follicular DCs), Gp38 (stromal marker expressed by T zone 
stromal cells) (all green), B220 (red) and CD4 (blue)  (B), CXCL13 (B cell area 
chemokine) and CD169 (marker for marginal metallophilic macrophages) (both 
green), B220 (red) and CD4 (blue) (C).  
 
For x10 magnification scale bar denotes 200µm. 
For x40 magnification scale bar denotes 50µm. 

 152 
Figure 5.3 Splenic mRNA levels of Cxcl13, Madcam-1, Ccl21 and Ccl19 
 
Real-time RT-PCR analysis of Cxcl13, Madcam-1, Ccl21 and Ccl19 genes. Ratio of 
genes of interest to β-actin is shown. Error bars indicate SD from two independent 
samples. 
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Figure 5.4 Effect of constitutive activation of NF-κB2 p100 on LN development 
in Ltα -/- mice 
 
A Photograph showing presence of inguinal LNs (iLNs) in one p100ΔLtα−/− mouse. 
 
B Cryostat sections of iLNs from WT, p100Δ and one p100ΔLtα−/− mouse found to 
have developed LNs, were immunofluorescently stained for follicular DCs (FDCM1, 
green), B cells (B220, red) and T cells (CD4, blue). 
 
C Cryostat sections of spleen from the p100ΔLtα−/− mouse that developed LNs, 
immunofluorescently stained for Gp38 (green), CD169 (green), CXCL13 (green), 
B220 (red) and CD4 (blue). 
 
Representative images are shown. 
For x10 magnification scale bar denotes 200µm. 
For x40 magnification scale bar denotes 50µm. 
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5.2.5. Marginal zone development in Ltα -/- and p100ΔLTα -/- spleen 
Within the marginal sinus of the spleen reside two subpopulations of 
macrophages: marginal zone macrophages (MZMs) and marginal metallophilic 
macrophages (MMMs) (Figure 1.2. B). MMMs are located at the inner surface of the 
marginal sinus and express the marker CD169 (Oetke et al., 2006). 
In Figure 5.2 B, (final column) positive CD169 staining can be seen in WT 
and p100Δ mice, showing the presence of MMMs. However, in p100Δ mice the 
staining appears more diffuse, with the emergence of B220+ B cells throughout and 
outside the MMM ring. In the spleens of both Ltα-/- and p100ΔLtα-/- mice, CD169+ 
MMMs were not found (Figure 5.2. B, final column). Interestingly, in the p100ΔLTα-
/- mouse that did develop B cell follicles, faint but positive CD169 staining could be 
seen in the marginal sinus of the spleen (Figure 5.4. C). Cells lining the marginal 
sinus express MAdCAM-1, and WT and p100Δ mice presented with similar levels of 
splenic Madcam-1 mRNA, while Ltα-/- and p100ΔLtα-/- mice present with minimal 
Madcam-1 expression (Figure 5.3).  
The splenic marginal zone does not develop in Ltα-/-, and after introduction of 
constitutive activation of NF-κB2 p100, as in p100ΔLtα-/- mice, MZ development was 
not recovered in 80% of mice.  
 
5.2.6. LN development in Ltα -/- mice with constitutive activation of 
NF-κB2 p100 
LN development is dependent on LT, and mice lacking LTα or LTβR, LNs 
fail to develop (De Togni et al., 1994; Banks et al., 1995; Fütterer et al., 1998). 
Signalling downstream of LTβR occurs via the classical and alternative NF-κB 
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activation pathways (Dejardin et al., 2002). Strikingly, one of the five p100ΔLtα-/- 
mice analysed demonstrated recovery of inguinal and mesenteric LN development 
(Figure 5.4. A). This was the same animal in which B cell follicle, CXCL13 
expression and CD169 expression in the marginal sinus was recovered (Figure 5.4. 
C). 
Figure 5.4 A, shows the presence of inguinal LNs in one p100ΔLtα-/- mouse. 
Cryostat sections of inguinal and mesenteric LNs from WT, p100Δ and p100ΔLtα-/- 
mice were stained with fluorescently labelled anti-B220 (red), for B cells, anti-CD4 
(blue), for CD4+ T cells and anti-FDCM-1 (green), for FDCs, or anti-CD3 (green) for 
T cells (Figure 5.4. B. inguinal LN only). The structure of the inguinal LN from the 
p100ΔLtα-/- mouse, showed normal architecture, with defined segregation of B and T 
cell areas, development of B cell follicles and presence of FDCs.  
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5.3. Discussion 
The organisation of the white pulp of the spleen into distinct B and T cell 
areas depends on the expression of specific chemokines, an LTβR-dependent process 
(Mebius and Kraal, 2005). This chapter presents the dramatic rescue of B and T cell 
segregation in the spleen of Ltα-/- mice with constitutive activation of the alternative 
NF-κB pathway (p100ΔLtα-/- mice) (Figure 5.1), with the recovery of 
Gp38/Podoplanin expression in the T zone in all p100ΔLtα-/- mice and recovery of T-
zone associated CCL21 expression in 60% of animals (Figure 5.2). The rescue of B/T 
demarcation in these mice was not accompanied by development of B cell follicles, 
except in one instance (Figure 5.2 A, and Figure 5.4 C). In addition, four of the five 
p100ΔLtα-/- mice examined did not recover development of peripheral LNs (Figure 
5.1. A). Interestingly, the remaining p100ΔLtα-/- mouse did develop iLNs and mLN, 
along with identification of B cell follicles in the spleen (Figure 5.4). 
Specialised stromal cells and FDCs in the B cell area express CXCL13 (Ansel 
et al., 2000), and stromal cells of the T cell area express CCL21 (Luther et al., 2000) 
and Gp38/Podoplanin (Ngo et al., 2001), staining of these markers can be seen in the 
appropriate areas in WT and p100Δ mice, corresponding with normal demarcation of 
B and T cell areas. In Ltα-/- mice, no expression of CXCL13, CCL21 or 
Gp38/Podoplanin is observed and the white pulp showed no organisation, with 
intermingling of B and T cells. Strikingly, the introduction of constitutive activation 
of NF-κB2 p100 into an LTα deficient environment, rescues the disorganisation in 
the spleen of Ltα-/- mice, and this organisation correlates with recovery of expression 
of Gp38/Podoplanin and a degree of recovery of CCL21 expression (Figure 5.2).  
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The recovery of CCL21 protein expression in p100ΔLtα-/- mice was only 
evident in 60% of mice examined, although CCL21 mRNA was detectable to similar 
levels in mice that expressed the protein and those that did not (Figure 5.3). This 
spectrum of CCL21 protein expression recovery could suggest a requirement of a 
threshold level of nuclear translocation of NF-κB heterodimers, such as p52/RelB, for 
transcription of the gene, a threshold that may not be met in each individual mouse. 
Interestingly, in p100ΔLtα-/- mice lacking detectable CCL21 protein in the T zone, 
demarcation of B and T cell areas was still rescued; this could be due to the fact that 
100% of p100ΔLtα-/- mice recovered Gp38/Podoplanin expression within the T zone. 
This indicates that constitutive activation of NF-κB2 p100 in an LTα deficient 
environment is sufficient to induce Gp38/Podoplanin expression, without LTα1β2-
induced LTβR signalling, suggesting that activation of the classical NF-κB pathway 
downstream of the LTβR may play a negligible role in the expression of this 
glycoprotein. 
The dramatic rescue of B and T zone organisation in p100ΔLtα-/- mice was not 
accompanied by recovery of B cell follicle formation or the development FDC 
networks, and, as a result, CXCL13 expression was not recovered. The lack of FDC 
and B cell follicle development in Ltα-/- mice is reflected in aly/aly mice, comprising 
a non-functional form of NIK, and mice lacking NF-κB2 also present with defects in 
B cell follicle formation (Miyawaki et al., 1994; Koike et al., 1996; Karrer et al., 
2000; Franzoso et al., 1998; Caamaño et al., 1998). Together these studies 
demonstrate that LTβR signalling through the alternative NF-κB pathway is required 
for FDC development and B cell follicle formation. The recruitment of B cells to the 
follicle requires the expression of CXCL13 by stromal cells and FDCs. Intriguingly, a 
recent paper has described the requirement for classical and alternative NF-κB 
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pathway activation in expression of CXCL13 by an established LN stromal cell line 
(Suto et al., 2009). Considering that in p100ΔLtα-/- mice, LTα-induced LTβR 
signalling via the classical NF-κB pathway is ablated, but alternative signalling is 
constitutive, owing to the knock-in p100Δ gene, this provides a possible explanation 
for the lack of recovery of CXCL13 expression. However, LIGHT is an alternative 
ligand for LTβR (Mauri et al., 1998) that in this situation appears unable to 
compensate for the lack of membrane bound LTα1β2 in p100ΔLtα-/- mice with regards 
to CXCL13 expression.  
In addition to its role in splenic organisation, LTβR plays a critical and well 
described role in LN development, with Ltα-/- and LtβR-/- mice lacking all LNs 
(Fütterer et al., 1998; Banks et al., 1995; De Togni et al., 1994). We observed the 
same phenotype in Ltα-/- mice, but strikingly in one of the five p100ΔLtα-/- mice 
examined, development of mLN and iLNs was clearly recovered (Figure 5.4). 
Moreover, the iLNs and mLN presented with well organised B and T cell areas and 
distinct B cell follicles, with presence of FDCM1+ FDCs. This data demonstrates that 
approximately 20% of p100ΔLtα-/- mice develop mature, fully organised iLNs and 
mLNs, however, it does not rule out the possibility that in those mice that do not 
develop mature LNs that rudimentary structures developed earlier in life and failed to 
fully mature. It would be of interest to study p100ΔLtα-/- mice younger than three 
weeks old, and during embryonic development. 
iLN development has been investigated in Ltα-/- and LtβR-/- embryos at E15 
and shown to be comparable with that in WT embryos (White et al., 2007; Bénézech 
et al., 2010). By E16-17, further iLN development in both Ltα-/- and LtβR-/- embryos 
was halted and the structures were difficult to identify (White et al., 2007; Bénézech 
et al., 2010). The process of LN development depends on maturation of LTo cells, a 
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two-step process. The first step occurs independently of LTα1β2-LTβR signalling, and 
can therefore be observed in E15 Ltα-/- and LtβR-/- embryos, whereas the second step 
depends on LTβR signalling and LNs fail to develop further without this signal 
(White et al., 2007; Bénézech et al., 2010). It could be envisaged that introducing 
constitutive activation of NF-κB2 p100 in Ltα-/- mice, thereby compensating for the 
lack of LTα-induced LTβR signalling, enables development of LNs to a later stage 
than that observed in Ltα-/- mice. Splenic mRNA levels of Cxcl13 and Madcam-1 
were not recovered in p100ΔLtα-/- mice (the individual mouse that developed LNs 
was not analysed) (Figure 5.3). It is possible that the lack of MAdCAM-1 and 
CXCL13 recovery could indirectly block maturation of LN anlage through prevention 
of lymphocyte recruitment and localisation, respectively, explaining the lack of 
mature LNs in the majority of adult p100ΔLtα-/- mice. Following early embryonic 
development, in the majority of p100ΔLtα-/- mice, the constitutively active NF-κB2 
p100 may not be able to compensate for the lack of LTα, resulting in atrophy of LN 
anlagen and their inability to develop into fully mature LNs. 
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6. General Discussion  
6.1. The role of NF-κB2 in ILF development 
The role of NF-κB2 in the development of secondary lymphoid tissues, such 
as LNs and PPs, has been well described. Mice lacking alternative pathway signalling, 
such as aly/aly (Shinkura et al., 1999; Miyawaki et al., 1994; Fagarasan et al., 2000; 
Karrer et al., 2000) and Relb-/- (Weih et al., 1995; Yilmaz et al., 2003; Weih and 
Caamaño, 2003) mice, fail to develop LNs and PPs, and the LNs and PPs that develop 
in Nfkb2-/- mice are reduced in size and disorganised in their microarchitecture 
(Carragher et al., 2004; Paxian et al., 2002). The alternative pathway signals 
downstream of LTβR (Dejardin et al., 2002; Müller and Siebenlist, 2003; Yilmaz et 
al., 2003) and mice deficient in LTβR or components of the membrane bound ligand, 
LTα1β2, fail to develop LNs and PPs (Fütterer et al., 1998). Additionally, alternative 
pathway signalling occurs downstream of several other TNF Receptor family 
members, including RANK and there is a critical role for RANKL-RANK interaction 
in LN development; Rankl-/- and Rank-/- mice do not develop peripheral LNs, whilst 
PP development is unaffected (Kong et al., 1999; Kim et al., 2000; Dougall et al., 
1999).  
 
6.1.1.1. CP development 
The role of NF-κB2 in the development of tertiary lymphoid tissue, such as 
CPs and ILFs, is less well understood. The development of CPs is considered to be 
genetically programmed (Bouskra et al., 2008; Eberl, 2007) and is dependent on the 
LTα1β2-LTβR signalling axis as these structures are not present in the intestine of 
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LtβR-/-, Ltα-/- and Ltβ-/- mice (Ivanov et al., 2006; Taylor et al., 2004; Lorenz et al., 
2003; Pabst et al., 2005; Hamada et al., 2002). However, it is unclear whether the 
alternative NF-κB pathway plays a crucial role in CP development. Aly/aly mice do 
exhibit CPs in the intestine (Ivanov et al., 2006; Hamada et al., 2002; Taylor et al., 
2004), but the presence of CP development in Relb-/- and Nfkb2-/- mice has not yet 
been investigated. We did observe CP-like structures in the colon of Relb-/- mice (data 
not shown) and in this thesis we present a lack of ILF development in these mice. 
Conversely initial analysis of Nfkb2-/- mice revealed the presence of colonic ILFs and 
as ILF formation has not been observed without the development of CPs, it can be 
assumed that CP development in Nfkb2-/- mice does occur. Accurate analysis and 
quantification of CP development in Relb-/- mice, Nfkb2-/- and p100Δ mice is needed 
to fully understand the contribution of the alternative pathway to this process. A 
useful tool to address this question is the RORγtYFP knock-in mouse, in this system the 
gene encoding enhanced yellow fluorescent protein (EYFP) was inserted in the first 
exon of the gene encoding RORγt (Eberl et al., 2004). Eberl et al, demonstrated that 
RORgt was expressed exclusively by LTi cells in the embryo. The generation of 
p100ΔRORγtYFP and Relb-/-RORγtYFP mice would enable reliable and accurate 
assessment of CP formation in these mice as YFP+ clusters, lacking B lymphocytes, 
within the colon could be enumerated by fluorescence microscopy. 
 
6.1.1.2. ILF Formation 
CPs are proposed to be the precursor structures for ILFs (Pabst et al., 2005; 
Eberl, 2005; Eberl, 2007; Eberl and Sawa, 2010), defined by the recruitment of B 
lymphocytes to the structure (Hamada et al., 2002). The presence of CPs has been 
described in aly/aly mice (Ivanov et al., 2006; Hamada et al., 2002; Taylor et al., 
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2004) thus suggesting that CP development may occur independently of alternative 
pathway activation. It would be beneficial to assess the development of CPs in Relb-/- 
mice to corroborate this theory. It is then conceivable that in the colon of p100Δ mice 
CP numbers are equivalent to WT mice. Therefore, the augmented ILF formation 
observed in p100Δ mice would likely be due to an increase in the proportion of CPs 
maturing into ILFs, rather than an increase in CP development.  
Similar to CP development, the formation of ILFs is dependent on the 
LTα1β2-LTβR signalling axis; LtβR-/-, Ltα-/- and Ltβ-/- mice do not develop ILFs 
(Ivanov et al., 2006; Taylor et al., 2004; Lorenz et al., 2003; Pabst et al., 2005; 
Hamada et al., 2002). In contrast to CP development, ILFs do not develop in aly/aly 
mice (Ivanov et al., 2006; Hamada et al., 2002; Taylor et al., 2004). Together these 
findings indicate that LTβR signalling via the alternative NF-κB pathway is involved 
in ILF formation. In support of this, we demonstrate that constitutive activation of this 
pathway results in augmented ILF formation and initial analysis of Relb-/- mice 
revealed no colonic ILF formation. 
Independent of the function of NF-κB2 in CP development, the significant 
increase in colonic ILF formation in p100Δ mice may elude to a role for alternative 
pathway signalling in recruitment of B cells to the intestine. The recruitment of B 
lymphocytes to the intestine, facilitating ILF formation, is dependent on interactions 
between specific ligands and receptors, for example LTα1β2-LTβR (Lorenz et al., 
2003; Taylor et al., 2004), CCL20:CCR6(Lügering and Kucharzik, 2006; Williams, 
2006) and Integrin α4β7:MAdCAM-1 (Wang et al., 2008). B lymphocytes lacking 
LTα, CCR6 or β7 are unable to migrate to the intestine and subsequently ILF 
formation is prevented (Lorenz et al., 2003; Taylor et al., 2004; Lügering and 
Kucharzik, 2006; Wang et al., 2008). CCL20 (Tanaka et al., 1999; McDonald et al., 
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2007) and MAdCAM-1 (Ando et al., 2005; Wang et al., 2008) are expressed by 
intestinal epithelium and we showed MAdCAM-1 expression in the colon of p100Δ 
mice (Figure 3.6. B). The expression level of MAdCAM-1 in the colon of p100Δ mice 
needs to be assessed. If expression is increased, as it is in the spleen (Guo et al., 
2007), this could provide an explanation for the enhanced recruitment of B cells to the 
intestine. Additionally, a recent study has postulated that CXCR5 is required for 
normal development of CPs and ILFs, together termed solitary intestinal lymphoid 
tissue (SILT), showing that Cxcr5-/- mice do not develop SILT by four weeks of age, 
whereas WT mice did (Velaga et al., 2009). CXCR5 and its ligand CXCL13, are 
involved in the positive feedback loop that occurs following LTi cell interaction with 
stromal cells and as such are indispensible for normal LN and PP development. 
Cxcr5-/- and Cxcl13-/- mice developed no or few PPs, and those that did form were not 
fully developed and development of LNs was severely, but not fully, impaired 
(Förster et al., 1996; Ansel et al., 2000). Expression of CXCL13 by a LN stromal cell 
line has been shown to require activation of both the classical and alternative NF-κB 
pathways (Suto et al., 2009). In p100Δ mice, the classical pathway is assumed to 
occur normally whereas the alternative pathway is constitutively active. We 
demonstrated CXCL13 expression within the colon of p100Δ (Figure 3.6. A), if this 
expression is elevated compared to WT mice, potentially due to the persistent 
activation of NF-κB2 p100, this could shift the balance of intestinal lymphoid tissue 
towards ILFs rather than CPs by the recruitment of B cells, potentially explaining the 
augmented ILF development. 
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6.1.1.3. Haematopoietic and stromal cells function during ILF 
formation 
Dissection of the contribution of haematopoietic and stromal cells to the 
colonic phenotype observed in p100Δ mice was investigated through the generation of 
WT mice reconstituted with p100Δ-derived FLCs (Chapter 2.7). Irradiated WT host 
mice received p100Δ FLCs, providing the situation where radiation resistant WT 
stromal cells are able to interact with haematopoietic cells in which the alternative 
NF-κB pathway is constitutively active. 
These reconstitution experiments demonstrated that constitutively active NF-
κB2 p100 in haematopoietic cells was sufficient to drive augmented ILF formation. 
The caveat being that the host mice were harvested three months post transfer, and as 
p100Δ mice demonstrate a significant increase in ILFs by 2-3 weeks of age, the two 
situations are difficult to compare. Two alternative scenarios could be occurring. In 
the first instance, augmented ILF formation in the chimeric mice may take several 
months to develop, in which case haematopoietic cells with constitutively active NF-
κB2 p100 may need to ‘induce’ intestinal stromal cells to increase chemokine 
expression thereby resulting in recruitment of lymphocytes and promotion of ILF 
formation, accounting for the discrepancy in measurable increased ILF formation. In 
the second instance, augmented ILF formation may be discernible at three weeks 
post-transfer, in which case the role of the stroma may be less prominent, with the 
phenotype driven predominately by the haematopoietic cells. However, the situation 
with ILF formation in p100Δ mice may well vary from either of these two scenarios; 
within p100Δ mice, the alternative pathway is constitutively active in both 
haematopoietic cells and stromal cells and there may be a synergistic effect occurring 
between the two. 
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Supplementing previously published studies, this thesis expands on current 
information relating to ILF formation by demonstrating that constitutive activation of 
the alternative NF-κB pathway results in a significant increase in colonic ILF 
formation and with the suggested future experiments, including assessment of CP 
development in p100Δ mice, the understanding of CP and ILF development would be 
further enhanced. It is important to understand whether or not the alternative NF-κB 
pathway plays a role in CP development because if it does not and is only involved in 
maturation of CPs to ILFs then inhibition of this pathway could be used as a 
therapeutic tool to limit ILF formation. The question then remains: what role do ILFs 
play in disease? 
 
6.1.2. Consequences of alterations in ILF formation 
 Regardless of the mechanism for increased ILF development in p100Δ 
mice, the resulting phenotype carries different potential outcomes. The limitation with 
the p100Δ mouse model is that the animals die prematurely, by 3-4 weeks of age, due 
to a currently unknown cause; this limits investigation of the long-term affect of 
increased colonic ILF numbers. Interestingly, the WT mice reconstituted with p100Δ 
FLCs, do develop increased numbers of ILFs, but do not present with signs of disease 
at the time of sacrifice three months post-transfer. The development of CPs and ILFs 
in the intestinal tract occurs under steady state conditions and can also be induced 
during inflammatory responses. Many studies have reported that during colitis an 
increase in lymphoid aggregates in the intestine can be observed (Spahn et al., 2002; 
Leithäuser et al., 2001), but the reason for this increase has not been elucidated. 
Numerous animal models of colitis have been established where colitis is induced 
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either chemically (Wirtz et al., 2007), by transfer of T cell subsets to immunodeficient 
hosts (Ostanin et al., 2009) or by genetic manipulation. Of particular interest is the 
chemically induced dextran sodium sulphate (DSS) colitis model (Wirtz et al., 2007). 
In this model animals are treated with DSS in either an acute or chronic model of 
colitis and present with inflammation in the colon. Interestingly, the presence of B 
and T cells is not required for DSS-induced colitis, as SCID mice develop colitis 
following DSS treatment (Dieleman et al., 1994). However, in WT mice the 
generation of lymphoid aggregates in the colon can be observed following DSS 
treatment and it was suggested that these structures resembled ILFs (Spahn et al., 
2002).  
The alternative NF-κB pathway is activated downstream of LTβR and the 
DSS-colitis model has been used by several groups to assess the role of LTβR 
signalling in the development of colitis. Jungbeck et al, used this acute colitis model 
to investigate the affect of inhibiting LTβR signalling on disease progression in LtβR-
/- mice. It was demonstrated that treatment of LtβR-/- mice with DSS resulted in 
increased severity of intestinal inflammation when compared with WT mice 
(Jungbeck et al., 2008). Additionally, it was shown that mice lacking LTβ expression 
specifically on B lymphocytes presented with decreased intestinal inflammation, 
whereas mice with loss of LTβ on T cells showed disease severity comparable to 
LtβR-/- mice; indicating that B cells play a role in promoting disease progression 
(Jungbeck et al., 2008). An additional study where acute DSS-colitis was induced in 
Ltα-/- mice, demonstrated a more severe disease phenotype in these animals compared 
with WT colitic mice (Spahn et al., 2002). Together these studies indicate that LTβR 
signalling plays a role in the induction and progression of colitis. LtβR-/- mice do not 
develop LNs or ILFs, a phenotype which could play a significant role in the 
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progression of colitis. The lack of LNs could mean that an effective immune response 
may not be mounted against the invading pathogens and the lack of PPs and ILFs, and 
subsequent lack of IgA, could mean there is an increase in bacterial load in the 
intestine of LtβR-/- mice before colitis is induced thereby exacerbating the disease.  
Considering these studies and relating them to the situation observed in p100Δ 
mice, where signalling downstream of LTβR is constitutively active instead of 
inhibited there are a number of points to discuss. Intestinal epithelial cells express 
LTβR (Browning and French, 2002) and in p100Δ mice the need for interaction of 
these stromal cells with LT expressing cells to induce LTβR signalling is ablated, as a 
result there is a potential premature expression of chemokine and cell adhesion 
molecules, such as MAdCAM-1, VCAM-1 and CXCL13, without the need for prior 
lymphocyte stimulation. As a result this could enable recruitment of lymphocytes into 
the colon, early than would be seen in WT mice, culminating in an increase in ILF 
formation. In the p100Δ model, MAdCAM-1 and VCAM-1, CXCL13 expression can 
be observed in the colon and quantification of this expression would reveal if levels 
were elevated. The association of MAdCAM-1 expression with colitis progression has 
been well described (Xu et al., 2007; Kang et al., 2007; Farkas et al., 2006; Stopfer et 
al., 2004; Teramoto et al., 2005) and elevated levels of MAdCAM-1 in the spleen of 
p100Δ mice has been previously reported (Guo et al., 2007), if levels were also 
increased in the colon this could be a sign of the beginning of colitis in these mice. 
Two potential systems for induction of ILFs may occur in colitis models. 
Firstly, they may be induced simply as a response to bacterial stimuli, which in the 
case of colitis is increased as the epithelial barrier is disrupted, allowing influx of 
bacteria into the tissue. In this situation, ILF formation occurs as an immune response 
to limit infection. Alternatively, the host’s immune system may respond 
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inappropriately to commensal bacteria, stimulating ILF development and progression 
of a pro-inflammatory response to harmless micro-organisms. These two situations 
are opposing in their function; the first protects against the infection induced by 
epithelial barrier decay, the second potential instigates epithelial barrier decay by 
promoting a pro-inflammatory ‘attacking’ environment. In mouse models where 
colitis occurs spontaneously, such as Il-10-/- mice, initiation of disease occurs from 
around two months of age (Sellon et al., 1998; Berg et al., 1996; Kühn et al., 1993). 
As p100Δ mice die by 3-4 weeks of age, assessment of colitis progression cannot be 
observed or analysed. However, when NF-κB2 p100 is constitutively active only in 
the haematopoietic cell compartment, as is the case when WT mice are reconstituted 
with p100Δ FLC, an environment is generated which does not spontaneously lead to 
inflammation; these mice do not develop signs of colitis. A set of interesting 
experiments could be pursued to ascertain the response of these mice to DSS 
treatment. Would the increased colonic ILF formation lead to protection against 
colitis or induce more severe disease? 
 
6.1.3. The role of DCs in intestinal immunity 
The significant increase in ILF formation in p100Δ mice was not the only 
interesting phenotype observed in the colon. A dramatic influx and or proliferation of 
DCs in the colon was noted and as DCs play a crucial role in maintaining gut 
immunity and initiating mucosal immune responses, investigation into the phenotypes 
of these cells was undertaken. The T cell transfer model of colitis results in increased 
total numbers of CD11chigh DCs in mLN and colon (Laffont et al., 2010). This model 
of colitis involves the transfer of naïve T cells into immunodeficent hosts, such as 
Rag-/- mice, and due to the lack of T regulatory cells these mice develop colitis 
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(Mottet et al., 2003). We observed a similar increase in CD11chigh DCs in the colon of 
p100Δ mice. Although, the cDC numbers were not increased in the mLN, it is 
conceivable that the potential inflammatory response occurring in the colon might not 
be observable in mLN due to the early death of p100Δ mice. Alterations in cell 
recruitment and retention might also play a role. 
Within the spleen the CD11chigh DC population can be subdivided into two 
distinct, groups: CD8α+CD11b- and CD8α-CD11b+ DCs. LtβR-/- mice exhibit a defect 
in splenic CD11chighCD8α- DC numbers (Wu et al., 1999; Abe et al., 2003; De Trez et 
al., 2008; Wang et al., 2005), as do aly/aly and Relb-/- mice (De Trez et al., 2008; Wu 
et al., 1998). Therefore, it appears that LTβR signalling through the alternative NF-
κB pathway maintains CD11chighCD8α- DC homeostasis. Interestingly, in p100Δ 
mice there is no preferential increase in either CD11chighCD11b+CD8α- or 
CD11chighCD11b-CD8α+ DC populations (Figure 4.2. A), suggesting that constitutive 
activation of NF-κΒ2 p100 can override homeostatic control of CD11chighCD11b-
CD8α+ DCs, a process that has not previously been described. 
Many subsets of mucosal DCs have been identified based on surface 
expression of different molecules; of particular interest is CD103. LP CD103+ DCs 
are able to sample antigen, migrate to the mLN and present antigen to T cells (Schulz 
et al., 2009), thereby inducing upregulation of gut-homing receptors, such as CCR9 
(Annacker et al., 2005). In p100Δ mice, there was an increase in CD103+ DCs in the 
colon (Figure 4.3. B and C); this was not observed in the mLN, potentially this could 
be due to retention of these cells in the colon or due to a reduced migration rate under 
steady-state conditions, by unknown mechanisms. This hypothesis is supported by 
FACs analysis of CD3+ T cells from the mLN of p100Δ mice, showing no change in 
CCR9 expression and no alteration in activation status, when compared to WT 
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counterparts (Appendix Figure 1). LP CD103+ DCs located in the small intestine are 
derived from a blood-bourne DC precursor (Jaensson et al., 2008), it is possible that 
LP CD103+ DCs from the colon are also derived from such a precursor. The role of 
the alternative NF-κB pathway in generation and/or release of pre-DCs into the blood 
from bone marrow has not been investigated neither has any potential role in 
homeostasis of CD103+ DC subsets. However, it has been demonstrated that RelB is 
required for the survival and maturation of CD8-CD11b+ DCs, but not for 
CD8+CD11b- DCs (Wu et al., 1998). Interestingly, lymphoid CD8+CD11b- DCs have 
been proposed to be developmentally and functionally linked to peripheral CD103+ 
DCs (Edelson et al., 2010). Considering that LTβR, CD40 and RANK signalling, and 
subsequent alternative pathway activation is involved in DC homeostasis, maturation 
and survival in the spleen, it would be interesting to extend this knowledge to the 
CD103+ DC population in the colon and mLN. It could be envisaged that the 
alternative pathway plays a role in DC homeostasis either through increased 
generation of pre-DCs, by increasing their proliferation via factors such as Cyclin-D1, 
or by affecting proliferation of DC subsets within tissues by similar mechanisms 
and/or due to signalling downstream of LTβR, CD40 or RANK. If this were the case 
it would provide a possible explanation for the increase in DC populations in the 
spleen and mLN of p100Δ. The role of p100 as a negative regulator of RelB function 
through heterodimerisation and cytoplasmic retention is highlighted in DC biology 
(Speirs et al., 2004). In mice lacking p100 (Nfkb2-/- mice) RelB can be found in the 
nucleus of DCs before activation, this is not the case in WT DCs. Furthermore, Nfkb2-
/- DCs present with elevated expression of activation markers, but normal levels of 
cytokine production and possess an increased capacity to stimulate CD4+ T cells 
(Speirs et al., 2004). Considering that in p100Δ mice the p100 protein has been 
 171 
replaced by p52, there will be no negative regulation of RelB activation, therefore 
with regards to DC maturation and activation the situation may be similar to that 
observed in Nfkb2-/- mice. 
We demonstrate that the alternative NF-κB pathway plays a role in DC 
homeostasis, with potential affects on their survival, maturation and activation. This 
area of work would be of great interest to pursue in the future as it may deepen our 
understanding of DC biology. 
 
6.1.4. The alternative NF-κB pathway and splenic organisation 
It is well established that the alternative NF-κB pathway is involved in the 
organisation of the spleen through activation downstream of LTβR ligation and 
transcription of genes encoding chemokines and cell adhesion molecules, such as 
CXCL13, CCL19/21 and MAdCAM-1. Mice lacking LTβR (Fütterer et al., 1998), or 
components of the ligand LTα1β2 (Kuprash et al., 2002; Banks et al., 1995; 
Alexopoulou et al., 1998; Matsumoto et al., 1997; Ngo et al., 1999; Alimzhanov et al., 
1997), fail to develop an organised spleen where B and T cell areas are clearly 
demarcated. Moreover, these knock-out mouse models also fail to develop LNs, as do 
mice in which signalling through the alternative pathway is ablated, such as Relb-/- 
(Weih et al., 1995; Yilmaz et al., 2003; Weih and Caamaño, 2003) and aly/aly 
(Shinkura et al., 1999; Miyawaki et al., 1994; Fagarasan et al., 2000; Karrer et al., 
2000) mice. We demonstrate that introducing constitutively active p100 into an LTα 
deficient environment results in the striking recovery of organised B and T cell areas 
within the white pulp of the spleen, but with only one out of five p100dLtα-/- mice 
developing B cell follicles (Figure 5.2 and 5.2). Our second significant finding was 
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the fact that the same animal that developed B cell follicles also developed mature 
and fully organised iLNs and mLN (Figure 5.4). This data confirms that splenic 
organisation and LN development are dependent on the LTα1β2-LTβR signalling axis 
and demonstrates that this signalling critically occurs through the alternative NF-κB 
pathway.  
In light of these findings it would be interesting to investigate the development 
of LNs in p100dLtα-/- mice during embryogenesis to elucidate at which point 
constitutively active NF-κB2 p100 can no longer compensate for the lack of LTβR 
ligation by LTα1β2, thus further deepening our understanding of LN development. 
 
In summary, this thesis presents compelling evidence that activation of the 
alternative NF-κB pathway plays a significant role in the promotion of colonic ILF 
formation, potentially through various roles in cell activation, survival, proliferation 
and migration, as well as through stimulation of chemokine expression by endothelial 
cells. This leads to the suggestion that this signalling pathway may also be involved in 
development of other tertiary lymphoid tissues. 
Additionally, this thesis highlights the role of the alternative NF-κB pathway 
in the cellular organisation of adult spleen, through the expression of B- and T-zone 
specific chemokines and we show that this pathway is a crucial signalling pathway 
downstream of LTβR. 
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7. Future Directions 
 
This thesis has demonstrated that constitutive activation of p100Δ results in an 
increase in colonic ILFs and as described in the general discussion there are several 
potential explanations for this increase. 
1. Increased ILF numbers may result from an increase in CP number, therefore 
an accurate assessment of CP number is vital to address this theory. 
2. During experimental models of inflammatory bowel disease increased ILF 
numbers are often observed. p100Δ mice die prematurely at three weeks of 
age and have reduced body weight compared with WT littermates, they do not 
present with any gross symptoms of colonic inflammation but this may be due 
to early death, therefore it would be useful to repeat the serum cytokine 
analysis and to assess the cytokine levels in colonic tissue. 
3. Constitutive activation of NF-κB2/p100 in a specific cell type could be 
responsible for the increase in ILFs. To address this theory repeats of the FLC 
transfer, along with splenocyte transfers would help to deduce whether the cell 
or cells responsible are precursors (i.e. from the foetal liver) or have a more 
mature phenotype (i.e. from the spleen). 
4. Dysregulation of the alternative NF-κB pathway has been shown to affect 
chemokine expression in the spleen and LNs, it may be that chemokine 
expression in the colon is altered and this affects the ILF formation, therefore 
analysis of chemokine levels in colon and assessment of the chemotactic 
potential of different p100Δ cell types would help to elucidate whether this 
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axis of lymphoid tissue development is involved in the augmented ILF 
development in p100Δ mice. 
 
The second area addressed in this thesis where future work could noticeably 
improve understanding is the potential role of the alternative NF-κB pathway in DC 
biology. Isolation of DC subsets from the colon of p100Δ mice and assessment of 
their function would reveal whether this heterogeneous population of cells plays a 
role in the colonic phenotype observed. Additionally, p100Δ mice may have defects 
in DC development and maturation, investigation of which encompasses a large and 
very interesting area of potential future research. 
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Figure 9.1 Expression of CCR6 and CCD9 on B and T lymphocytes 
 
Single cell suspensions from spleen, mLN and colon from WT and p100Δ mice where 
analysed for expression of CCR6 (A) and CCR9 (B) by flow cytometry. Populations 
were gated on B220+ B cells and CD3+ T cells and the percentage of cells positive 
for CCR6 (A) or CCR9 (B) are shown. Bar indicates median. 
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Figure 9.2 CD103 and CD11b expression on CD11chigh DCs 
 
Single cell suspensions from spleen, mLN and colon from WT and p100Δ mice where 
analysed for CD103 and CD11b expression on CD11chigh DCs. Cells were gated on 
CD11chigh and the profile of CD103 and CD11b expression analysed. Representative 
FACs plots are shown. 
 
Cells were gated on CD11chighCD103+ and CD11b expression analysed. Graph 
showing percentage of CD11chighCD103+ DCs not expressing CD11b. Bar indicates 
median. n≥5, from two independent experiments. ns= not significant, * p≤0.01. 
 
10 0 10 1 10 2 10 3 10 4 
10 0 
10 1 
10 2 
10 3 
10 4 
38.8 5.3 
33.6 22.4 
10 0 10 1 10 2 10 3 10 4 
10 0 
10 1 
10 2 
10 3 
10 4 
22.6 1.2 
37.9 38.4 
Spleen 
WT 
p100Δ
10 0 10 1 10 2 10 3 10 4 
10 0 
10 1 
10 2 
10 3 
10 4 41.1 27.9 
8.4 22.6 
10 0 10 1 10 2 10 3 10 4 
10 0 
10 1 
10 2 
10 3 
10 4 
37.6 13.6 
30.5 18.3 
mLN 
10 0 10 1 10 2 10 3 10 4 
10 0 
10 1 
10 2 
10 3 
10 4 
35.2 17.5 
17.5 29.8 
10 0 10 1 10 2 10 3 10 4 
10 0 
10 1 
10 2 
10 3 
10 4 17.3 13.7 
32.5 36.6 
colon 
C
D
10
3 
CD11b 
Gated on CD11chighCD103+ 
Gated on CD11chigh 
% 
Spleen mLN colon 
% CD11b
-
20
40
60
80
100
ns ns
*
Figure 9.2 
 198 
Figure 9.3 CD4/CD8 profile of CD11chigh DCs 
 
Single cell suspensions from spleen, mLN and colon from WT and p100Δ mice where 
analysed for CD4 and CD8 expression on CD11chigh DCs. Cells were gated on B220-
CD3-CD11chigh and the profile of CD4 and CD8 expression analysed. Representative 
FACs plots are shown. 
 
Graph showing the percentage of CD4+CD11chigh and CD8+CD11chigh DCs. Cells 
were gated on B220-CD3-CD11chigh. Bar indicates median. n≥4. ns= not significant. 
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Figure 9.4 Foetal liver cell reconstitutions. 
 
WT mice were lethally irradiated and reconstituted with either WT (CD45.1+, n=4), 
p100Δ (CD45.2+, n=3) or a mixture of WT:p100Δ (n=5) foetal liver cells (FLCs) and 
harvested three months post transfer. Isolated splenocytes were stained with anti-
CD45.1, anti-CD45.2, anti-CD3 and anti-B220 anitobodies, and analysed by flow 
cytometry. Representative FACs plots show the relative populations of transferred 
cells in the host mice. 
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